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SNAREs (soluble N-ethylamaleimide sensitive factor attachment protein receptor) are 
central players in the last stage of vesicle docking and subsequent fusion in diverse 
intracellular membrane transport events. The pairing between the vesicle-associated 
SNARE (v-SNARE) and its cognate target membrane-associated SNARE (t-SNARE) 
facilitates the fusion of these opposing membranes and confers specificity to vesicular 
transport. Since the function of SNAREs is regulated primarily by their localization, it 
is important to understand their targeting mechanisms. The mammalian VAMP 
subfamily (vesicle-associated membrane protein) contains nine SNAREs (VAMP1, 2, 
3, 4, 5, 7 and 8, Ykt6 and Sec22b), most of which function as v-SNAREs. VAMP4 is 
the only VAMP that is located mainly in the trans-Golgi network (TGN). It functions 
in membrane traffic from the sorting and recycling endosomes to the TGN, but its 
trafficking itinerary is unknown. The N-terminal domain preceding the SNARE motif 
of VAMP4 contains an autonomous targeting signal for the TGN, which resides in a 
region consisting of a double-Leu motif followed by two acidic clusters. To find 
which residue(s) within this region participates in regulating the targeting of VAMP4, 
Ala-mutagenesis screening was performed. Immunofluorescence study shows that the 
double-Leu motif and an acidic cluster play essential roles in mediating efficient TGN 
targeting. An antibody internalization assay using C-terminally EGFP-tagged VAMP4 
also shows that VAMP4-EGFP cycles between the PM and the TGN and that its N-
terminal domain participate in regulating this recycling. Results from detailed time-
course analysis of anti-GFP antibody transport to the TGN as well as pharmacological 
and thermal perturbation experiments indicate that VAMP4-EGFP is endocytosed by 
clathrin-dependent pathways. The protein is then transported to the TGN via the 
viii  
sorting and recycling endosomes, but not the late endosome. The double-Leu motif of 
the TGN-targeting signal participates in the internalization of VAMP4-EGFP, 
whereas the acidic cluster is crucial for its efficient endosome-to-TGN transport. Site-
directed mutagenesis in VAMP4-EGFP shows that the negative charge and steric size 
of the phosphorylated Ser-30, which is sandwiched between the two acidic clusters, 
are important for the TGN-to-PM transport of VAMP4-EGFP. These results indicate 
that the TGN-targeting signal of VAMP4 mediates the efficient cycling of VAMP4 


















List of Tables 
 
 Page 
Table 1: List of mammalian SNAREs 



























Figure 1 : Intracellular vesicular transport pathways 
Figure 2 : General stages of vesicular transport 
Figure 3 : General structure of SNARE 
Figure 4 : SNARE core complexes 
Figure 5 : General mode of action of SNARE 
Figure 6 : The schematic illustration of the EGFP-fusion protein 
expression  constructs for VAMP4, VAMP5, V4nV5 and 
mutants of V4nV5  
Figure 7 : The double-Leu motif and the second acidic cluster 
play important role(s) in mediating efficient TGN 
targeting of V4nV5-EGFP 
Figure 8          : VAMP4-EGFP is faithfully targeted to the TGN 
Figure 9 : VAMP4-EGFP is incorporated into an authentic 
SNARE complex        
Figure 10 : The N-terminal extension of VAMP4 mediates its 
recycling from the PM to the TGN 
Figure 11    : VAMP4-EGFP recycles between the PM and the TGN in 
MDCK cells 
Figure 12 : Study the transport of proteins that recycle between the 
PM and intracellular compartments using antibody 
internalization assay 
Figure 13 : Low but detectable amounts of VAMP4-EGFP and 
V4nV5-EGFP are accessible to surface biotinylation 
Figure 14 : Involvement of vesicular intermediates in VAMP4-
EGFP recycling   
Figure 15 : Inhibition of internalization of VAMP4-EGFP by either 
potassium depletion or hypertonic treatment 
Figure 16 : The schematic illustration of the expression constructs 





























Figure 17 : Inhibition of endocytosis of VAMP4-EGFP from the 
PM by a dominant-negative Eps15 mutant 
Figure 18 : Inhibition of VAMP4-EGFP endocytosis in CHC-
depleted cells 
Figure 19 : VAMP4-EGFP recycles through the SE and RE  
Figure 20 : VAMP4-EGFP does not recycle through the LE  
Figure 21 : VAMP4-EGFP and Tac-TGN38 are co-transported 
from the PM to the TGN 
Figure 22 : VAMP4-EGFP recycling is arrested at the peri-Golgi 
RE at 18oC 
Figure 23 : Nocodazole does not affect VAMP4-EGFP recycling 
Figure 24 : Arrest of VAMP4-EGFP recycling in peri-Golgi RE 
when vacuolar ATPase is inhibited by BFLA1 or ConA 
Figure 25 : Rescue of VAMP4-EGFP recycling after treatment 
with BFLA1 or ConA 
Figure 26 : The double-Leu motif and the second acidic cluster 
play important role(s) in mediating efficient recycling of 
V4nV5-EGFP 
Figure 27 : The schematic illustration of the expression  constructs 
of VAMP4-EGFP and its mutants 
Figure 28 : The TGN targeting signal of VAMP4 plays a role in 
mediating VAMP4-EGFP recycling 
Figure 29 : The level of VAMP4-EGFP on the cell surface is 
enhanced by mutation of double-Leu motif as assessed 
by flow cytometry 
Figure 30 : The schematic illustration of expression  constructs of 
various Ser-30 mutants in VAMP4-EGFP context 
Figure 31 : The Ser-30 residue participates in regulating VAMP4-
EGFP transport to the PM 
Figure 32 : A schematic model depicting the recycling pathway of  



































ACTH : Adrenocorticotropic hormone 
ADP : Adenosine diphosphate 
Ala : Alanine (A) 
AP : Adaptor protein complex  
APP : Amyloid precursor protein 
Arf : ADP-ribosylation factor 
Arg : Arginine (R) 
ARH : Autosomal recessive hypercholesterolemia protein 
Arl : Arf-like protein 
Asp : Aspartic acid (D) 
ATP : Adenosine triphosphate 
ATPase: Adenosine triphosphatase 
BACE2: β-site APP-cleaving enzyme 2 
Bet : Block early in transport 
BFA : Brefeldin A 
BFLA1: Bafilomycin A1 
BICD : Bicaudal-D 
BSA : Bovine serum albumin 
CD-M6PR : Cation-dependent M6PR 
CHC : Clathrin heavy chain 
CHO : Chinese hamster ovary 
CI-M6PR : Cation-independent M6PR 
CKII : Casein kinase II 
xiii  
COG : Conserved oligomeric Golgi 
ConA : Concanamycin A 
COP : Coat protein complex  
CORVET: Class C core vacuole/endosome tethering 
Cy : Cyanine dye 
DMEM: Dulbecco’s Modified Eagle’s Medium 
DMSO : Dimethyl sulfoxide 
DNA : Deoxyribonucleic acid 
dNTP : deoxynucleotide triphosphate 
DOI : Digital object identifier 
Dsl1 : Dependent on Sly1-20 protein 1 
DTT : Dithiothreitol 
EDTA : Ethylenediaminetetraacetic acid 
EE : Early endosome  
EEA1 : Early endosome antigen 1 
e.g. : Exempli gratia (meaning: ‘for example’ in Latin) 
EGFP : Enhanced GFP 
EGFR : Epidermal growth factor receptor 
EGTC : ER-Golgi transport container 
EH : Eps15 homology 
EM : Electron microscopy 
ER : Endoplasmic reticulum 
Erd2 : ER retention-defective complementation group 2 
ERGIC: ER-Golgi intermediate compartment 
Eps15 : EGFR pathway substrate clone 15 
xiv  
et al. : et alii (meaning: ‘and others’ in Latin) 
FBS : Fetal bovine serum 
FDB : Fluorescence dilution buffer 
FITC : Fluorescein isothiocyanate 
GARP : Golgi-associated retrograde protein 
GDP : Guanosine diphosphate 
GFP : Green fluorescent protein 
GGA : Golgi-localizing, γ-adaptin ear homology, ARF-binding protein 
Gln : Glutamine (Q) 
Glu : Glutamic acid (E) 
GLUT4: Glucose transporter 4 
GM130: Golgi matrix protein of 130 kD 
GMAP210 : Golgi microtubule-associated protein of 210 kD 
gpI : Glycoprotein I 
GRAB : GRIP-related Art-binding domain 
GRIP : from the names of: Golgin-97, Ran-binding protein 2α, Imh1 and p230 
GST : Glutathione S-transferase 
GTP : Guanosine triphosphate 
GTPase: Guanosine triphosphatase 
HCMV-gB: Human cytomegalovirus glycoprotein B 
HOPS : Homotypic fusion and vacuole protein sorting 
HRP : Horseradish peroxidase 
Hsc70 : Heat shock protein of 70kD 
IF : Immunofluorescence 
IgG : Immunoglobulin G 
xv  
Imh1 : Integrins and myosins homology protein 1 
IP : Immunoprecipitation 
ISG : Immature secretory granule 
kD : kiloDalton 
KIF17 : Kinesin family member 17 
LBPA : Lysobiphosphatidic acid 
LDL : Low-density lipoprotein 
LE : Late endosome 
Leu : Leucine 
LRP3 : LDL receptor-related protein 3 
M6P : Mannose-6-phosphate 
M6PR : M6P receptor 
MDCK: Madin-Darby canine kidney 
MSG : Mature secretory granule 
MT-MMP: Matrix metalloproteinase 
MTOC : Microtubule organizing center 
Munc-18: Mammalian homolog of unc-18 protein 
NE : N-terminal extension 
Nef : Human immunodeficiency negative factor 
NEM : N-ethylmaleimide 
NMDA: N-methyl-D-Aspartic acid 
NRK : Normal rat kidney 
NSF : NEM sensitive factor 
p115 : Protein of 115 kD 
p230 : Protein of 230 kD 
xvi  
PACS-1: Phosphofurin acidic cluster sorting protein 1 
PBS : Phosphate buffered saline 
PBSCM: PBS supplemented with 1mM CaCl2 and 1 mM MgCl2 
PBST : PBS with 0.1% Tween-20 
PBSTM: PBST with 5% nonfat milk 
PC6B : Proprotein convertase 6B 
PCR : Polymerase chain reaction 
PE : Phycoerythrin 
PH : Pleckstrin homology 
Phe : Phenylalanine (F) 
PM : Plasma membrane 
PMSF : Phenylmethylsulphonyl fluoride 
PI(4,5)P2: phosphatidylinositol(4,5) biphosphate 
PTH : Parathyroid hormone 
PTHrP : PTH-related peptide 
Q-SNARE: SNARE with a Gln (Q) residue at the 0 layer 
R-SNARE: SNARE with an Arg (R) residue at the 0 layer 
Rab : ras in the brain 
Ran : Ras-related nuclear protein 
Ras : Rat sarcoma 
RCSB PBB: Research Collaboratory for Structural Bioinformatics Protein Data Bank 
RE : Recycling endosome 
RNA : Ribonucleic acid 
RPMI : Roswell Park Memorial Institute Medium 
Sar : Suppressor of activated ras 
xvii  
SDS : sodium dodecyl sulfate 
SDS-PAGE: SDS polyacrylamide gel electrophoresis 
SE : Sorting endosome  
Sec : Secretory (these proteins are found to be function in the secretory pathway) 
Sed5 : Suppressor of erd2 deletion 5 
Ser : Serine (S) 
scRNA : scramble RNA 
siRNA : short interfering RNA 
Slt1 : SNARE-like tail-anchored protein 1 
Sly1 : Suppressor of loss of Ypt1 protein 1 
SM : Sec1/Munc18  
SNAP : Soluble NSF attachment protein 
SNAP-25: Synaptosome-associated protein of 25 kD 
SNARE: SNAP receptor 
Snc1p : Suppressor of the null allele of CAP 
STX : Syntaxin 
Sulfo-NHS-biotin: Sulfo-N-hydroxysuccinimidobiotin 
t-SNARE: target compartment-associated SNARE 
Tac  : T cell antigen  
Tf-AF555: AlexaFluor 555-conjugated transferring 
Tf-AF647: AlexaFluor 647-conjugated transferrin 
Tf-FITC: FITC-conjugated transferrin 
TfR : Transferrin receptor 
TGN : trans-Golgi network 
TGN38/46: rat TGN protein of 38 kD or its human orthologue of 46 kD 
xviii  
xix  
Thr : Threonine (T) 
TMD : Transmembrane domain 
TNFR1p55: p55 tumor necrosis factor receptor 1 
TRAPP: Transport protein particle 
Unc18 : Uncoordinated protein 18 
UNC-104: Uncoordinated protein 104 
Uso1p : yusou (meaning: transport in Japanese) 
V-ATPase: Vacuolar proton pump 
v-SNARE: vesicle-associated SNARE 
v/v : Volume to volume 
Vac8p : Vacuole partitioning protein 8 
VAMP : Vesicles-associated membrane protein 
VFT : Vps fifty-three 
Vps : Vacuolar protein sorting 
VTC : Vesicular tubular cluster 
Vti1b : Vesicle transport through interaction with the t-SNARE homologue 1b 






1.1 Intracellular vesicular transport pathways  
 
All living beings are made up of cells. Except for bacteria and archaea, which are 
prokaryotes, all other organisms are eukaryotes. While a prokaryotic cell typically 
consists of a single intracellular compartment surrounded by a plasma membrane 
(PM), the intracellular compartment of a eukaryotic cell is further divided into many 
membrane-bounded compartments, or ‘organelles’. Both the PM and the membrane 
surrounding each organelle are composed of a lipid bilayer and a characteristic set of 
proteins. This membrane functions as a barrier to the passage of most polar 
molecules. It ensures that cells and organelles are able to efficiently partition 
macromolecules spatially. Most proteins are synthesized by the ribosomes and then 
delivered to the required organelles. This delivery process usually involves a passage 
through a few membranous compartments, thus forming a transport pathway through 
which the involved organelles communicate with each other. Taken together, 
intracellular transport pathways link all the organelles together. This system not only 
allows macromolecules to be transported between organelles, but also for cells to 
secrete substances into, as well as receive them from the extracellular environment. 
Thus, intracellular transport is important for cells to grow and function normally.  
 
Since the membrane that surrounds either cell or organelle acts as a barrier, cells need 
a transport system that is able to overcome these barriers. The moving of molecules 
across biological membranes is termed ‘membrane transport’. While small molecules 
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such as ions can cross cellular membranes by diffusion or through a variety of 
specialized transmembrane carriers or channels, the transport of macromolecules such 
as proteins occurs in several different ways (Alberts et al., 2008).  
 
The synthesis of most proteins occurs in the cytosol. Their subsequent fate depends on 
whether their amino acid sequence contains specific signals (sorting signals) that 
direct their delivery to certain intracellular locations. There are three types of 
transport by which proteins move from one compartment to another. Proteins move 
between the cytosol and the nucleus through nuclear pore complexes in a process 
termed ‘gated transport’ (Nigg et al., 1991; Silver, 1991; Dingwall and Laskey, 1992). 
In ‘transmembrane transport’, specific proteins are transported from the cytosol across 
a membrane by transmembrane protein translocators into the lumen of certain 
organelles, such as the endoplasmic reticulum (ER) or mitochondria (Glick and 
Schatz, 1991; Blobel and Dobberstein, 1975; Simon, 1993). In the last type, ‘vesicular 
transport’ (or ‘vesicle-mediated transport’), proteins are ferried by membrane-bound 
transport intermediates between organelles. These carriers may be small, spherical 
vesicles or larger, irregular shaped vesicles or tubules. All forms of these cargo 
carriers are generally referred to as ‘transport vesicles’ (Warren, 1990; Pryer et al., 
1992). This thesis focuses on vesicular transport. 
 
The intracellular vesicular transport system forms a complicated network. 
Traditionally, this transport system has been divided into two major pathways: the 
endocytic and the biosynthetic/secretory pathway. Extracellular substances are 
transported inward into the cells along the endocytic pathway, via a process called 
‘endocytosis’. In the opposite direction, newly synthesized proteins and other 
2
macromolecules are transported outward along the biosynthetic/secretory pathway to 
various organelles as well as secreted to the exterior via ‘exocytosis’. However, it is 
now clear that traffic along these pathways is not simply unidirectional. The two 
pathways converge at several points. The traffic along both pathways is also further 
regulated by various retrieval pathways (Alberts et al., 2008). 
 
These intracellular vesicular transport pathways are illustrated in Figure 1. The 
membrane-bound compartments of the eukaryotic cell involved in these pathways 
include the ER, the ER-Golgi intermediate compartment (ERGIC), the Golgi 
apparatus, the sorting endosome (SE) (also known as early endosome or EE), the 
recycling endosome (RE), the late endosome (LE), the lysosome, the plasma 
membrane and various types of  membrane-enclosed transport intermediates (Alberts 
et al., 2008). The lysosome and all the different types of endosome, as well as various 
cell-type specific, lysosome-related organelles (for example, melanosomes or 
cytotoxic granules) are also collectively known as the endosomal-lysosomal system 
(Bonifacino and Rojas, 2006).  
 
1.1.1 The endocytic pathway 
 
The endocytic pathway starts with the process of endocytosis, by which extracellular 
solid matter or liquid is transported (internalized) into cells. In this process, small 
portions of the PM surround the material to be internalized, invaginate and then pinch 
off to form endocytic vesicles containing the ingested material. There are two main 
types of endocytosis categorized based on the size of the endocytic vesicles: 
pinocytosis (‘cellular drinking’), in which fluid and soluble matter are transported into 
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the cell via small vesicles (≤ 150 nm in diameter), and phagocytosis (‘cellular 
eating’), in which large particles such as bacteria or cell debris, are internalized via 
large vesicles (≥ 250 nm in diameter). While virtually all eukaryotic cells continually 
ingest fluid and solutes using pinocytosis, phagocytosis is a process that occurs 
mainly in specialized phagocytic cells (Watts and Marsh, 1992). The term 
‘endocytosis’ mentioned in this thesis henceforth will refer to pinocytosis exclusively. 
 
After being formed, the endocytic vesicles fuse with the SE. Most of the endocytosed 
materials are then often transported to the LE and later end up in the lysosomes, 
where they are digested. However, many endocytosed molecules, especially those that 
are components of the PM, are specifically diverted from this route. In the process of 
endocytosis, extracellular substances are internalized together with the surrounding 
small portions of the PM of eukaryotic cells. The rate at which the PM is internalized 
varies for different cell types, but it is usually rather extensive. Most of the PM 
components that are removed by endocytosis would then be sorted in the SE and 
retrieved by exocytosis to the cell surface, usually through the RE. Thus, the 
processes of endocytosis and exocytosis are linked in a large endocytic-exocytic cycle 
(Alberts et al., 2008).  
 
1.1.2The biosynthetic/secretory pathway 
 
The transport of proteins along the endocytic pathway, which leads inwards toward 
the endosomal-lysosomal system from the PM is counterbalanced by the outward 
flow of transport along the biosynthetic/secretory pathway. In the 
biosynthetic/secretory pathway, newly made proteins first enter the pathway at the 
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ER. The ER has many ribosomes bound to its cytosolic side, which are involved in 
producing all the transmembrane proteins and soluble proteins destined for the 
biosynthetic/secretory pathway. All of these proteins contain specific signal sequences 
that allow them to be translocated into the ER co-translationally by transmembrane 
transport. Subsequent transport from the ER to the Golgi apparatus and from the 
Golgi to the cell surface or elsewhere is mediated by membrane-enclosed transport 
intermediates in vesicular transport (Balch, 1990; Saraste and Kuismanen, 1992).  
 
In the early stage of the biosynthetic/secretory pathway, newly synthesized proteins 
pass through the ER and Golgi system without diversion, except for retrieval of 
certain ER resident proteins. However, as they reach the trans-Golgi network (TGN), 
proteins face several possible destinations: the extracellular space, different domains 
of the PM, secretory vesicles and the endosomal-lysosomal system. According to the 
conventional, TGN-based model for Golgi sorting, proteins destined for different 
destinations are sorted in the TGN into specific sets of membrane-enclosed carriers 
that ferry them to their specific destination (Griffiths and Simons, 1986; Gu et al., 
2001; Rodriguez-Boulan and Musch, 2005). Beside its role as the major transport hub 
of the biosynthetic/secretory pathway, the TGN also receives proteins by retrograde 
transport from the PM and other post-Golgi compartments, most notably the 
endosomes (Rohn et al., 2000).  
 
1.1.3 Retrograde transport to the TGN 
 
Efficient retrograde transport from the endosomes to the TGN is mostly limited to 
specific sets of transmembrane proteins that recycle between these compartments, 
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such as the acid-hydrolase receptors, the transmembrane enzymes, or SNAREs 
(Bonifacino and Rojas, 2006). The acid-hydrolase receptors are proteins that sort 
lysosomal hydrolases to the lysosome or equivalent organelles. The mammalian 
mannose-6-phosphate receptors are the best studied examples of such proteins. There 
are two types of M6PRs in human, known as the cation-independent M6PR (CI-
M6PR) and the cation-dependent M6PR (CD-M6PR). These receptors recognize the 
mannose-6-phosphate (M6P) groups, which are added post-translationally to 
lysosomal hydrolases. M6PRs bind and segregate these enzymes into specific 
transport vesicles that then deliver the M6PR-hydrolase complexes to endosomal 
compartments. The complexes are disassociated in endosomes because of the lower 
pH environment. Lysosomal enzymes are subsequently delivered to the lysosome, 
while M6PRs are retrieved to the TGN along various endosome-to-TGN transport 
pathways (Kornfeld and Mellman, 1989; Traub and Kornfeld, 1997; Gu et al., 2001, 
Ghosh et al., 2003; Medigeshi and Schu, 2003; Lin et al., 2004; Bonifacino and 
Rojas, 2006).  
 
Several other proteins, such as the transmembrane peptidase furin, carboxypeptidase 
D, TGN38/46 (rat trans-TGN protein of 38 kD and its human orthologue of 46 kD), 
or the yeast SNARE (soluble NSF [N-ethylmaleimide (NEM) sensitive factor] 
attachment protein receptor) Snc1p, also undergo retrograde transport from the 
endosomes to the TGN. Most of these proteins, as well as the M6PRs, to some extent, 
also traffic to the PM. They are then endocytosed and retrieved to the TGN via the 
PM-endosome-TGN retrograde pathway (Stanley and Howell, 1993; Ghosh et al., 
1998; Varlamov and Fricker, 1998; Molloy et al., 1999; Mallet and Maxfield, 1999; 
Lewis et al., 2000; Ghosh et al., 2003, Bonifacino and Rojas, 2006). This retrieval 
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pathway is also exploited by certain toxins secreted by bacteria (e.g. Shiga toxin, 
cholera toxin) or plants (e.g. ricin, abrin). These toxins are usually composed of two 
subunits: a subunit that binds to the cell surface, and an enzymatic subunit that causes 
the actual toxic effects by inhibiting essential cytosolic reactions. The toxins bind to 
the cell surface and are internalized into the cells. They then undergo retrograde 
transport to the TGN, where some may be activated by furin (Molloy et al., 1999). 
These toxins can be transported even further back along the biosynthetic/secretory 
pathway, through the Golgi apparatus and eventually to the ER, from which the 
enzyme subunits are ultimately released into the cytosol and lead to harmful reactions 
(Sandvig and van Deurs, 2000, 2002, 2005). 
 
1.2 Vesicular transport 
 
The vesicular transport hypothesis was first proposed by Palade and colleagues in 
their study on protein secretion (Palade, 1975). It was reported that the cargo proteins, 
which are transported along the biosynthetic/secretory pathway, are often found 
enclosed in small, membrane-bounded vesicles scattered among the major organelles 
of the pathway. This gave rise to the hypothesis that cargo proteins are transported 
between organelles of the biosynthetic/secretory pathway by means of shuttling 
transport vesicles. Any given vesicle allows transport between a pair of membrane-
bounded organelles. One organelle (the donor compartment) produces the vesicle 
carrier; while the other organelle (the target compartment) receives the vesicle and its 
cargo. Vesicles are first formed from a donor compartment in a process termed 
‘vesicle budding’. In this process, cargo proteins are specifically selected and 
incorporated into the forming vesicles (‘protein sorting’). The vesicles are 
8
subsequently transported to a specific target compartment (‘vesicle targeting’). At the 
final step, the membranes of the vesicles and the target compartment are merged 
together (‘vesicle fusion’) and the cargo is unloaded into the target organelle. 
 
Parallel to the forward flow of cargo, the components of the transport machinery, 
which were contributed by the donor compartments, as well as escaped resident 
proteins, are retrieved to the donor organelles during retrograde transport. This 
process is also proposed to occur through vesicular transport. All of these processes 
are tightly regulated to ensure the smooth flow of cargo without dramatically affecting 
the composition and identity of the organelles (Bonifacino and Glick, 2004). 
 
Notably, studies from two independent approaches on the molecular mechanisms of 
the vesicular transport have shown that this mechanism is evolutionarily conserved in 
yeast and mammals. The basic membrane transport machinery has been studied using 
both genetic and biochemical approaches (Novick et al., 1980; Balch et al., 1984; 
Wilson et al., 1989; Griff et al., 1992). Subsequent studies using these tools have 
produced more details on the molecular mechanisms of trafficking in the 
biosynthetic/secretory pathway and the related endocytic pathway. Figure 2 illustrates 
the general steps of vesicular transport.  
 
Vesicular transport generally involves four stages: vesicle formation (vesicle 
budding), vesicle movement, vesicle tethering and vesicle docking-fusion. Each stage 
is regulated by a specific set of proteins. These proteins are components of the 
transport machineries. They are grouped into different families, among them the main 
players are: the small GTPases (guanosine triphosphatases), the coat proteins, the 
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Figure 2: General stages of vesicular transport























tethering proteins, the Sec1/Munc18 family, and the SNAREs. These protein families 
are evolutionarily conserved from yeast to man, with paralogous proteins found 
throughout the cell from the ER to the PM. Each vesicle-transport event between 
organelles involves a similar set of proteins drawn from these families. By having 
different members of these families distributed to distinct membrane compartments, 
the specificity of intracellular transport is achieved (Bock et al., 2001; Bonifacino and 
Glick, 2004; Cai et al., 2007a). 
 
1.2.1 Vesicle formation 
 
Vesicle formation is a process in which the flat membrane of the donor compartment 
is deformed into round buds, which then pinch off as vesicles. During this process, 
cargo would also be selectively incorporated into the forming vesicles. Both 
membrane deformation and cargo selection are mediated by protein coats (Rothman 
and Wieland, 1996; Kirchhausen, 2000b; Bock et al., 2001; Bonifacino and 
Lippincott-Schwartz, 2003; Bonifacino and Glick, 2004; Cai et al., 2007a).  
 
A. Protein coats 
 
Coats are large multi-subunit protein complexes. They are dynamic structures that 
cycle on and off the membranes. Subunits are recruited from the cytosol onto the 
donor membranes, where they are assembled stepwise. The assembly of protein coats 
causes membrane deformation and leads to the release of vesicles. The newly formed 
vesicles are encased in coats (coated vesicles), which are later dissociated to allow the 
fusion of uncoated vesicles with the acceptor membrane. The budding process is 
11
generally regulated by members of the small GTPases Arf (Adenosine diphosphate 
[ADP]-ribosylation factor)/Sar (suppressor of activated ras) family. The GTPases 
cycle between the guanosine triphosphate (GTP)- and the guanosine diphosphate 
(GDP)-bound forms. The GTP-bound proteins are membrane-associated and trigger 
coat assembly; whereas the GTP hydrolysis triggers release of the coat (Rothman and 
Wieland, 1996; Bock et al., 2001; Bonifacino and Glick, 2004; Cai et al., 2007a). 
 
There are different coat complexes recruited to different membrane compartments, 
mediating the biogenesis of transport vesicles at specific transport steps. Clathrin was 
the first coat protein to be identified (Pearse, 1975). This coat functions in post-Golgi 
transport, at the PM, the TGN and endosomes (Bonifacino and Glick, 2004; Owen et 
al., 2004). Subsequent studies reported two other coats: COPI (coat protein complex 
I) and COPII. These mediate vesicular transport in the early secretory pathway 
(Waters et al., 1991; Barlowe et al., 1994; Letourneur et al., 1994). COPI mediates 
retrograde traffic from the Golgi to the ER as well as intra-Golgi transport 
(Letourneur et al., 1994). The anterograde transport from the ER to either the ERGIC 
or the Golgi complex is mediated by COPII (Barlowe et al., 1994). 
 
The assembly/disassembly of COPI and COPII coats is mostly regulated by the small 
GTPases Arf1 (for COPI) and Sar1 (for COPII). In their GTP-bound forms, these 
proteins bind directly and recruit the cytosolic coat subunits to the donor membrane, 
where they assemble into spherical coats, budding off vesicles in the process (Serafini 
et al., 1991; Donalson et al., 1992a, 1992b; Helms and Rothman, 1992; Ostermann et 
al., 1993; Barlowe et al., 1994; Hara-Kuge et al., 1994; Huang et al., 2001; 
Lederkremer et al., 2001; Bi et al., 2002). After budding, the bound GTP is 
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hydrolyzed, leading to the disassociation of Arf/Sar1. The coat becomes unstable and 
disassembles (Tanigawa et al., 1993; Barlowe et al., 1994).  
 
Clathrin coats are assembled similarly to COPI and COPII. GTP-bound Arf and/or 
phosphatidylinositol derivatives are required for the assembly of clathrin coats on the 
membrane (Stamnes and Rothman., 1993; Traub et al., 1993). They recruit a variety 
of cytosolic clathrin ‘adaptors’ onto the membrane (Bonifacino and Lippincott-
Schwartz, 2003; Wang et al., 2003). These adaptors are proteins that are able to bind 
both clathrin and cargo proteins. These are a heterogenous group, from the 
heterotetrameric adaptor protein (AP) complexes such as AP-1, AP-2, AP-3 and AP-4 
to the monomeric proteins like stonins, or GGAs (Golgi-localizing, γ-adaptin ear 
homology, ARF-binding proteins) (Pearse, 1975; Andrews et al., 1996; Dell’Angelica 
et al., 1998; Kirchhausen, 1999; Kirchhausen, 2000a; Boman et al., 2000; 
Dell’Angelica et al., 2000; Hirst et al., 2000; Poussu et al., 2000; Takatsu et al., 2000; 
Martina et al., 2001; Walther et al., 2001; Barois and Bakke, 2005). These adaptors 
then recruit clathrin to the vesicle budding sites. The clathrin-coat assembly process is 
regulated by an ensemble of kinases, phosphatases, and other accessory proteins 
(Lafer, 2002). Clathrin and clathrin-adaptor complexes can polymerize into spherical, 
cage-like structures, indicating that they are able to deform flat membranes into buds 
(Kirchhausen and Harrison, 1981). Clathrin coats are intrinsically stable even after 
Arf dissociation, unlike the COP coats (Woodward and Roth, 1978; Kartenbeck, 
1978). Thus, the uncoating of clathrin vesicles is additionally regulated by a cytosolic 
70 kD heat shock protein (Hsc70) and auxilin (Rothman and Schmid, 1986; 
Ungewickell et al., 1995).  
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B. Cargo selection 
 
Protein coats also participate in cargo selection through the recognition of sorting 
signals present in the selected cargo. A sorting signal is a structural feature of a given 
protein that determines if the protein is sequestered into a given vesicle, and thus be 
transported to certain destinations. Sorting signals are most often short peptides 
comprised of 4 to 25 residues (Pfeffer and Rothman, 1987; Baranski et al., 1991). A 
given protein can have multiple sorting signals, each specifying the traffic route of 
that protein at certain stages of transport. The combined effects of these signals would 
eventually determine the localization of that protein (Rothman and Wieland, 1996).  
 
A sorting signal that restricts the entry of a protein into a vesicle is termed a ‘retention 
signal’. These signals are compartment specific and they have been found in the 
transmembrane domains of a number of integral membrane proteins (Tang et al., 
1992; Machamer, 1993; Nilsson et al., 1991; Nilsson and Warren, 1994). It has been 
proposed that these signals may either cause protein aggregation or participate in the 
interaction between the transmembrane domains and the lipid bilayers; thus leading to 
the retention of proteins in certain compartments (Pfeffer and Rothman, 1987; 
Baranski et al., 1991; Machamer, 1991; Bretscher and Munro, 1993; Nilsson et al., 
1993, 1994; Rothman and Wieland, 1996). However, it is to be noted that other 
studies have also shown that retention signals have been found in regions other than 
the transmembrane domains (Dahdal and Colley, 1993; Burke et al., 1994, Graham 




A sorting signal that is responsible for the incorporation of a protein into a budding 
vesicle is termed a ‘transport signal’ (Rothman and Wieland, 1996). For membrane 
proteins, transport signals that are located in the cytoplasmic domain of cargo proteins 
bind directly to coat proteins (Pearse, 1988). For example, the tyrosine-based signal 
present in the cytoplasmic tail of the low-density lipoprotein (LDL) receptor interacts 
with ARH (autosomal recessive hypercholesterolemia protein), a clathrin adaptor (He 
et al., 2002; Mishra et al., 2002). Transport signals that are not exposed to the cytosol 
(such as the case with soluble cargo proteins) bind to the luminal domain of 
specialized transmembrane cargo receptors. These receptors possess a cytoplasmic 
domain that, in turn, contains a transport signal that binds to the coat (Anderson et al., 
1977; Appenzeller et al. 1999; Muniz et al. 2000; Powers and Barlowe, 2002). The 
LDL receptor is one such example. It binds to extracellular LDL and as the receptor is 
packaged into clathrin-coated vesicles, LDL would be carried into the cell together 
with the receptor (Anderson et al., 1977). This, in brief, illustrates the notion of 
receptor-mediated endocytosis. 
 
1.2.2 Vesicle movement 
 
After budding, vesicles are transported to their target compartments. The vesicles are 
usually driven along cytoskeleton tracks by motor proteins such as myosin, dynein or 
kinesin. Kinesin and dynein are two major superfamilies of microtubule motor 
proteins, and myosin is responsible for the transport along actin tracks (Hammer and 
Wu, 2002; Matanis et al., 2002; Short et al., 2002; Vale, 2003; Miki et al., 2005). 
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Many motor proteins are able to interact with cargo proteins through indirect 
associations, such as via adaptor or scaffolding proteins. For example, kinesin KIF17 
(kinesin family member 17) interacts with the vesicle-bound cargo, the N-methyl-D-
Aspartic acid (NMDA) receptor, through an association mediated by three adaptor 
proteins: mLin-10, mLin-2 and mLin-7 (Hirokawa and Takemura, 2005). Similarly, 
the scaffold protein gephyrin links dynein to the glycine receptor (Maas et al., 2006). 
These interactions link vesicles to the cytoskeleton tracks, along which they are 
driven. 
 
Vesicles can also be linked to the cytoskeleton via the association of their membrane 
lipids with motor proteins. For example, kinesin UNC-104 binds directly to 
phosphatidylinositol (4,5) biphosphate (PI(4,5)P2) via a pleckstrin homology (PH) 
domain; whereas dynein associates with membrane lipids through its accessory 
complex, dynactin, and the cytoskeletal protein spectrin (Holleran et al., 2001; 
Muresan et al., 2001; Klopfenstein et al., 2002). 
 
The family of small GTPases Rab (ras in the brain) (or Ypt [yeast protein transport] in 
yeast) is a class of potential regulators of motor proteins recruitment to the vesicles. 
Rab proteins form the largest subfamily of the Ras superfamily of monomeric, small 
GTPases. Members of the Rab family are specifically distributed at distinct 
intracellular compartments and facilitate the specificity of vesicular trafficking (Zerial 
and McBride, 2001; Deneka et al., 2003). Like all other GTPases, Rabs function as 
molecular switches that oscillate between a GTP, membrane-bound, active state and a 
GDP, cytosolic, inactive state. The active conformation recruits a set of proteins, 
loosely termed Rab effectors (Novick and Zerial, 1997; Ali and Seabra, 2005), which 
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includes motor proteins. For example, the actin-based motor myosin-V is specifically 
recruited to melanosomes by melanophilin and GTP-bound Rab27a (Seabra and 
Coudrier, 2004), and Rab6 regulates the recruitment of the dynein-dynactin complex 
to the Golgi (Short et al., 2002). Through their ability to cycle on/off the membrane, 
their specific membrane localization, and their effectors, Rab proteins provide specific 
spatial and temporal regulation of vesicular transport (Zerial and McBride, 2001). 
 
1.2.3 Vesicle tethering 
 
The third step in vesicular transport is tethering. ‘Vesicle tethering’ is a term that 
broadly describes the events that target vesicles to specific membrane domains and 
precede the pairing of SNAREs. Tethering is believed to represent the first point of 
contact between a vesicle and its target membrane (Waters and Pfeffer, 1999; Derby 
and Gleeson, 2007; Cai et al., 2007a). Tethering proteins, termed tethers or tethering 
factors, have been identified in nearly all membrane trafficking events (Whyte and 
Munro, 2002; Sztul and Lupashin, 2006). Tethers are also found to be able to interact 
with a number of other key transport proteins such as SNARE, coat proteins, small 
GTPases or cytoskeleton proteins. They could also participate in other steps of 
vesicular transport (Lupashin and Sztul, 2005; Cai et al., 2007a; Derby and Gleeson, 
2007). Tethers have been shown to be comprised of either long coiled-coil protein or 
large multisubunit complexes (Gillingham and Munro, 2003; Oka and Krieger, 2005; 
Derby and Gleeson, 2007; Cai et al., 2007a). Together with small GTPases, most 
notably those of the Rab/Ypt family, tethers play a critical role in mediating the 
specificity of vesicle transport.  
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Long coiled-coil tethers are among the first tethering factors identified. Most of these 
proteins are peripheral membrane proteins and most are associated with the Golgi 
apparatus (termed ‘golgins’) or endosomes. These include the endosomal protein 
EEA1 (early endosome antigen 1), p115/Uso1p, GM130 (Golgi matrix protein of 130 
kD), giantin and a number of other golgins (Nakajima et al., 1991; Nakamura et al., 
1995; Sapperstein et al., 1995; Simonsen et al., 1998; Moyer et al., 2001; Sonnichsen 
et al., 1998; Barr and Short, 2003; Gillingham and Munro, 2003; Lupashin and Sztul, 
2005; Derby and Gleeson, 2007). All of the long coiled-coil tethers described to date 
are implicated in Golgi and endosomal trafficking. For example, yeast protein Uso1p 
(yusou means transport in Japanese) is involved in ER-to-Golgi transport, as it tethers 
the ER-derived COPII-coated vesicle to the Golgi (Nakajima et al., 1991; Sapperstein 
et al., 1996; Barlowe, 1997; Cao et al., 1998). The mammalian homologue of Uso1p, 
p115 (protein of 115 kD), is located at the cis-Golgi, COPII-coated vesicles, and the 
vesicular tubular clusters (VTCs) (Nelson et al., 1998; Allan et al., 2000), and 
participates in a number of tethering events. It promotes the clustering of COPII-
coated vesicles to form VTCs and tethers VTCs and COPII vesicles to the cis-Golgi 
membranes (Alvarez et al., 1999, 2001; Allan et al., 2000; Moyer et al., 2001) 
through its interaction with the golgin GM130 (Nakamura et al., 1997; Alvarez et al., 
2001; Moyer et al., 2001). p115 is also required for intra-Golgi transport (Waters et 
al., 1992; Sapperstein et al., 1995), possibly through tethering COPI-coated vesicles 
to the cis-Golgi in retrograde transport, via its interaction with both GM130 and 
giantin (Sonnichsen et al., 1998; Lesa et al., 2000). Furthermore, p115 is also shown 
to be required for the reassembly of the Golgi apparatus after mitosis (Levine et al., 
1996; Shorter and Warren, 1999; Dirac-Svejstrup et al., 2000) and for the 
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maintainence of a stable Golgi structure (Alvarez et al., 1999; Puthenveedu and 
Linstedt, 2001, 2004; Sohda et al., 2005)  
 
Tethering proteins could also take the form of multisubunit complexes (Whyte and 
Munro, 2002; Lupashin and Sztul, 2005; Cai et al., 2007a). There are eight tether 
complexes described to date, including the conserved oligomeric Golgi (COG), 
GARP/VFT (Golgi-associated retrograde protein/Vacuolar protein sorting [Vps] fifty 
three), HOPS (homotypic fusion and vacuole protein sorting, also known as Class C 
Vps), transport protein particle I (TRAPPI), TRAPPII, CORVET (class C core 
vacuole/endosome tethering), Dsl1 (dependent on Sly1-20 protein 1) and the exocyst 
complexes (TerBush et al., 1996; Andag et al., 2001; Peterson and Emr, 2001; Ungar 
et al., 2002; Seals et al., 2000; Sacher et al., 1998, 2001; Conibear et al., 2003; 
Peplowska et al., 2007). These tethers participate in a number of membrane 
trafficking events, some acting at only one step, while others may participate in more 
than one. For example, the GARP/VFT complex tethers vesicles which originating 
from endosomes onto the late Golgi membrane (Conibear and Stevens, 2000; 
Conibear et al., 2003). The exocyst, one of the best characterized tethering 
complexes, has been implicated in many trafficking events. It is important for yeast 
polarized growth, tethering transport vesicles to the growing bud during the cell cycle 
(TerBush et al., 1996; Guo et al., 1999). In mammalian cells, the exocyst is 
implicated in polarized transport of vesicles to the basolateral, but not the apical, 
surface of MDCK (Madin-Darby canine kidney) cells (Grindstaff et al., 1998). It also 
takes part in many (but not all) transport events to the PM, including both Golgi-to-
PM and endosome-to-PM trafficking (Whyte and Munro, 2001; Munson and Novick, 
2006). It is still not clear if multisubunit complexes function as a single complex or 
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separate subcomplexes. It also remains to be determined whether individual tethering 
events are regulated by either long coiled-coil tethers or multisubunit complexes, or 
both. However, the results so far imply that tethering is a multistep process that is 
mediated through the interactions of tethers with coat proteins, small GTPases, 
cytoskeleton and SNAREs (Derby and Gleeson, 2007; Cai et al., 2007a). 
 
The Rab family of small GTPases is one of the main players in membrane tethering. 
In their active, GTP-bound form, Rab proteins facilitate the recruitment of tethers to 
specific locations. For example, Rab1 interacts with a number of golgins, such as 
p115, GM130 or Golgin-84. It recruits these tethers to their respective membranes and 
mediates the tethering of both COPI- and COPII-coated vesicles to the cis-Golgi. The 
exocyst complex is another well-studied Rab effector. It is required for tethering post-
Golgi and recycling vesicles to the PM (TerBush et al., 1996; Munson and Novick, 
2006). Two subunits of the exocyst complex, Sec3p and Exo7p, are located at the PM; 
while others are delivered to exocytic sites on post-Golgi vesicles (Finger et al., 1998; 
Boyd et al., 2004). The recruitment of these subunits to the vesicles is mediated by the 
Rab protein Sec4p (Guo et al., 1999). The exocyst complex is assembled when the 
post-Golgi vesicles are tethered to the PM (Boyd et al., 2004). 
 
Other small GTPases of the Arf and Arl (Arf-like protein) have also been shown to 
interact with tethering proteins. Arl1 recruits Golgin-97 and Golgin-245 (or p230) to 
the TGN through its interaction with their GRIP domains (Golgin-97, Ran-binding 
protein 2α, Imh1 and p230) (Lu and Hong, 2003; Panic et al., 2003a; Wu et al., 2004). 
The multisubunit complex tethering factor GARP is another effector of Arl1 (Panic et 
al., 2003b). Another tether, GMAP210 (Golgi microtubule-associated protein of 210 
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kD) is recruited to the cis-Golgi by Arf1 through a GRIP-related Arf-binding domain 
(GRAB) at the C-terminal region (Gillingham et al., 2004). 
 
Other studies have also shown that tethering factors can interact with coat proteins. 
Both mammalian and yeast COG show specific interactions with COPI subunits, 
suggesting that the COG complex tethers COPI vesicles during retrograde transport 
(Suvorova et al., 2002; Zolov and Lupashin, 2005). Another multi-subunit tether, 
TRAPPI, binds directly to COPII vesicles (Sacher et al., 2001). A TRAPPI subunit, 
Bet3, interacts with the COPII subunit Sec23 and mediates vesicle tethering (Cai et 
al., 2007b). These findings imply that vesicles are not uncoated until the coat is 
recognized by a specific tether. They also indicate a connection between vesicle 
tethering and cargo recognition, thus providing a mechanism to maintain the 
directionality of vesicle transport. 
 
Besides tethering two membranes together, some tethering factors also link 
membranes to the cytoskeleton. Bicaudal-D1 (BICD1) and –D2 (BICD2) are located 
to the TGN and cytoplasmic vesicles. They are associated with membranes in a Rab6-
dependent manner. BICDs bind the cargo via their C-terminal region and interact with 
the dynein-dynactin motor complex via their N-terminal portion, thus linking the 
vesicles to the cytoskeleton and mediate COPI-independent ER-Golgi transport 
(Hoogenraad et al., 2001; Matanis et al., 2002; Short et al., 2002). 
 
Vesicle tethering occurs prior to the pairing of SNAREs and the subsequent vesicle 
fusion. Many tethers have been found to interact directly or indirectly with SNARE 
proteins (Allan et al., 2000; Shorter et al., 2002; Suvorova et al., 2002; Kraynack et 
21
al., 2005; Zolov and Lupashin, 2005; Stroupe et al., 2006). It has been suggested that 
the tethering factors may bring the vesicle to closer contact with the target 
compartment and increase the probability of the pairing of the shorter SNAREs, 
which then leads to fusion (Malsam et al., 2005). Alternatively, tethers may also 
stimulate the formation of trans-SNARE complexes and promote membrane fusion 
(Shorter et al., 2002). The tethering factor p115 interacts with a select set of COPII 
vesicle-associated SNAREs, including syntaxin 5 (STX5) and GS27 (Golgi SNARE 
of 27 kD) (Allan et al., 2000). The recruitment of p115 to the COPII vesicles is 
dependent on SNAREs and is necessary for vesicle tethering as well as VTC 
formation (Bentley et al., 2006; Brandon et al., 2006). At the same time, the N-
terminal coiled-coil domain of p115 also stimulates SNARE complex assembly 
(Shorter et al., 2002). Hence, p115 not only tethers vesicles onto the target 
compartment through an interaction with SNAREs, but also facilitates SNARE-
mediated membrane fusion. 
 
In summary, tethers appear to work in conjunction with Rab GTPases, coat proteins 
and SNAREs to mediate the targeting to the intracellular destination of a transport 
vesicle. 
 
1.2.4 Vesicle docking-fusion 
 
The final step in vesicular transport is docking-fusion. ‘Vesicle docking’ describes the 
events that proceed from vesicle tethering, at the distance of less than 25 nm from the 
target membrane, prior to fusion. ‘Vesicle fusion’ is the term for events that lead to 
the complete mixing of the two lipid bilayers in apposition: the vesicle membrane and 
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the target compartment membrane (Jahn and Scheller, 2006). Vesicle docking-fusion 
mostly involves a regulated interaction between membrane bound SNARE proteins 
(Rothman and Wieland, 1996; Lin and Scheller, 2000; Hong, 2005; Jahn and Scheller, 
2006). The role of SNARE as a key regulator of vesicle docking-fusion will be 
discussed in details in the following section. 
 
1.3 SNAREs in vesicular transport 
 
Although the term ‘SNARE’ was coined in 1993 (Sollner et al., 1993b), the study of 
SNARE proteins and its regulators started much earlier during the late 1980s 
(reviewed by Jahn and Scheller, 2006). Biochemical studies using a cell-free intra-
Golgi transport assay (Fries and Rothman, 1980; Balch et al., 1984) first led to the 
identification and purification of an N-ethylmaleimide (NEM)-sensitive factor (NSF) 
based on its ability to restore transport between Golgi cisternae (Glick and Rothman, 
1987; Block et al., 1988). Further studies showed that NSF is required for the fusion 
of transport vesicles with the target membrane (Malhotra et al., 1988; Orci et al., 
1989). The association of NSF to the membrane requires co-factors in the form of 
soluble NSF attachment proteins (SNAPs), and integral membrane proteins, which 
serve as the receptors for SNAPs (Weirdman et al., 1989; Clary and Rothman, 1990; 
Clary et al., 1990; Wilson et al., 1992; Whiteheart et al., 1992). NSF only binds to 
SNAP in the presence of the integral membrane receptor, resulting in a 20S 
multisubunit protein complex, which is suggested to function as a ‘fusion machine’ 
(Wilson et al., 1992). Once formed, this 20S complex would then subsequently 
disassemble in a process that requires ATP (Adenosine triphosphate) hydrolysis. On 
the basis of the assembly and disassembly of the 20S multisubunit complex, pure 
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recombinant NSF and SNAPs were used to isolate putative SNAP receptors 
(SNAREs) from a crude bovine brain membrane fraction (Sollner et al., 1993b). 
Interestingly, the principal proteins isolated from this affinity purification assay had 
been reported previously as proteins associated with the neuronal synapse: syntaxin 
(Bennett et al., 1992), SNAP-25 (synaptosome-associated protein of 25 kD) (Oyler et 
al., 1989) and synaptobrevin/VAMP2 (vesicles-associated membrane protein 2) 
(Elferink et al., 1989; Sudhof et al., 1989). 
  
At the same time, evidence from another independent approach has strongly 
suggested that these synapse-related proteins are involved in the neuronal exocytosis. 
Several studies have found that VAMP/synaptobrevin, syntaxin as well as SNAP-25 
are proteolyzed by the botulinum and tetanus neurotoxins, indicating that these 
powerful neuronal exocytosis inhibitors block membrane fusion by cleaving the 
neuronal SNAREs (Schiavo et al., 1992, 1993; Blasi et al., 1993a, 1993b). Since 
VAMP/synaptobrevin is found on synaptic vesicles (Baumert et al., 1989; Elferink et 
al., 1989; Sudhof et al., 1989) while syntaxin is found on the presynaptic plasma 
membrane (Bennett et al., 1992), the implication that they belong to the fusion 
complex suggests a simple mechanism for vesicle targeting and fusion. In this model, 
the interaction between the two complimentary SNAREs on the opposite membranes 
would initiate and facilitate their fusion (Sollner et al., 1993b). This fusion 
mechanism is not limited to the synapse, since the components of the 20S complex 
appear to be found in all eukaryotic cells, from yeast to neuron (Bennett and Scheller, 
1993; Ferro-Novick and Jahn, 1994).  
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An earlier screening study for temperature-sensitive trafficking mutants in 
Saccharomyces cerevisae has reported 23 gene products that are required for the 
transport of secretory proteins from the site of synthesis to the cell surface (Novick et 
al., 1980). Among these were mutations of SEC18, the gene encoding the yeast 
homologue of NSF (Eakle et al., 1988; Wilson et al., 1989); and of SEC17, the gene 
encoding the yeast homologue of α-SNAP (Clary et al., 1990; Griff et al., 1992); as 
well as mutations of SEC20 and SEC22, which were later reported to encode SNARE 
homologues (Dascher et al., 1991; Newman et al., 1992; Lewis et al., 1997). Since 
then, the SNARE superfamily has grown rapidly. SNARE proteins have now been 
found in all eukaryotic cells and are implicated in regulating membrane fusion in 
most, if not all, transport steps along the intracellular trafficking pathways (Chen and 
Scheller, 2001; Jahn et al., 2003; Hong, 2005).  
 
1.3.1 General structure of SNAREs 
 
There are 41 reported mammalian SNARE proteins at the moment (Hong, 2005; Holt 
et al., 2006; Okamura et al., 2006; Stow et al., 2006; Kloepper et al., 2007 and 
summarized in Table 1). These are generally small proteins of around 100-300 amino 
acids, with a simple domain structure, characterized by the presence of an 
evolutionarily conserved domain, termed the ‘SNARE motif’ (Weimbs et al., 1997; 
Fasshauer et al., 1998). In most SNARE proteins, the SNARE motif is usually located 
adjacent to a single C-terminal transmembrane domain, which anchors the protein on 
the cytoplasmic side of the membrane. Many SNAREs also contain an extended N-
terminal region preceding the SNARE motif. The lengths and structures of this N-
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Table 1: List of mammalian SNAREs 
 
Name Type TM domain N-terminal region Localization References 
Syntaxin 1 Qa Yes Habc with preceding N-terminal domain PM Hong, 2005 
Syntaxin 2 Qa Yes Habc with preceding N-terminal domain PM Hong, 2005 
Syntaxin 3 Qa Yes Habc with preceding N-terminal domain PM Hong, 2005 
Syntaxin 4 Qa Yes Habc with preceding N-terminal domain PM Hong, 2005 
Syntaxin 5 Qa Yes Habc with preceding N-terminal domain Golgi Hong, 2005 
Syntaxin 6 Qc Yes Habc   TGN and Endosome Hong, 2005 
Syntaxin 7 Qa Yes Habc with preceding N-terminal domain EE and LE Hong, 2005 
Syntaxin 8 Qc Yes Habc   EE and LE Hong, 2005 
Syntaxin 10 Qc Yes Habc   TGN  Hong, 2005 
Syntaxin 11 Qa No Habc with preceding N-terminal domain TGN and LE Hong, 2005 
Syntaxin 13 Qa Yes Habc with preceding N-terminal domain EE   Hong, 2005 
Syntaxin 16 Qa Yes Habc with preceding N-terminal domain TGN Hong, 2005 
Syntaxin 17 Qa Yes Habc with preceding N-terminal domain ER Hong, 2005 
Syntaxin 18 Qa Yes Habc with preceding N-terminal domain ER Hong, 2005 
Syntaxin 19 Qa No Habc with preceding N-terminal domain ND Kloepper et al., 2007 
Syntaxin 20 Qa Yes Habc with preceding N-terminal domain ND Kloepper et al., 2007 
Syntaxin 21 Qa Yes Habc with preceding N-terminal domain ND Kloepper et al., 2007 
SNAP-23 Qb and Qc No Short, presumably unstructured PM Hong, 2005 
SNAP-25 Qb and Qc No Short, presumably unstructured PM Hong, 2005 
SNAP-29 Qb and Qc No Short, presumably unstructured Golgi and Endosome Hong, 2005 
SNAP-47 Qb and Qc No 
Longer than other Qbc SNARE, structure 
ND 
Synaptic vesicle and other 
intracellular membranes Holt et al., 2006 
VAMP1 R Yes Short, presumably unstructured Synaptic vesicles Hong, 2005 
VAMP2 R Yes Short, presumably unstructured Synaptic vesicles Hong, 2005 
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Name Type TM domain N-terminal region Localization References 
VAMP3 R Yes Short, presumably unstructured EE and RE Hong, 2005 
VAMP4 R Yes TGN targeting signal TGN and EE Hong, 2005 
VAMP5 R Yes Short, presumably unstructured PM Hong, 2005 
VAMP7 R Yes Longin domain LE and Lysosome and PM Hong, 2005 
VAMP8 R Yes Short, presumably unstructured EE and LE Hong, 2005 
Ykt6 R No Longin domain Golgi Hong, 2005 
Sec22a ND Yes Longin domain ER and ERGIC Hong, 2005 
Sec22b R Yes Longin domain ERGIC and cis-Golgi Hong, 2005 
Sec22c ND Yes Longin domain ER and ERGIC Hong, 2005 
Bet1 Qc Yes Short, presumably unstructured ERGIC and cis-Golgi Hong, 2005 
GS15 Qc Yes Short, presumably unstructured Golgi Hong, 2005 
GS27 Qb Yes Habc   ERGIC and Golgi Hong, 2005 
GS28 Qb Yes Habc   Golgi Hong, 2005 
Vti1a Qb Yes Habc   trans-Golgi Hong, 2005 
Vti1b Qb Yes Habc   EE and LE Hong, 2005 
Slt1 Qc Yes ND ER Hong, 2005 
Sec20 ND Yes ND ER Hong, 2005 
D12 ND Yes ND, similar to Slt1 
ER and ERGIC,  
(post-Golgi also?) Okamura et al., 2006 
 
 
ND: Not determined 
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terminal region vary between the subgroups of the SNARE superfamily (Table 1 and 
Figure 3). 
 
A. The SNARE motif 
 
The SNARE motif is the signature motif of all SNARE proteins. It is a conserved 
domain of around 60-70 amino acids that are arranged in heptad repeats and form 
coiled-coil structures (Chen and Scheller, 2001; Jahn and Scheller, 2006). This motif 
is one of the main factors that mediate the function of SNARE in membrane fusion. 
Most SNAREs contain a single SNARE motif that is immediately adjacent to a C-
terminal transmembrane domain anchor. However, there are four SNARE proteins 
(SNAP-23, SNAP-25, SNAP-29 and SNAP-47) that harbor two tandem SNARE 
motifs separated by a linker region (Table 1 and Figure 3). 
 
Monomeric SNARE motifs are unstructured in solution. However, when appropriate 
sets of SNAREs are combined, the SNARE motifs could self-assemble to form highly 
organized, extraordinarily stable SNARE core complexes (Fasshauer, 2003). The 
crystal structures of three, only distantly related SNARE core complexes, show 
remarkable similarities (Figure 4A, 4B and 4C) (Sutton et al., 1998; Antonin et al., 
2002b; Zwilling et al., 2007). In these complexes, the SNARE motifs are aligned as 
elongated, parallel coiled-coils to form a four-helix bundle with each SNARE motif 
contributing one helix. Within the interior of the SNARE core complex, the four 
helices are connected by 16 layers of interacting side chains (Figure 4D). These layers 
are mostly hydrophobic, except for the central layer (termed as the 0 layer) that is 
highly conserved and composed of four polar residues, including three glutamine (Gln 
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NE SNARE TMD
VAMP1, 2, 3, 5, 8, GS15, Bet1
SNAP-25, SNAP-23, SNAP-29, SNAP-47
Linker region
Ha Hb Hc STX11, 19
Ha Hb Hc STX1, 2, 3, 4, 5, 7, 13, 16, 17, 18, 20, 21 
N C
Ha Hb Hc STX6, 8, 10, Vti1a, Vti1b, GS27, GS28








Undetermined Slt1, Sec20, D12
NE
 












































Figure 4: SNARE core complexes
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A: Ribbon diagram of the synaptic SNARE complex (Sutton et al., 1998; raw data obtained from Research Collaboratory
 
for 





Scientific LLC, CA, USA]). This complex contains the SNARE motifs of STX1 (Qa; red), SNAP-25 (Qb
 
[green] and Qc 
[cyan]), and VAMP2 (R; blue). The C-terminal ends of the helices, which are all point towards the membrane, are oriented to 
the right.




et al., 2007; raw data obtained from RSCB PDB, DOI: 
2nps; and subjected to PyMol).
 
This complex contains the SNARE motifs of STX13 (Qa; red), Vti1a (Qb; green), STX6 (Qc; 
cyan) and VAMP4 (R; blue). The C-terminal ends of the helices, which are all point towards the membrane, are oriented to the 
right.




et al., 2002b; raw data obtained from RSCB PDB, DOI: 1gl2; 
and subjected to PyMol).
 
This complex contains the SNARE motifs of STX7 (Qa; red), Vti1b (Qb; green), STX8 (Qc; cyan) and 
VAMP8 (R; blue). The C-terminal ends of the helices, which are all point towards the membrane, are oriented to the right.
D: The diagram of the organization of the synaptic SNARE complex (obtained and modified with permission from Kloepper
 
et al., 2007, http://www.molbiolcell.org/cgi/content/full/18/9/3463). The ribbon diagram of the complex in 4A is shown with the 
helical axes highlighted by lines of the same colour
 
as the helixes. The layers of interacting side chains are numbered and 
indicated by virtual bonds between corresponding Cα
 
positions. 





This layer is composed of the side chains from one Arg (R; 
VAMP2, blue) and three Gln (Q: Qa, STX1, red; Qb, SNAP-25N, dark green; and Qc, SNAP-25C, light green)
Figure 4: SNARE core complexes
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or Q) residues and one arginine (Arg or R) residue (Figure 4E). Thus, SNAREs are 
structurally classified as Q- or R-SNAREs, depending on the residue at the 0 layer 
(Weimbs et al., 1997; Fasshauer et al., 1998).  
 
Based on their positions within the four-helix bundle, the Q-SNAREs can be further 
classified into Qa-, Qb-, and Qc-SNAREs. In reference to the neuronal SNARE core 
complex structure (Sutton et al., 1998), the Qa subfamily comprises those with the 
SNARE motif structurally homologous to that of STX1. The Qb and Qc subfamilies 
comprise those that are homologous to the N-terminal and C-terminal SNARE motif 
of SNAP-25, respectively (Fasshauer et al., 1998; Bock et al., 2001; Table 1). The 
SNARE superfamily may therefore be structurally classified into four major 
subfamilies: Qa-, Qb-, Qc-, and R-SNAREs, based on the amino acid sequence 
homologies of the SNARE domains. Hence, the SNARE core complexes are also 
termed ‘QabcR-complexes’ (Bock et al., 2001). A phylogenetic analysis of SNARE 
sequences showed that these subfamilies are highly conserved and diverged early 
during eukaryotic evolution (Bock et al., 2001; for review see Hong, 2005; Jahn and 
Scheller, 2006). 
 
Besides this QabcR combination, SNARE motifs can also assemble into other types 
of helical bundles although they are usually less stable than a typical core complexe 
(Margittai et al., 2001; Weninger et al., 2003). Notably, it has been reported that 
complexes assembled exclusively from Q-SNARE motifs are structurally possible and 
able to function in vivo (Katz and Brennwald, 2000; Ossig et al., 2000). Regardless, 
physiological complexes normally include one, and only one, R-SNARE (Pelham, 
2001; Jahn et al., 2003). It is now generally believed that functional SNARE 
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complexes in membrane fusion are hetero-oligomeric, parallel four-helix bundles, 
with Qa:Qb:Qc:R configuration.   
 
B. The transmembrane domain 
 
Most SNARE proteins have a single transmembrane domain (TMD) at their C-
terminal ends. This transmembrane domain is connected to the SNARE motif by a 
short linker. The TMD anchors SNARE protein on the cytoplasmic side of the 
membrane so that the rest of the protein is exposed into the cytoplasm (Hong, 2005; 
Jahn and Scheller, 2006).  However, there are a few SNAREs that lack a TMD: Ykt6, 
STX11, STX19, SNAP-25, SNAP-23, SNAP-29 and SNAP-47 (Table 1 and Figure 
3). These SNAREs are usually modified post-translationally to allow membrane 
anchorage. Ykt6 is attached to the membrane via palmitoylation, prenylation and 
farnesylation (McNew et al., 1997; Fukasawa et al., 2004; Hasegawa et al., 2004; 
Dietrich et al., 2005). STX11 is also shown to be palmitoylated (Prekeris et al., 2000). 
The flexible linker between the two tandem SNARE motifs in SNAP-25, or SNAP-
23, contains palmitate anchors (Hess et al., 1992; Veit et al., 1996; Vogel and Roche, 
1999). SNAP-25 is also recruited to the membrane via interaction with other SNAREs 
that are anchored by C-terminal tails (Vogel et al., 2000). 
 
Although SNAREs that lack TMD are still able to attach to the membrane, SNARE-
mediated fusion can occur only if there is at least one SNARE on each bilayer that is 
anchored by a TMD (McNew et al., 1999; Grote et al., 2000; Rohde et al., 2003; 
Ungermann and Langosch, 2005). Thus, TMDs appear to play a role in mediating the 
fusion process (for review see Langosch et al., 2007). Several studies have reported 
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that replacing or altering the primary structures of the TMD can cause fusion defects 
to varying degrees (McNew et al., 2000b; Langosch et al., 2001; Giraudo et al., 2005; 
Hofmann et al., 2006). It is suggested that TMDs may be able to ‘translate’ the 
conformational changes in the ectodomains of SNAREs during complex formation 
into local bilayer stress (Langosch et al., 2007). Thus, TMDs may contribute to the 
fusion process via bilayer deformation (Cohen and Melikyan, 2004; Chernomordik 
and Kozlov, 2003) or bilayer destabilization (Dennison et al., 2006). Furthermore, 
TMDs also take part in mediating SNARE-SNARE interactions (Laage and 
Langosch, 1997; Margittai et al., 1999; Laage et al., 2000). It is suggested that 
homotypic lateral TMD-TMD interactions play a role in supporting the transition 
from hemifusion to fusion between two lipid bilayers.  
 
C. The N-terminal region 
 
The N-terminal region varies greatly between different subgroups of SNAREs. 
Several SNAREs (VAMP1, 2, 3, 5, 8, GS15, Bet1 [block early in transport 1], SNAP-
23, SNAP-25, SNAP-29 and SNAP-47) only have a short, presumably unstructured 
peptide at the N-terminal of the SNARE motif. However, most other SNAREs contain 
a more extended N-terminal region (also known as the N-terminal extension or NE), 
with varying lengths and structures (Figure 3) (Dietrich et al., 2003, Hong, 2005; Jahn 
and Scheller, 2006).  
 
The N-terminal region of Qa-SNAREs contains an antiparallel three-helix (termed 
Ha, Hb, and Hc regions) bundle preceded by a short N-terminal domain (Figure 3). 
The Habc bundle is connected to the SNARE motif by a flexible linker. In some 
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SNAREs, e.g. STX1 or STX7, this three-helix bundle can interact with the SNARE 
motif of the same SNARE, thus forming a ‘closed’ conformation. This conformation 
prevents the SNARE motif from forming a SNARE complex with other SNARE 
motifs (Dulubova et al., 1999; Misura et al., 2000; Antonin et al., 2002a; Dietrich et 
al., 2003; Fasshauer, 2003). In other Qa-SNAREs such as STX5 or STX16, the Habc 
bundle does not interact with the SNARE motif and these SNAREs have an ‘open’ 
conformation (Bracher and Weissenhorn, 2002; Yamaguchi et al., 2002; Dulubova et 
al., 2002, 2003; Dietrich et al., 2003). This indicates that the closed conformation 
may not be essential for the function of SNARE.  
 
Several Qb- and Qc-SNAREs (Vti1b [vesicle transport through interaction with the t-
SNARE homologue 1b], STX6 and STX8) also contain the Habc three-helix bundle at 
the N-terminal region (Figure 3). However, unlike Qa-SNAREs, there is no short N-
terminal domain preceding the Habc bundle in these SNAREs (Antonin et al., 2002a; 
Misura et al., 2002; Hong, 2005). It is predicted that the N-terminal region of Vti1a, 
GS27, GS28 and STX10 may also have a similar structure (Misura et al., 2002; Hong, 
2005).  
 
A subgroup of R-SNAREs (VAMP7, Ykt6 and Sec22b) has a third type of N-terminal 
extension region, termed a ‘longin’ domain (Figure 3). Thus, these R-SNAREs are 
also referred to as the ‘longins’ (Fillippini et al., 2001; Rossi et al., 2004). The longin 
domains of Ykt6 and Sec22b have a profilin-like structure (Gonzalez et al., 2001; 
Tochio et al., 2001). Bioinformatics analysis suggests that the N-terminal regions of 
the longin VAMP7, and two Q-SNAREs (Sec22a and Sec22c), are also likely to have 
profilin-like folds (Fillippini et al., 2001; Hong, 2005). The longin domain of Ykt6, 
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but not Sec22b, is able to fold back and bind intramolecularly to the SNARE motif, 
resulting in a ‘closed’ conformation and inhibiting the formation of a fusion complex 
(Gonzalez et al., 2001; Tochio et al., 2001). The longin domain of Ykt6 also catalyses 
the palmitoylation of itself and other proteins such as yeast Vac8p (vacuole 
partitioning protein 8) during vacuolar fusion (Dietrich et al., 2004; Veit, 2004). 
 
The remaining SNAREs have N-terminal regions that either have not been clearly 
characterized (Sec20, Slt1 [SNARE-like tail-anchored protein 1], D12) (Burri et al., 
2003; Dilcher et al., 2003; Nakajima et al., 2004, Okamura et al., 2006) or are unique 
(VAMP4). The N-terminal extension of VAMP4 is considerably shorter than the 
longins and the three-helix types. It contains a double-leucine (double-Leu) motif, 
followed by a phosphorylable serine (Ser) residue, both of which could function as 
TGN-targeting signals (Peden et al., 2001; Hinners et al., 2003). These signals of 
VAMP4 will be discussed further in section 1.4.2 
 
In many cases, the N-terminal domain of a SNARE participates in its own regulation. 
It can interact intramolecularly with the SNARE motif to mediate the SNARE 
complex formation (Calakos et al., 1994; Dulubova et al., 1999; Misura et al., 2000; 
Tochio et al., 2001; Antonin et al., 2002a). The N-terminal domain may also function 
as a platform to recruit SNARE regulators such as the Sec1/Munc18 (SM)-related 
proteins. Vps45, a SM protein, opens up the closed conformation of STX16 by 
binding to its N-terminal portion (Dulubova et al., 2002). Sly1 (suppressor of loss of 
Ypt1 protein 1) also binds to STX5 and STX18 in a similar fashion, thus releasing 
their SNARE motifs and aiding in SNARE complex formation (Yamaguchi et al., 
2002; Bracher and Weissenhorn, 2002). On the other hand, the SM proteins Munc-18-
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1, Munc-18-2 and Munc-18-3 bind to the closed conformation of STX1-4 via both the 
N-terminal extension and the SNARE motif. In this case, the SM proteins enclose and 
stabilize the SNARE closed conformation (Misura et al., 2000; Toonen and Verhage, 
2003). However, the N-terminal domain, in general, seems to be dispensable for 
fusion (Wang et al., 2001; Van Komen et al., 2006). 
 
1.3.2 General mode of action of SNAREs 
 
SNAREs are presently considered the minimal fusion machinery in the secretory 
pathway (Weber et al., 1998; Chen and Scheller, 2001). The general mode of action 
of SNAREs in vesicular transport (Figure 5) is based mostly on studies in yeast and 
neural transmitter exocytosis. At the first stage, vesicles bud from the donor 
compartment. In this step, SNAREs are packed together with other cargo proteins into 
the budding vesicle. These vesicle-associated SNAREs are termed v-SNAREs 
(Sollner et al., 1993b). v-SNAREs usually belong to the R-SNARE subfamily 
(Weimbs et al., 1997; Fasshauer et al., 1998). SNAREs may interact directly with 
coat proteins and be recruited into the forming vesicle as a result of this interacation. 
For example, Bet1, Sed5 (suppressor of erd2 [ER retention-defective 
complementation group 2] deletion 5) and Sec22 bind to the Sec23-24 complex of the 
COPII during the formation of vesicles from the ER (Miller et al., 2003; Mossessova 
et al., 2003). Interactions between SNAREs and COPI (Rein et al., 2002) or between 
VAMP4 and the AP1 (Peden et al., 2001) have also been reported. Moreover, 
SNAREs may even actively function in driving the vesicle formation process (Deak et 
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Figure 5: General mode of action of SNARE




After the vesicle is formed, it is transported to the target compartment. The vesicle 
will then be captured and tethered to the target membrane at the docking site, where 
the target compartment-associated SNARE (t-SNARE) is located. The cognate t-
SNARE usually consists of two or three Q-SNAREs (Fukuda et al., 2000). In vitro 
studies on yeast and neuronal exocytic complexes have shown that these SNAREs can 
be pre-assembled in a partially helical Qabc intermediate complex, termed the 
acceptor complex. The v-SNARE would then be incorporated into this acceptor 
complex to form the SNARE core complex (Nicholson et al., 1998; Fiebig et al., 
1999; Fasshauer and Margittai, 2004). However, it is still not clear if such acceptor 
complexes exist in vivo (Jahn and Scheller, 2006).  
 
In the next stage, the v- and t-SNAREs on the two opposing membranes interact in a 
circular array, forming ring-like conducting channels (Cho et al., 2002; Jeremic et al., 
2004). The SNARE motifs are then assembled in a trans-SNARE complex. 
According to the ‘zipper’ model, the assembly of SNAREs in a trans configuration, 
with at least one SNARE containing a TMD on each apposing membrane, is the key 
step in membrane fusion (Nichols et al., 1997; McNew et al., 1999; Grote et al., 
2000; Chen and Scheller, 2001; Jahn et al., 2003; Rohde et al., 2003; Sudhof, 2004; 
Jahn and Scheller, 2006). The assembly is supposed to start from the distal N-termini 
of the SNARE motifs and then proceed towards the C-terminal membrane anchors in 
a zipper-like fashion. This would overcome the repulsive charge between the two 
opposing membranes, clamping them together and initiate fusion (Hanson et al., 
1997; Lin and Scheller, 1997). The formation of the trans-SNARE complex pulls the 
two bilayers within a distance of 2-3 Å. In the presence of calcium, calcium-
phosphate bridges are formed between opposing layers. This leads to the expulsion of 
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water between the bilayers at the bridging sites and causes bilayer destabilization. 
This bilayer destabilization, together with the free energy released upon the formation 
of the trans-SNARE complex, lead to membrane fusion (Jeremic et al., 2004; Leabu, 
2006), at least at the hemifusion stage (Chernomordik et al., 1995; Chernomordik and 
Kozlov, 2003; Ungermann and Langosch, 2005). It is suggested that the TMDs of 
SNAREs play an important role in promoting the transition from the hemifusion to 
the complete merging of bilayers (Ungermann and Langosch, 2005).  
 
After fusion, the trans-SNARE complex is transformed to a cis-configuration, in 
which all SNAREs of a complex reside together on the same membrane. This cis-
SNARE complex needs to be disassembled to allow SNAREs to be recycled for 
subsequent rounds of transport. The disassembly requires both α-SNAP and NSF, 
which is an ATPase (adenosine triphosphatase) (Sollner et al., 1993a). Firstly, three 
α-SNAPs bind to the middle of the SNARE complex (Marz et al., 2003). These bound 
α-SNAPs then recruit and activate NSF (in a hexamer form), leading to the formation 
of a transient 20S complex (Hohl et al., 1998; Wimmer et al., 2001; Furst et al., 
2003). ATP hydrolysis by NSF would provide the necessary energy to disassemble 
the 20S complex as well as the cis-SNARE complex. The released v-SNAREs would 
then be recycled to the donor compartment via retrograde transport. On the other 
hand, the t-SNARE subunits can be reorganized into functional cognate t-SNAREs, 






1.3.3 SNARE localization and the specificity of transport 
 
Eukaryotic cells contain numerous SNARE proteins. They have been found in all 
membrane-bound subcellular compartments along the secretory pathway (Table 1). 
Most of them reside predominantly in specific cellular compartments, suggesting that 
they function in specific intracellular trafficking steps (Jahn and Sudhof, 1999; Chen 
and Scheller, 2001; Hong, 2005; Jahn and Scheller, 2006).  
 
Initially, the SNARE hypothesis proposed that the specific formation of SNARE 
complexes would confer specificity on intracellular membrane trafficking (Sollner et 
al., 1993b; Rothman, 1994). However, more recent studies have shown that the 
specificity of membrane trafficking may be determined when the vesicle is tethered 
and docked on the target compartment, prior to the fusion stage (Chen and Scheller, 
2001). During these steps, the small GTPases of the Rab/Ypt family and tethering 
factors are the key regulators, rather than the SNAREs (Pfeffer, 1999; Pfeffer and 
Aivazian, 2004; Cai et al., 2007a). Although SNAREs are the central players of the 
fusion step in membrane trafficking, it is still not clear to what extent SNAREs 
contribute to the vesicle targeting specificity.  
 
In vitro studies have shown that the specificity of SNARE complex formation is lower 
than originally assumed, as SNAREs assemble rather promiscuously into core 
complexes (Fasshauer et al., 1999; Yang et al., 1999; Tsui and Banfield, 2000). The 
specificity level seems to be higher ex vivo (Scales et al., 2000) or in fusion studies 
with SNAREs reconstituted in liposomes (McNew et al., 2000a; Parlati et al., 2000; 
Paumet et al., 2004). However, even in these situations, a certain degree of 
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promiscuity is still present. For example, certain SNARE combinations, which are not 
known to interact physiologically in vivo, are still able to cause efficient liposome 
fusion (McNew et al., 2000a; Brandhorst et al., 2006). SNAREs can also functionally 
replacing each other to a certain extent in vivo. For example, the yeast R-SNAREs 
Ykt6p and Sec22p can substitute for each other in the ER-Golgi transport (Liu and 
Barlowe, 2002). Some SNAREs can also participate in more than one complex and 
function in several trafficking steps. STX5 is incorporated into different SNARE 
complexes (STX5/GS27/Bet1/Sec22b, STX5/GS28/Bet1/Ykt6, 
STX5/GS28/GS15/Ykt6) to mediate several steps in ER-Golgi transport (Zhang et al., 
1997, 1999; 2001), or intra-Golgi (Parlati et al., 2002; Xu et al., 2002), or endosome-
to-Golgi transport (Tai et al., 2004). VAMP8 interacts with the endocytic SNAREs 
STX7, STX8 and Vti1b to mediate homotypic fusion of the early and late endosomes 
(Antonin et al., 2000a and 2000b). It has also been reported that in pancreatic acinar 
cells, VAMP8 is the v-SNARE of zymogen granules. It interacts with STX4 and 
SNAP-23 to mediate regulated fusion with the apical surface (Wang C et al., 2004). 
Thus, the contribution of SNAREs to fusion specificity seems to be questionable. 
 
On the other hand, SNAREs are indeed specialized for individual intracellular fusion 
events (Chen and Scheller, 2001; Hong, 2005; Jahn and Scheller, 2006). Specific sets 
of SNAREs have been found or proposed for many of the fusion steps in yeast and 
mammalian cells (Jahn and Scheller, 2006). Considering the relative promiscuity of 
SNARE complexes formation in vitro, it is conceivable that other factors are required 
to ensure fusion specificity. The restriction on SNARE complexes formation in vivo 
may be due partly to their specific distribution between subcellular compartments. 
Although one cannot predict the function of a given SNARE based solely on its 
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predominant localization, there is still a close connection between the subcellular 
distribution of a SNARE protein and its possible function in transport (Hong, 2005; 
Jahn and Scheller, 2006). Thus, the function of SNARE is primarily regulated by its 
localization (Hong, 2005).  
 
There must be some sorting mechanisms to ensure that each intracellular membrane is 
equipped with the correct set of SNARE proteins. Furthermore, since v-SNAREs are 
shuffled between the donor and target compartments, it is important that they are 
retrieved to the correct donor membrane for the continuation of transport. Accessory 
proteins that bind to SNARE play an important role in regulating SNARE sorting and 
localization. Studies have shown that certain SNAREs are able to interact with 
specific coat proteins and be recruited into vesicles (Peden et al., 2001; Rein et al., 
2002; Mossessova et al., 2003; Miller et al., 2003). Nevertheless, not much is known 
about the sorting signals of SNAREs. There are a number of SNARE mutations that 
cause missorting. Many of these are in the SNARE motif and include the amino acids 
of the central layers (Grote et al., 1995; Jahn and Scheller, 2006). Hence, sorting may 
also depend on SNARE conformation. However, it should be noted that due to their 
mode of action, the localization of SNARE depends on the steady state between 
SNARE biosynthesis, fusion and recycling. It is possible that these mutations may not 
directly affect the sorting of SNAREs. Rather, they may impair the assembly or 
disassembly of the mutated SNAREs, and thus changing their steady state distribution 





1.4 VAMPs and the focus of this study  
 
1.4.1 The mammalian R-SNARE subfamily 
 
At present, the mammalian R-SNARE subfamily, also known as the VAMP (vesicles-
associated membrane protein) subfamily, consists of nine proteins: Sec22b, Ykt6, 
VAMP1, VAMP2, VAMP3, VAMP4, VAMP5, VAMP7 and VAMP8. Most of them 
function as v-SNAREs. They are distributed in different compartments of the 
secretory and endocytic pathway (for review see Chen and Scheller, 2001; Hong, 
2005). With the exception of VAMP4, the VAMP subfamily can be further divided 
into two subgroups, based on the structure of their N-terminal extension: 
 
A. The ‘brevins’ 
 
There are five VAMPs (VAMP1, 2, 3, 5 and 8) that contain only a short and 
presumably unstructured N-terminal extension preceding the SNARE motif. They are 
known as ‘short VAMPs’ or ‘brevins’ (from the Latin word ‘brevis’, meaning short) 
(Filippini et al., 2001). They are major v-SNAREs distributing and functioning in the 
post-Golgi compartments.  
 
VAMP1 and VAMP2 localize to the synaptic vesicles and function in regulated 
exocytosis in neurons (Sollner et al., 1993b; Sutton et al., 1998; Jahn et al., 2003; 
Sudhof, 2004). VAMP2 also participates in regulated secretion in adipocytes and 
endocrine cells. It functions as a v-SNARE for GLUT4 (glucose transporter 4)-
containing vesicles and interacts with STX4 and SNAP-23 in insulin-dependent 
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exocytosis (Bryant et al., 2002; Watson et al., 2004). It is implicated in regulating 
insulin secretion in pancreatic β cells (Nevins and Thurmond, 2005) as well as in 
aquaporin 2 translocation in renal collecting duct cells (Gouraud et al., 2002). There is 
evidence of VAMP2’s involvement in the fusion of the early/sorting endosome, as the 
partner of the t-SNARE containing SNAP-25 and STX13 (McBride et al., 1999; Sun 
et al., 2003). In addition, recent studies also suggest that VAMP2 is a crucial player in 
rapid endocytosis of synaptic vesicles (Deak et al., 2004). 
VAMP3 is enriched in early and recycling endosomes (McMahon et al., 1993; Galli 
et al., 1994; Lin and Scheller, 2000). Not much is known about its function. Several 
studies indicate that VAMP3’s functions may overlap with other v-SNAREs. 
VAMP3-knock-out mice show little change in development or various physiological 
processes, such as endocytosis or GLUT4 (glucose transporter 4) translocation (Yang 
et al., 2001), suggesting that other proteins provide functional redundancy. VAMP3 
can form complex with the TGN t-SNARE (STX6/STX16/Vti1a). This t-SNARE can 
also form complex with VAMP4. Both complexes function in the retrograde traffic 
from the SE to the TGN, but the VAMP3-containing complex seems to play only a 
minor role in this pathway (Mallard et al., 2002). VAMP8 is another candidate with 
potential functional overlap with VAMP3, although this remains to be confirmed 
(Wang C et al., 2004; Hong, 2005). 
 
VAMP5 is mainly expressed in the skeletal muscle and heart. It is enriched at the 
plasma membrane and its expression level is enhanced during in vitro myogenesis of 
mouse myoblast C2C12 cells (Zeng et al., 1998). 
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VAMP8 was first shown to be located at the early and late endosomes (Advani et al., 
1998; Wong et al., 1998; Antonin et al., 2000a and 2000b). It forms a complex with 
the t-SNARE containing STX7, Vti1b and STX8 to mediate the homotypic fusion of 
early and late endosomes (Antonin et al., 2000a and 2000b). More recently, a study in 
VAMP8 knock-out mice has shown that VAMP8 is enriched in zymogen granules in 
pancreatic acinar cells. It interacts with STX4 and SNAP-23 to mediate fusion of the 
granules with the apical surface in regulated exocytosis (Wang C et al., 2004). 
 
B. The ‘longins’ 
 
The ‘longins’ are characterized by a conserved profilin-like domain at the N-terminal 
region, termed the ‘longin domain’ (Fillipini et al., 2001; Rossi et al., 2004). This 
domain seems to be essential for membrane trafficking (Martinez-Arca et al., 2000; 
2003; Rossi et al., 2004). It also has other functions based on its protein-protein 
interactions and intramolecular binding specificities (Tochio et al., 2001; Veit et al., 
2001; Martinez-Arca et al., 2003; Hasegawa et al., 2003; Dietrich et al., 2004). 
Longins are the only R-SNAREs that are conserved in all eukaryotes. Hence, it is 
suggested that the longin domain is likely to be an essential module and that the R-
SNARE motif of longins could substitute for that of the brevins (Dietrich et al., 
2003). There are three known mammalian longins: VAMP7 (Galli et al., 1998; 
Advani et al., 1998), Ykt6 (McNew et al., 1997) and Sec22b (Sacher et al., 1997). 
 
VAMP7 is enriched in the LE and the lysosomes (Advani et al., 1998). It is involved 
in a number of biological functions. It interacts with STX7, Vti1b and STX8 to 
mediate fusion of the LE with the lysosome or homotypic fusion of the lysosome 
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(Ward et al., 2000; Pryor et al., 2004). VAMP7 is also required in apical transport in 
epithelial cells (Galli et al., 1998; Lafont et al., 1999). It is implicated in lysosome 
secretion and membrane repair in fibroblasts (Reddy et al., 2001; Rao et al., 2004).  In 
developing cerebral neurons, VAMP7 concentrates at the tips of growing axons and 
dendrites and is involved in neurite outgrowth; (Coco et al., 1999; Martinez-Arca et 
al., 2000; Martinez-Arca et al., 2001; Alberts and Galli., 2003).  
 
Ykt6 is located in the cis-Golgi and Golgi stack (Sögaard et al., 1994; McNew et al., 
1997; Zhang and Hong, 2001; Xu et al., 2002). Ykt6 forms a complex with STX5, 
GS28 and Bet1 to mediate the fusion of matured ER-Golgi transport containers 
(EGTCs) with the cis-Golgi (Zhang and Hong, 2001). It is also incorporated into 
another complex with STX5, GS28 and GS15 and functions in intra-Golgi traffic (Xu 
et al., 2002). In addition, this complex is suggested to participate in the retrograde 
endosome-to-Golgi transport (Tai et al., 2004). 
 
Sec22b is enriched in the transport intermediates between the ER and the cis-Golgi 
(Hay et al., 1997; Paek et al., 1997; Zhang et al., 1999). Together with STX5, GS27 
and Bet1, Sec22b appears to function in mediating homotypic fusion of ER-derived 
COPII vesicles into larger transport carriers known as EGTC, ERGIC or VTC (Zhang 
et al., 1997, 1999). Sec22b also seems to take part in another SNARE complex, 
together with STX18, Sec20 and Slt1, to mediate the retrograde Golgi-ER transport 





1.4.2 Previous studies on VAMP4 
 
VAMP4 was first described in 1998 by Advani et al. as an R-SNARE and a member 
of the VAMP subfamily. VAMP4 is the only R-SNARE that is mainly localized to the 
TGN membranes, which is partly coated with clathrin. It is also found at the medial 
and trans side of the Golgi stack, on clathrin-coated and noncoated vesicles, and on 
endosomes as well as on immature secretory granules (ISGs) (Steegmaier et al., 
1999).  Steegmaier’s study also found that VAMP4 is likely to interact with STX6, a 
TGN/endosomal Qa-SNARE. Due to the distribution of VAMP4 and its probable 
interacting partner, the authors proposed that VAMP4 possibly functions in TGN-to-
endosome transport.  
 
Subsequent to Steegmaier’s work, there have been a few other reports addressing the 
possible function of VAMP4. Since SNAREs function as complexes, functional 
studies of VAMP4 at first focused on its partners in its cognate SNARE complex. 
Mallard et al. (2002) reported that VAMP4 interacts with STX16, STX6 and Vti1a in 
a NEM-dependent fashion to form a SNARE complex that regulates the transport 
from the SE/RE to the TGN. The same report also suggested that VAMP4 is likely to 
act as the v-SNARE in this complex. The study by Eaton et al. (2000) found that 
VAMP4 is involved in the ISGs sorting process by a sorting pathway that seems to be 
responsible for the remodeling of the granule membrane during the maturation period. 
The authors proposed that this sorting pathway is critical for the transition of ISGs, 
which have features of unregulated secretory carriers, to mature secretory granules 
(MSGs), which are regulated secretory carriers. However, the role which VAMP4 
plays in this maturation process of ISGs is still not known. 
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 The ability of one SNARE to be incorporated into more than one complex enables it 
to regulate different transport pathways. The location of a SNARE protein at a given 
time is therefore one of the important factors that decide which SNARE complex it 
forms with the appropriate partners. In other words, the function of a SNARE protein 
is regulated primarily through its location (Sollner et al., 1993b; Jahn and Sudhoff, 
1999; Lin and Scheller, 2000; Chen and Scheller, 2001; Bock et al., 2001; Hong, 
2005). It is important for each SNARE to be accurately targeted to its destination for 
appropriate function. For v-SNAREs such as VAMP4, which shuffle between the 
donor and target compartments, it is clear that there is some mechanism to regulate 
their localizations. Studying the targeting of VAMP4 is thus clearly an important 
aspect in the attempt to better understand this protein and how it functions in cells.  
 
There have been a few studies about the targeting of VAMP4 to the TGN, focusing on 
its N-terminal extension (NE). Although the exact roles of the NE domain of SNAREs 
have not yet been fully understood, there is evidence that the NEs of certain SNAREs 
could regulate their localization (for review see Hong, 2005). VAMP4 contains a 50-
amino acid N-terminal domain, and has unique features compared to other VAMP 
proteins. This NE is much longer than the NE of the brevins. On the other hand, it is 
considerably shorter than the NE of the longins and does not contain profilin-like 
structure. Instead, the N-terminal extension of VAMP4 includes a double-Leu motif at 
position 25 and 26, followed by two acidic clusters. There is also a serine residue at 
position 30 (Ser-30), between these two acidic clusters, and its flanking sequence fits 
the consensus ([S/T)XX(D/E]) target for phosphorylation by casein kinase II (CKII) 
(Allende and Allende, 1995). Motifs like these are known to function as sorting 
49
signals for a number of TGN proteins, which participate in regulating their targeting 
to the TGN. (Schafer et al., 1995; Voorhees et al., 1995; Alconada et al., 1996; Jones 
et al., 1995; Takahashi et al., 1995; Gleeson, 1998; Gu et al., 2001). In this thesis, 
these signals are referred to as ‘TGN-targeting signals’. 
 
Most of the studies regarding the targeting of VAMP4 to the TGN have focused on 
the double-Leu motif and the downstream Ser-30 residue. Peden et al. (2001) reported 
that the double-Leu motif is involved in the targeting of VAMP4. When this motif 
was mutated, the resulting mutant protein was less tightly stacked at the TGN 
compared to the wild-type. The study also showed that the double-Leu motif interacts 
with AP-1, which most likely accounts for its localization and may explain its 
function, since AP-1 functions prominently in the transport pathways between the 
TGN and endosomes (Le Borgne and Hoflack, 1998). In another study in 2003, 
Hinners et al. found that the phosphorylation of the Ser-30 residue is also important 
for the interaction of VAMP4 with AP-1. When both Ser-30 and the double-Leu motif 
were mutated, mislocalization of the mutant occurred in AtT20 cells. Both studies 
have suggested the role of the double-Leu as well as the downstream Ser-30 in 
mediating the localization of VAMP4. However, the possible role(s) of the acidic 
clusters in regulating VAMP4 targeting still remain to be addressed. 
 
Recently, Zeng et al. (2003) studied the structural domains and motifs responsible for 
the subcellular targeting of two members of the VAMP subfamily: VAMP4 and 
VAMP5. The basis for choosing these two VAMPs was that they are clearly 
segregated into distinct post-Golgi structures (TGN for VAMP4 and PM for 
VAMP5), which could be easily resolved by indirect immunofluorescence 
50
microscopy. Unlike VAMP4, the brevin VAMP5 only consists of a short NE 
preceding a SNARE domain, followed by a tail anchor region (Zeng et al., 1998). The 
results show that the cytoplasmic domains of the two SNAREs contain signals for 
their targeting. Further experiments indicate that the N-terminal extension of VAMP4 
carries a dominant autonomous signal for TGN targeting, which seems to reside 
within the double-Leu and downstream acidic clusters. But the study of Zeng et al. 
(2003) did not determine exactly which residues are important for the targeting of 
VAMP4. More detailed experiments are required to address this. 
 
Previous studies have shown that the double-Leu motif, the acidic clusters and CKII 
phosphorylation sites in the TGN targeting signals of a number of proteins, including 
furin, PC6B (proprotein convertase 6B), M6PR or some viral proteins such as gpI 
(glycoprotein I), the human immunodeficiency negative factor (Nef), or HCMV-gB 
(human cytomegalovirus glycoprotein B), participate in the endocytosis and recycling 
of these proteins between the PM and the TGN (Jones et al., 1995; Takahashi et al., 
1995; Voorhees et al., 1995; Alconada et al., 1996; Gleeson, 1998; Molloy et al., 
1999; Wan et al., 1998; Xiang et al., 2000; Piguet et al., 2000; Crump et al., 2001; Gu 
et al., 2001; Crump et al., 2003; Jarvis et al., 2004). Therefore, the presence of similar 
signals in the NE of VAMP4 indicate that this SNARE might also cycle between the 
PM and the TGN. However, not much is known about the recycling of VAMP4, 
except for one report by Steegmaier et al. (2000), which used EGFP (enhanced green 
fluorescent protein)-fusion SNAREs and attempted to follow the recycling of these 
proteins using an antibody internalization assay. In Steegmaier’s study, various 
EGFP-fusion SNAREs, including VAMP4, were transiently transfected and 
overexpressed in MDCK cells. The results showed that VAMP4-EGFP was not 
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transported to the PM, thus they could not study its recycling pathway using this 
method. Hence, it was concluded that VAMP4 did not recycle between the TGN and 
the PM. However, the very high and non-physiological levels of transiently 
overexpressed SNAREs may cause incorrect localization of the fusion protein (Lowe 
et al., 1997; Subramaniam et al., 2000). Using stable transfected NRK cells would 
avoid this problem. 
 
In summary, there are two issues that plague recent studies about the targeting and 
recycling of VAMP4. Firstly, there is no information about the role(s) of the acidic 
clusters in the N-terminal portion of VAMP4 in the regulation of its targeting. 
Secondly, although there have been a few attempts to study its trafficking pathway, 
the only reported experiment regarding the possible recycle of VAMP4 between the 
PM and the TGN did not account for the potential protein mislocalization associated 
with the employed technique. These two issues will be addressed in this thesis. 
 
1.4.3 Rationale of the study 
 
The aim of this study is to understand the targeting and recycling of VAMP4. The 
specific objectives of this research are: 
(i)  To determine whether the acidic clusters in the N-terminal extension of 
VAMP4 play a role in regulating the targeting of VAMP4 to the TGN 
(ii)  To examine how the different components of the targeting signal in the N-
terminal extension of VAMP4 act in concert to mediate its TGN localization 
(iii) To determine whether VAMP4 recycles between the TGN and the PM. If this 
is an affirmative, then: 
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(iv) To map out the recycling pathway of VAMP4  
 
To achieve these aims, the antibody internalization assay, a strategy that has been 
employed previously to study the traffic of TGN proteins, such as TGN38 or furin, 
from the PM to the TGN (Ghosh et al., 1998; Mallet and Maxfield, 1999) was used. 
This strategy relies on the exposure of the luminal domain of the studied protein on 
the cell surface. A specific antibody can bind to this exposed domain and travel 
together with the protein into the cell. By detecting this antibody, one can investigate 
the transport pathway of the desired protein in question.  
 
VAMP4 is a tail-anchored protein, composed of a cytoplasmic domain, followed by a 
transmembrane domain and a very short lumenal domain. This luminal domain is too 
short to be recognized and bound efficiently by an antibody. This poses problems in 
studying the trafficking of endogenous VAMP4 using the antibody internalization 
assay. To overcome this problem, this study took advantage of an EGFP-fused version 
of VAMP4, which was used in Zeng’s study (2003). This protein consists of full-
length VAMP4, followed by a 25 kD EGFP tail fused to the luminal C-terminus end 
of VAMP4. Thus, if the fusion protein is transported to the PM, this EGFP tail will be 
exposed on the cell surface and detectable by anti-GFP antibody. Steegmaier et al. 
(2000) also used the same strategy to study the transport pathway of various SNAREs, 
including VAMP4. However, Steggmaier's study used transiently transfected cells, in 
which the overexpressed EGFP-fusion SNAREs may have incorrect localizations. To 
avoid this problem, cells stably expressing VAMP4-EGFP at physiological levels 
were used in this study. In order to study the function of various targeting signals in 
the NE of VAMP4, point mutations were introduced into VAMP4-EGFP, and the 
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 transport of these mutants was then investigated. 
 
Although SNAREs play important roles in intracellular membrane transport, not 
much is known about how SNAREs themselves are transported. Moreover, there are 
many variations in the N-terminal extensions of SNAREs that are poorly understood 
and which seem to participate in the regulation of these proteins (reviewed in Hong, 
2005). Thus, studying the targeting signal and recycling pathway of VAMP4, one of 
the major v-SNARE proteins in the post-Golgi traffic pathways, could contribute to a 
better understanding of the targeting mechanisms of SNAREs. Furthermore, it is 
envisaged that this research will be of importance in explaining and/or conjecturing 






















Rabbit antibody against GFP was purchased from Clontech (Mountain View, CA, 
USA). Mouse antibody against GFP was from Roche Diagnostics (Mainheim, 
Germany). Monoclonal anti-EEA1, anti-rat transferrin receptor (TfR), anti-GM130 
(Golgi matrix protein of 130kD), anti-STX6, anti-Vti1a, anti-GS15 and anti-clathrin 
heavy chain (CHC) were obtained from BD Biosciences (San Jose, CA, USA). 
Antibody against VAMP3 was from Affinity BioReagent (Golden, CO, USA). Rabbit 
anti pericentrin was from Covance (Berkeley, CA, USA). Mouse anti-FLAG antibody 
was purchased from Sigma (St. Louis, MO, USA). Fluorescein isothiocyanate (FITC)- 
or PE (Phycoerythrin)- or Cyanine dye 3 (Cy3)- or Cy5-conjugated secondary 
antibodies were from Jackson ImmunoResearch Laboratories (West Grove, PA, 
USA). Mouse anti-LBPA (lysobiphosphatidic acid) antibody was a gift from Dr. Jean 
Gruenberg of University of Geneva, Switzerland. Mouse anti-Tac antibody was a gift 
from Dr. Frederick R. Maxfield (Cornell University Medical College, New York, 
USA). Rabbit anti-Ykt6 and rabbit anti-STX16 antibodies were raised in our lab 





2.1.2 Cell lines 
 
Normal rat kidney (NRK), MDCK and HeLa cells were obtained from American 
Type Culture Collection (Manassas, VA, USA). CHO (Chinese hamster ovary) cells 
stably expressing TacTGN38 (CHO-TacTGN38) was a gift from Dr. Frederick R. 
Maxfield (Cornell University Medical College, New York, USA). NRK and MDCK 
were grown in Dulbecco’s Modified Eagles Medium (DMEM) supplemented with 
10% fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA, USA). CHO-TacTGN38 
and HeLa were maintained in Roswell Park Memorial Institute Medium (RPMI) (also 
Invitrogen).  
 
2.2 Plasmid constructs 
 
The sequences for the oligonucleotides used in this study are listed in Table 2. All 
restriction enzymes were from New England Biolabs (Beverly, MA, USA). All PCRs 
(polymerase chain reaction) were done using high fidelity Pfu DNA polymerase 
(Promega, Madison, WI, USA) using PTC225 Thermal Cycler (MJ Research, 
Waltham, MA, USA). PCR products or digested DNA were subjected to agarose gel 
electrophoresis, following with purification using QIAEX Gel Extraction Kit 
(QIAGEN, Hilden, Germany). Digested and purified PCR products were ligated into 
appropriate vectors using Rapid DNA Ligation Kit (Roche). All vectors and ligated 
constructs were transformed into DH5α E.coli Chemically Competent cells 
(Invitrogen) unless otherwise stated. All vectors and constructs were then purified 





pEGFP-N1 was commercially available from Clontech. Besides, for the purpose of 
this study, pFLAG-C2 was modified from the commercial vector pEGFP-C2 
(Clontech) as followed: 
 
Oligonucleotides Flagc2F and Flagc2R (Table 2) were annealed, gel-purified and then 
digested with NheI and BglII before inserting into the corresponding sites in pEGFP-
C2 vector. The resulting pFLAG-C2 vector would allow the expression of fusion 
protein which is N-terminally tagged with FLAG epitope instead of EGFP. 
 
2.2.2 Expression Constructs 
 
VAMP5-EGFP - Oligonucleotides 1 and 3 (Table 2) were used to retrieve the coding 
region of human VAMP5 by PCR using human VAMP5 cDNA as the template. The 
PCR fragment was gel-purified, digested with EcoRI and BamHI, and then inserted 
into the corresponding sites in pEGFP-N1 vector.  
 
VAMP4-EGFP - Oligonucleotides A and B (Table 2) were used to retrieve mouse 
VAMP4 coding region by PCR using mouse VAMP4 cDNA as the template. The 
resulting PCR fragment was gel-purified, digested with EcoRI and BamHI, and 
inserted into the corresponding sites in pEGFP-N1 vector. 
  
V4nV5-EGFP - Oligonucleotides A and J (Table 2) were used to retrieve the coding 
region for the N-terminal 51-residue extension of VAMP4 by PCR using mouse 
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The restriction sites are in italics. The mutated sites are underlined. 
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VAMP4 cDNA as the template. The retrieved fragment was cut with EcoRI and 
ligated into the EcoRI site of the human VAMP5-EGFP construct. Colonies harboring 
constructs with correct orientation of the inserted fragment were identified by PCR 
with oligonucleotides A and 3 (right orientation gives rise to a 524-bp fragment).  
 
V4nV5-EGFP/LL-AA - With V4nV5-EGFP construct as the template, two separate 
PCR products using oligonucleotides A and N1 as well as N2 and 3 (Table 2) were 
generated. The two PCR fragments were mixed and then used for PCR employing 
oligonucleotides A and 3. The final PCR fragment was gel-purified, digested with 
EcoRI and BamHI, and then ligated into pEGFP-N1.  
 
V4nV5-EGFP/EDD-3A - With V4nV5-EGFP construct as the template, two separate 
PCR products using oligonucleotides A and N3 as well as N4 and 3 (Table 2) were 
generated. The two PCR fragments were mixed and then used for PCR employing 
oligonucleotides A and 3. The final PCR fragment was gel-purified, digested with 
EcoRI and BamHI, and then ligated into pEGFP-N1.  
 
V4nV5-EGFP/S-A - With V4nV5-EGFP construct as the template, two separate PCR 
products using oligonucleotides A and N5 as well as oligonucleotides N6 and 3 (Table 
2) were generated. The two PCR fragments were mixed and then used for PCR 
employing oligonucleotides A and 3. The final PCR fragment was gel-purified, 
digested with EcoRI and BamHI, and then ligated into pEGFP-N1.  
 
V4nV5-EGFP/5A - With V4nV5-EGFP construct as the template, two separate PCR 
products using oligonucleotides A and N7 as well as oligonucleotides N8 and 3 (Table 
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2) were generated. The two PCR fragments were mixed and then used for PCR 
employing oligonucleotides A and 3. The final PCR fragment was gel-purified, 
digested with EcoRI and BamHI, and then ligated into pEGFP-N1.  
 
V4nV5-EGFP/FF-AA - With V4nV5-EGFP construct as the template, two separate 
PCR products using oligonucleotides A and N9 as well as oligonucleotides N10 and 3 
(Table 2) were generated. The two PCR fragments were mixed and then used for PCR 
employing oligonucleotides A and 3. The final PCR fragment was gel-purified, 
digested with EcoRI and BamHI, and then ligated into pEGFP-N1.  
 
V4-EGFP/LL-AA - Using VAMP4-EGFP as the template, two separate PCR products 
using oligonucleotides A and N1 as well as N2 and B (Table 2) were generated. The 
two PCR fragments were mixed and used as the template for PCR employing 
oligonucleotides A and B. The final PCR fragment was gel-purified, digested with 
EcoRI and BamHI, and ligated into the corresponding sites of pEGFP-N1. 
  
V4-EGFP/EDD-3A - Using VAMP4-EGFP as the template, two separate PCR 
products using oligonucleotides A and N3 as well as N4 and B (Table 2) were 
generated. The two PCR fragments were mixed and used as template for PCR 
employing oligonucleotides A and B. The final PCR fragment was gel-purified, 
digested with EcoRI and BamHI, and ligated into pEGFP-N1.  
 
V4-EGFP/S-A - Using VAMP4-EGFP as the template, two separate PCR products 
using oligonucleotides A and N5 as well as N6 and B (Table 2) were generated. The 
two PCR fragments were mixed and used as template for PCR employing 
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oligonucleotides A and B. The final PCR fragment was gel-purified, digested with 
EcoRI and BamHI, and ligated into pEGFP-N1.  
 
V4-EGFP/S-E - Using VAMP4-EGFP as the template, two separate PCR products 
using oligonucleotides A and N11 as well as N12 and B (Table 2) were generated. 
The two PCR fragments were mixed and used as template for PCR employing 
oligonucleotides A and B. The final PCR fragment was gel-purified, digested with 
EcoRI and BamHI, and ligated into pEGFP-N1. 
 
V4-EGFP/S-D - Using VAMP4-EGFP as the template, two separate PCR products 
using oligonucleotides A and N13 as well as N14 and B (Table 2) were generated. 
The two PCR fragments were mixed and used as template for PCR employing 
oligonucleotides A and B. The final PCR fragment was gel-purified, digested with 
EcoRI and BamHI, and ligated into pEGFP-N1. 
 
V4-EGFP/S-T - Using VAMP4-EGFP as the template, two separate PCR products 
using oligonucleotides A and N15 as well as N16 and B (Table 2) were generated. 
The two PCR fragments were mixed and used as template for PCR employing 
oligonucleotides A and B. The final PCR fragment was gel-purified, digested with 
EcoRI and BamHI, and ligated into pEGFP-N1.  
 
V4-EGFP/5A - With VAMP4-EGFP as the template, two separate PCR products using 
oligonucleotides A and N7 as well as oligonucleotides N8 and B (Table 2) were 
generated. The two PCR fragments were mixed and then used as template for PCR 
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employing oligonucleotides A and B. The final PCR fragment was gel-purified, 
digested with EcoRI and BamHI, and then ligated into pEGFP-N1.  
 
V4-EGFP/FF-AA - With VAMP4-EGFP as the template, two separate PCR products 
using oligonucleotides A and N9 as well as oligonucleotides N10 and B (Table 2) 
were generated. The two PCR fragments were mixed and then used for PCR 
employing oligonucleotides A and B. The final PCR fragment was gel-purified, 
digested with EcoRI and BamHI, and then ligated into pEGFP-N1.  
 
FLAG-tagged mutants of Eps15 (FLAG-EH29, FLAG-DIII and FLAG- D3Δ2) - the 
Eps15 mutants were originally inserted in pEGFP-C2 and they were kindly provided 
from Dr. Alexandre Benmerah (Inserm, Paris, France). They were each transformed 
into GM2163 E.coli strain (NEB) to make them susceptible to cleavage by Dam 
(DNA adenine methylase)- or Dcm (DNA cytosine methylase)-sensitive restriction 
endonucleases. These plasmids were then digested with EcoRI and XbaI to release 
DNA fragment that encode Eps15 mutants. These fragments were then ligated to 
pFLAG-C2 vector using the same restriction sites. 
 
2.3 Expression of constructs in mammalian cells 
 
The constructs were each transfected into either NRK or stable CHO-Tac-TGN38 or 
HeLa cells using a LipofectAMINE 2000-based system according to the protocol 
provided by the manufacturer (Invitrogen). Stable transfectants were selected by 
culturing the cells in media with G418 (1000 µg/ml), and pooled transfectants were 
sorted by flow cytometry using a BD FACSAria flow cytometer (BD Biosciences) 
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before use in further studies. LipofectAMINE 2000 and G418 were purchased from 
Invitrogen.  
 
2.4 Flow cytometry and cell sorting 
 
NRK cells or various EGFP-fusion protein-expressing stable pools were trypsinized 
and resuspended in PBS (phosphate buffered saline) before subjecting to flow 
cytometry to detect and sort EGFP-positive cells using a BD FACSAria flow 
cytometer (BD Biosciences). To detect the level of cell surface EGFP-fusion protein, 
NRK or stable pools expressing EGFP-fusion proteins were trypsinized and incubated 
with anti-GFP antibody on ice for 1 hour. After washing with ice cold PBS, cells were 
then incubated with PE-conjugated secondary antibody for 1 hour on ice before 
subjected to flow cytometry using a BD FACSort flow cytometer (BD Biosciences). 
 
2.5 Immunofluorescence (IF) microscopy 
 
Cells grown on coverslips (Fisher Scientific, Pittsburgh, PA, USA) were washed twice 
with PBSCM (PBS supplemented with 1 mM CaCl2 and 1 mM MgCl2) and then fixed 
in PBSCM containing 3% paraformaldehyde for 20 min. Fixed cells were washed 
twice with PBSCM, twice with PBSCM containing 50mM NH4Cl, and then a further 
three times with PBSCM (5-10 min each). The cells were permeabilized with 0.1% 
saponin (Sigma) in PBSCM for 15 min. Cells were then immunolabeled with 
appropriate primary antibodies diluted in Fluorescence dilution buffer (FDB) 
(PBSCM with 5% FBS and 2% bovine serum albumin [BSA]) for 1 hour at room 
temperature. The coverslips were then washed four times with 0.1% saponin PBSCM. 
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Cells were subsequently incubated with secondary antibodies diluted (usually 100 
times) in FDB for 1 hour at room temperature. The coverslips were washed four times 
with 0.1% saponin PBSCM and then rinsed twice with PBSCM. The cells were then 
mounted on microscopic slide with Vectashield mounting medium (Vector 
Laboratories, Burlingame, CA, USA). Confocal microscopy was performed with Zeiss 
AxioplanII microscope (Oberkochen, Germany) equipped with a Zeiss confocal 
scanning optics. 
 
2.6 Immunoprecipitation (IP) 
 
VAMP4-EGFP-expressing NRK cells were incubated on ice with 1 mM of NEM 
(Sigma) for 15 min. The reaction was stopped by subsequently incubating cells with 2 
mM DTT (dithiothreitol) for 15 min to quench exceeded NEM. As control, parallel 
sample was incubated with 1mM pre-quenched NEM on ice for 30 min. Cells were 
then incubated for 30 min at 37oC before harvesting. Harvested cells were lysed in IP 
buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.1 mM PMSF 
[phenylmethylsulphonyl fluoride] and protease inhibitor cocktail [Roche]). The 
lysates were incubated with either rabbit anti-GFP antibody or rabbit IgG at 4oC for 1 
hour, followed by overnight incubation with TrueBlot anti-rabbit IgG IP beads 
(eBiosciences, San Diego, CA, USA) at 4oC. Beads were washed five times with IP 
buffer, two times with IP buffer without Triton X-100 and prepared with 2×Laemmli 
sample buffer (62.5 mM Tris-HCl pH 6.8, 25% glycerol (v/v), 2% SDS, 0.01% 






SDS (sodium dodecyl sulfate) polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed by the Laemmli method (Laemmli, 1970). SDS polyacrylamide gels were 
made discontinuously with stacking gels (0.125 M Tris-HCl pH 6.8, 0.1% SDS and 
3.9% acrylamide) and separating gels (0.375 M Tris-HCl pH 8.8, 0.1% SDS and 10% 
acrylamide). Protein samples were prepared in 2×Laemmli sample buffer  and then 
analyzed by electrophoresis in 1×SDS Running Buffer (20 mM Tris Base, 200 mM 
glycine, 0.1% SDS) at constant 150 volts, using the Bio-Rad Mini-PROTEAN 2 
system (Hercules, CA, USA). 
 
2.8 Western Blot 
 
The SDS-PAGE gels were tranferred onto Hybond-C-Extra membranes (GE-
Healthcare, Piscataway, NJ, USA) in ice cold 1×Transfer Buffer (20 mM Tris Base, 
200 mM glycine and 10% methanol) with a constant voltage of 100 volts for 2 hours 
at 4oC using Bio-Rad Mini Trans-Blot system. The membranes were then blocked in 
PBST (PBS with 0.1% Tween-20) containing 5% nonfat milk (PBSTM) overnight at 
4°C. The membranes were subsequently incubated at room temperature with primary 
antibody diluted appropriately in PBSTM for 1 hour, washed with PBST for three 
times (15 min each) and then incubated with HRP (horseradish peroxidase)-
conjugated secondary antibody diluted appropriately in PBSTM for 1 hour. After 
three times washing with PBST (15 min each), the membranes were incubated with 
the chemiluminescent detection system for 5 min (SuperSignal West PicoTM 
Chemiluminescent Substrate, Pierce, Rockford, IL, USA). The chemiluminescence 
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signals were detected by exposing the blots to Hyperfilm (GE-Healthcare) and the 
films were developed using Kodak X-ray film developer (Kodak, Rochester, NY, 
USA). If probing by another antibody was required for the same blot, the membrane 
was stripped using RestoreTM Western Blot Stripping Buffer (Pierce) before subjected 
to another round of blocking and subsequent antibody incubation. 
 
2.9 Selective surface biotinylation and analysis 
 
NRK cells, stable pooled NRK expressing VAMP4-EGFP, VAMP5-EGFP, or 
V4nV5-EGFP were biotinylated twice (15-20 min each) on ice with 0.5 mg/ml EZ-
Link® sulfo-NHS-biotin (sulfo-N-hydroxysuccinimidobiotin, Pierce). The reaction 
was stopped by washing the cells four times (10 min each) with 50 mM NH4Cl at 4oC 
and then rinsing twice (10 min each) with ice cold PBSCM. The biotinylated cells 
were scraped off the plate and then lysed in lysis buffer (25 mM Tris-HCl, pH 7.5, 
250 mM NaCl, 5 mM EDTA (ethylenediaminetetraacetic acid), 1% Triton X-100, 1% 
BSA, 10% FBS, and 1 mM PMSF) at 4°C with agitation for 1 hour. The extracts were 
spun down at 14,000 rpm for 10 min at 4°C to remove the cell debris. The 
supernatants were then incubated with streptavidin-agarose (Pierce) at 4oC for 2 
hours. After washing once with lysis buffer, three times with buffer A (25 mM Tris-
HCl, pH 7.5, 500 mM NaCl, 0.5% Triton X-100, and 1 mM PMSF), and three times 
with buffer B (10 mM Tris-HCl, pH 7.5, 150 mM NaCl), the beads were then boiled 





2.10 Internalization assay 
 
2.10.1 Continuous internalization of antibodies and/or ligands 
 
Cells were incubated with required antibodies and/or ligands at appropriated 
concentration in DMEM at 37°C for various periods of time. At the end of the 
incubation, cells were washed with cold PBSCM and subjected to fluorescence 
microscopy. 
 
2.10.2 Discontinuous internalization of antibodies  
 
Cells were incubated at 4°C with required antibodies and/or ligands at appropriated 
concentration in cold DMEM for 1 hour. Unbound antibodies were removed by brief 
rinses using cold DMEM. The cells were then incubated at 37°C for different periods 
of time in fresh DMEM. After incubation, the cells were fixed and subjected to 
fluorescence microscopy.  
 
2.11 Inhibition of endocytosis 
 
2.11.1 Potassium depletion 
 
Cells were washed twice with K+-free buffer (140 mM NaCl, 20 mM Hepes pH 7.4, 1 
mM CaCl2, 1 mM MgCl2, 1 mg/ml of D-glucose) and then incubated with hypotonic 
buffer (K+-free buffer diluted 1:1 with water) for 5 min at 37°C. Cells were then 
washed twice with K+-free buffer and then incubated in the same buffer for 30 min at 
68
37°C followed by incubation with rabbit anti-GFP antibody in K+-free buffer for 30-
60 min before subjecting to immunofluorescence microscopy.  As controls, parallel 
cultures were incubated in the same buffer supplemented with 10 mM KCl after 
hypotonic shock. 
 
2.11.2 Hypertonic treatment 
 
Cells were washed twice with hypertonic medium (DMEM supplemented with 0.45 
M sucrose) and then incubated in the same medium for 30 min at 37°C. Rabbit anti-
GFP antibody was added and incubated for 30-60 min before cells were fixed and 
mounted and subjected to immunofluorescence microscopy. As control, after 
hypertonic treatment, cells were incubated with antibody in DMEM. 
 
2.11.3 Inhibition of endocytosis using Eps15 mutants 
 
FLAG-tagged mutants of Eps15 (FLAG-EH29, FLAG-DIII and FLAG-D3Δ2) were 
transiently expressed in HeLa cells or stable VAMP4-EGFP-expressing HeLa cells. 
Transfected cells were incubated with either AlexaFluor 555 (AF555)-conjugated 
transferrin (Tf-AF555) (Molecular Probes, Eugene, OR, USA) alone or Tf-AF555 and 







2.11.4 Clathrin knock-down 
 
Clathrin was knocked-down in HeLa cells expressing VAMP4-EGFP using short 
interfering RNA (siRNA) designed against clathrin heavy chain (CHC). As control, 
parallel culture was transfected with scrambled siRNA (scRNA). The sequences for 
the siRNA and scRNA for CHC as well as the knock-down process will be described 
in detail in section 2.14. 48 hours after the second transfection, cells were incubated 
with rabbit anti-GFP antibody for 10 min at 37oC, followed by 30 min chase. The 
internalization of anti-GFP antibody was performed in the continuous presence of Tf-
AF555. The endocytosed antibody, Tf-AF555 and the EGFP signal were then 
revealed by fluorescence microscopy. 
  
2.12 Recycling perturbation 
 
2.12.1 Thermal perturbation 
 
Cells were washed twice with cold DMEM and then incubated at 18°C for 15 min. 
FITC -conjugated transferrin (Tf-FITC) alone or rabbit anti-GFP antibody and 
AlexaFluor 647 (AF647)-conjugated transferrin (Tf-AF647) (Molecular Probes) were 
added followed by further incubation at 18°C for 1 hour.  As controls, parallel 
cultures were either incubated with antibody and/or ligand at 18°C or subjected to 
further incubation in fresh DMEM for 30 min at 37°C after the 18oC block. Cells were 




2.12.2 Pharmacological perturbation 
 
Cells were pre-incubated in culture medium alone or with either 50 nM of BFLA1 or 
100 nM of ConA (Sigma) in DMEM at 37°C for 30 min. After the pre-incubation, 
rabbit anti-GFP antibody and/or fluorescent dye-conjugated transferrin were added to 
the cells and incubated in the presence or absence of drugs for 30 min at 37°C before 
cells were fixed for immunoflorescence microscopy. As controls, parallel cultures 
were washed twice with DMEM after treatment and then subjected to further 30 min 
incubation in fresh DMEM in the absence of drugs at 37°C.  
 
2.12.3 Nocodazole treatment 
 
Cells were pre-treated with either 33 μM of nocodazole (Calbiochem, Darmstadt, 
Germany) or 0.1% DMSO (dimethyl sulfoxide) as a control in DMEM for 30 min at 
37°C. After the pre-treatment, cells were incubated with rabbit anti-GFP antibody for 
30-60 min at 37°C in the continuous presence of either nocodazole or DMSO. 
 
2.13 Acid stripping 
 
Cells were incubated at 4°C with rabbit anti-GFP antibody in cold DMEM for 1 hour. 
Unbound antibodies were removed by a brief rinse with cold DMEM. The cells were 
then incubated at 37°C for 15 min in fresh DMEM.  Cells were then washed twice in 
cold acid stripping buffer (0.2 M acetic acid, 0.5 M NaCl, 0.2% BSA, pH 2.5) to 
remove antibodies that remained on the surface (not internalized).  After rinsing twice 
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with cold PBSCM at 4oC, cells were incubated at 37°C for 30 min in fresh DMEM 




2.14.1 Sequences for siRNAs  
 
All siRNA duplexes were synthesized by Proligo (Sigma). The targeting sequences 
are as followed: 
siRNA for human CHC (Motley et al., 2003; Hirst et al., 2005): 5’- 
UAAUCCAAUUCGAAGACCAAU - 3’ 
Scrambled siRNA for CHC: 5’- AACCGAACUAAUUUUCAGACA – 3’ 
 
2.14.2 siRNA transfection 
 
siRNA duplexes were transfected into HeLa cells or HeLa cells stably expressing 
VAMP4-EGFP with OligofectAMINE (Invitrogen) according to the protocol 
provided by the manufacturer. For efficient knock-down, cells were transfected twice 








 2.15 Brefeldin A (BFA) treatment 
 
NRK cells stably expressed VAMP4-EGFP were incubated with 1 μg/ml of BFA 
(Epicentre Biotechnologies, Madison, WI, USA) for 1 hour at 37°C. Cells were then 
rinsed briefly, followed by fixed and subjected to immunofluorescence microscopy. 
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Chapter 3 
Role(s) of the N-terminal extension of VAMP4 in its targeting  
 
3.1 Dissection of targeting signals at the N-terminal extension of VAMP4  
 
It has previously been shown that VAMP4 contains an autonomous and dominant 
TGN-targeting signal located within the region of the N-terminal extension carrying 
the double-Leu motif and downstream acidic clusters (Zeng et al., 2003). This was 
deduced mostly through immunofluorescence microscopy analysis of EGFP-tagged 
VAMP4 and VAMP5, and their various chimeras as well as deletion mutants. In the 
present study, a number of these constructs were further analysed, namely VAMP4-
EGFP, VAMP5-EGFP and V4nV5-EGFP. V4nV5-EGFP is a chimera consisting of 
the 48-residue N-terminal extension of VAMP4 fused to the N-terminus of VAMP5-
EGFP. The detailed construction of these proteins is described in Zeng’s report (2003) 
and also in section 2.2.2. Schematic diagrams for these constructs are illustrated in 
Figure 6A. Both VAMP4-EGFP and V4nV5-EGFP are found to be located at the 
TGN. VAMP5-EGFP is found at the PM and also at the perinuclear region, which is 
likely to representing those molecules in transit through this compartment (Zeng et 
al., 2003). 
 
To identify the key residues in the N-terminal extension of VAMP4 that are crucial 
for the TGN targeting capability, five different mutants were created via site-directed 
mutagenesis in the context of the V4nV5-EGFP chimera (Figure 6B). The double-Leu 
motif (residues 25–26) of V4nV5-EGFP/LL-AA (V4nV5-LL) was replaced by two 
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Figure 6: The schematic illustration of the EGFP-fusion protein expression constructs for VAMP4, VAMP5, V4nV5 and
 
mutants of V4nV5
A: The expression constructs for VAMP4-EGFP, VAMP5-EGFP and V4nV5-EGFP.
 
The entire coding region of VAMP4 
(pink) and VAMP5 (yellow) was inserted into pEGFP-N1 vector so that VAMP4 and VAMP5 are expressed as C-terminally 
EGFP-tagged proteins. The EGFP tag is illustrated in green. The coding region of the N-terminal extension (residue 1-48) of 
VAMP4 was fused in-frame with the second residue of VAMP5 to create a construct for
 
expressing V4nV5-EGFP (which 
consists of VAMP4 N-terminal extension fused to VAMP5-EGFP). NE, N-terminal extension; SNARE, SNARE domain; TM, 
transmembrane domain. 
B: The schematic illustration for the expression constructs of V4nV5-EGFP and its mutants.
 
Site-directed mutations 
were created in the context of V4nV5-EGFP. V4nV5-EGFP/LL-AA has the double-Leu motif (residues 25–26) replaced by two 
Ala residues. The first acidic cluster EDD (residues 27–29) was mutated into three Ala residues in V4nV5-EGFP/EDD-3A. The 
Ser30 residue was replaced by Ala in V4nV5-EGFP/S-A. V4nV5-EGFP/DEEED-5A has the distal acidic cluster (DEEED, 
residues 31–35) replaced by a stretch of five Ala residues. The two Phe residues at positions 36–37 were replaced by Ala 
residues in V4nV5-EGFP/FF-AA. 
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by three Ala residues in V4nV5-EGFP/EDD-3A (V4nV5-EDD). In V4nV5-EGFP/S-
A (V4nV5-SA), the serine-30 residue (Ser-30) between the two acidic clusters was 
changed to an Ala residue. The distal acidic cluster (DEEED, residues 31–35) was 
replaced by a stretch of five Ala residues in V4nV5-EGFP/5A (V4nV5-5A), whereas 
the two phenylalanine (Phe) residues at positions 36–37 were replaced by Ala 
residues in V4nV5-EGFP/FF-AA (V4nV5-FF). These constructs were transfected into 
NRK cells. Stably transfected cells expressing the chimeric proteins were selected 
with G418, pooled, and expanded. The subcellular distribution of the various mutant 
forms of V4nV5-EGFP was then analysed by immunofluorescence microscopy. 
 
As shown in Figure 7, V4nV5-EGFP was primarily detected in the Golgi apparatus, 
as it was colocalized with the Golgi marker GM130 (panels p-r). This is consistent 
with the previous report of Zeng et al. (2003). The mutants V4nV5-EDD (panel d), 
V4nV5-SA (panel g), and V4nV5-FF (panel m) were also found to be similarly 
colocalized with GM130, suggesting that the first acidic cluster downstream of the 
double-Leu motif, the Ser-30 residue, and the two Phe residues following the second 
acidic cluster are not essential for the TGN targeting of V4nV5-EGFP. In marked 
contrast, the majority of V4nV5-LL was detected on the PM (Figure 7, panel a), 
clearly establishing a role of this double-Leu motif in mediating V4nV5-EGFP TGN 
targeting. Another mutant, V4nV5-5A was also observed to be no longer confined to 
the TGN, and it was also broadly distributed across the cell in a diffuse pattern 
(Figure 7, panel j). This suggests a role for the second acidic cluster in mediating 
efficient targeting of the chimeric protein. As the overall distributions of V4nV5-LL 























Figure 7: The double-Leu
 








fusion proteins are green, endogenous GM130 is red. The merged images are also shown. Bar: 50μm.
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cluster may play overlapping, but distinct roles in a concerted action to regulate 




Prior to this study, Zeng et al. (2003) had defined the region containing the TGN-
targeting signal in the N-terminal extension of VAMP4. The current study aimed to 
further identify the key residues in this region by using Ala mutagenesis screening. 
Several mutations were generated in a V4nV5-EGFP chimeric background instead of 
VAMP4-EGFP.  The distributions of V4nV5-EGFP and VAMP5-EGFP are distinctly 
different: V4nV5-EGFP is located at the TGN; while VAMP5-EGFP is found at both 
the perinuclear region and the PM (Zeng et al., 1998; Zeng et al., 2003). Therefore, if 
the  dominant targeting signal of VAMP4 was impaired, the default signal in VAMP5 
would influence the targeting of the chimeric proteins to the PM. Thus, mutations 
within V4nV5-EGFP would be expected to yield more predictable, clearer and more 
meaningful phenotypes than when similar mutations are analyzed in the VAMP4 
background. 
 
A previous study of Peden et al. (2001) has shown that mutation of the double-Leu 
motif in VAMP4 affects its TGN targeting, suggesting that it is a signal necessary for 
the TGN targeting of VAMP4. Consistent with the report of Peden et al. (2001), the 
immunofluorescence results presented here using a series of point mutations in the 
chimera V4nV5-EGFP have also established that the double-Leu motif is important 
for efficient TGN targeting. The results also show that the first acidic cluster, the Ser-
30 residue between the two acidic clusters, and the di-Phe motif are not essential for 
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the targeting of V4nV5-EGFP to the TGN. Furthermore, this study also clearly 
establishes a role for the second acidic cluster in mediating efficient TGN targeting. 
Because the mutation of the double-Leu and the second acidic cluster have different 
effects on the localization of the mutants, these two structural features may work in 
tandem to mediate TGN targeting of VAMP4. Further studies are needed to 
understand how these two structural motifs regulate the TGN targeting of VAMP4. 
 
TGN-targeting signals based on double-Leu and/or acidic residues have been shown 
in other proteins, including sortilin, LDL receptor-related protein 3 (LRP3), CI-
M6PR, CD-M6PR, β-site APP (amyloid precursor protein)-cleaving enzyme 2 
(BACE2), p55 tumor necrosis factor receptor 1 (TNFR1p55), furin, and PC6B (Ghosh 
et al., 1998; Molloy et al., 1999; Xiang et al., 2000; Nielsen et al., 2001; Kato et al., 
2002; He et al., 2002; Storey et al., 2002). In these proteins, the acidic cluster is 
usually found upstream of the double-Leu motif, which is usually near the C-terminal 
region. In VAMP4, the acidic cluster is instead located downstream of the double-Leu 
motif. These structural motifs of VAMP4 are not near the end of the polypeptide. 
These differences may indicate different mechanisms of targeting and/or could be 
partially explained by the differences in membrane topologies of VAMP4 to the 
mentioned proteins. As type I integral membrane proteins, the signals in sortilin, 
LRP3, CI-M6PR, CD-M6PR, BACE2, and TNFR1p55 are located in the very C-
terminal cytoplasmic domain in such a way that the acidic cluster, which is found 
upstreams of the double-Leu motif, is located closer to the lipid bilayer. For the tail-
anchored VAMP4, the acidic cluster is located downstreams of the double-Leu motif. 
However, the acidic cluster is actually closer than the double-Leu motif relative to the 
lipid bilayer. In this consideration, the geometry of VAMP4 signal relative to the lipid 
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bilayer is similar to the aforementioned type I proteins except that the polarity of the 
polypeptide backbone is reversed. Although the underlying mechanism for the action 
of this VAMP4 targeting signal remains to be explored, one possible model could be 
proposed based on our knowledge of VAMP4 and the mechanisms of action of 
double-Leu and acidic cluster signals of other proteins. The TGN targeting of sortilin, 
furin, and TGN38 involves internalization from the PM followed by selective delivery 
from either the SE/RE (such as TGN38) or LE (such as furin) to the TGN (Ghosh et 
al., 1998; Mallet and Maxfield, 1999). VAMP4 may follow similar pathway(s) to 
achieve a steady- state accumulation in the TGN. For example, the double-Leu motif 
may be first exploited for efficient endocytosis from the PM (Kirchhausen, 1999; 
Rohn et al., 2000). Once in the endosome, the distal acidic cluster may act alone or in 
conjunction with the double-Leu motif to mediate specific transport to the TGN. This 
scenario could explain the observed accumulation of mutant V4nV5-LL in the PM 
(Figure 7, panel a), as this mutant is expected to have defects in internalization from 
the PM according to this scenario.  
 
The accumulation of V4nV5-5A mutant in a diffused manner (Figure 7, panel j) could 
potentially be explained by a defect in efficient concentration in the endosomes and/or 
transport to the TGN. As the double-Leu motif is still intact in this mutant, 
endocytosis from the plasma membrane still occurs, as accumulation of this mutant on 
the plasma membrane is not observed. The acidic TGN signal of furin and the acidic 
cluster double-Leu-based signal of CI-M6PR are known to be regulated by Ser 
phosphorylation mediated by CKII (or related kinases), such that phosphorylation of 
Ser residue(s) within the acidic cluster enhances the interaction of the signal with 
PACS-1 (phosphofurin acidic cluster sorting protein 1) and GGA1–3, respectively 
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(Molloy et al., 1999; Kato et al., 2002). Interaction of phosphorylated furin with 
PACS-1 is implicated in its delivery from the endosome to the TGN. 
Dephosphorylation by protein phosphatase 2A reduces the affinity of the furin acidic 
signal for PACS-1 (Molloy et al., 1999). Also, Hinners et al. (2003) has reported that 
the phosphorylation of the Ser-30 residue between the two acidic clusters in VAMP4 
is important for the interaction of VAMP4 with AP-1. They have also found that 
when both the Ser-30 and the double-Leu motif are mutated, the mutant is mislocated 
to the ACTH (Adrenocorticotropic hormone)-positive MSGs at the tips of AtT20 cell, 
implying that the dynamic accumulation of VAMP4 in the TGN can be potentially 
regulated by phosphorylation and dephosphorylation of this Ser-30 residue. 
Therefore, this study examined this possibility by replacing Ser-30 with an Ala 
residue. However, since the resulting mutant V4nV5-SA was primarily detected in the 
Golgi apparatus (Figure 7, panel g), it seems that Ser-30 phosphorylation is not 
essential for Golgi accumulation, although a role for this residue in other aspects of 
trafficking can not be formally excluded. The double-Leu motif has been shown to be 
important for VAMP4 to interact with the AP-1 adaptor complex that is operational 
between the endosome and TGN (Peden et al., 2001). Taken together, these 
observations suggest that VAMP4 may follow a recycling pathway between the PM 
and the TGN. Its TGN-targeting signal, such as the double-Leu motif and the second 
acidic cluster, may act in this recycling pathway to regulate the steady state 
distribution of VAMP4, possibly through the interaction with AP-1 and/or other 
cytosolic factors to govern the selective trafficking from the endosome to the TGN. 
The detection of some VAMP4 in the SE compartment (Mallard et al., 2002) is in 
agreement with this possibility. To examine this proposed model, this study 
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VAMP4-EGFP recycles from the plasma membrane to the TGN 
 
4.1 VAMP4-EGFP is faithfully targeted to the TGN 
 
Due to the topology of VAMP4, there are limited available approaches for studying 
the recycling of endogenous VAMP4. Therefore, it was necessary to investigate the 
transport of a fusion protein VAMP4-EGFP instead of endogenous VAMP4. 
Consequently, for the findings with the tagged protein to be considered as accurate 
reflections of the physiological behaviour of VAMP4, it was important to show that 
VAMP4-EGFP was able to behave like endogenous VAMP4. Since the function of a 
SNARE protein is primarily regulated by its localization (Hong, 2005), this study first 
investigated the subcellular localization of VAMP4-EGFP using immunofluorescence 
microscopy. VAMP4-EGFP construct was stably expressed in NRK cell. Figure 8 
shows that the majority of VAMP4-EGFP was found in the perinuclear structures that 
were marked by TGN38 (panels a-c), a marker of the TGN (Luzio et al., 1990). The 
result suggests that the majority of VAMP4-EGPF was targeted to the TGN. To 
further confirm this observation, we took advantage of the fact that proteins in the 
Golgi stack and TGN respond differently to the treatment of fungal metabolite BFA 
(Klausner et al., 1992; Gu et al., 2001). When cells were treated with BFA, VAMP4-
EGFP (Figure 8, panels e, h and k), as well as the TGN protein TGN38 (panel d), 
were re-distributed into a compact structure. This compact structure was found near 
the microtubular organizing center (MTOC) marked by pericentrin (Doxsey et al., 
1994). This restribution of VAMP4-EGFP under BFA treatment is a characteristic 
response of proteins in the TGN, such as TGN38 (Reaves and Banting, 1992) or 
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localization of VAMP4-EGFP in NRK stable cells was visualized using immunofluorescence
 
microscopy (panels a-c). 
EGFP signal is green, TGN38 is red.
NRK cells stably expressing VAMP4-EGFP were incubated with 1μg/ml BFA for 1 hour. Cells were then fixed and subjected to 
immunofluorescence
 
microscopy. EGFP-VAMP4 is green; endogenous TGN38 (panels d-f) or pericentrin
 
(panels g-i) or Ykt6 (panels 





endogenous VAMP4 (Steegmaier et al., 1999; Klausner et al., 1992). In contrast, the 
majority of Ykt6, a Golgi SNARE (Zhang and Hong, 2001), was redistributed into an 
endoplasmic reticulum-like labeling (Figure 8, panel j). These results indicate that, 
similar to endogenous VAMP4, VAMP4-EGFP was faithfully targeted to the TGN. 
These results are also consistent with the findings in the previous study of Zeng et al. 
(2003). Therefore, VAMP4 C-terminally tagged with EGFP is correctly targeted to its 
subcellular destination in the stable transfectants.  
 
4.2 VAMP4-EGFP is incorporated into an authentic SNARE complex 
 
This study next opted to show that the EGFP-tagged VAMP4 behaved in a similar 
fashion to VAMP4 by demonstrating the ability of VAMP4-EGFP to form a complex 
with endogenous cognate SNARE partners of VAMP4 by immunoprecipitation 
(Figure 9). 
 
VAMP4-EGFP-expressing NRK cells were incubated on ice with NEM, which would 
inactivate NSF and thus stabilize the formed SNARE complexes within cells, 
followed by the quenching of excess NEM with DTT. As a control, cells were treated 
in parallel with only DTT-treated NEM (inactivated NEM) on ice. After a 30 min 
recovery at 37oC in normal medium, cells were then lysed and the extracted proteins 
were processed for immunoprecipitation using either rabbit-anti-GFP antibody or 
control rabbit IgG. The immunoprecipitates were subjected to SDS-PAGE and 
Western Blot and probed for the presence of the SNARE interacting partners of 
VAMP4: STX6, STX16 and Vti1a (Mallard et al., 2002). VAMP3 was used as the 












































Figure 9: VAMP4-EGFP is incorporated into an authentic SNARE complex
VAMP4-EGFP-expressing NRK cells were treated with either NEM or DTT-quenched NEM.  Cells were then lysed
 
and 
the extracted proteins were used for immunoprecipitation
 







as indicated. Syntaxin6 (STX6), syntaxin16 (STX16) and Vti1a but 




co-immunoprecipitated with VAMP4-EGFP in a NEM-dependent manner. This 
established that VAMP4-EGFP is able to incorporate into an authentic SNARE 
complex, and hence behave like the native VAMP4. This EGFP-tagged protein was 
consequently used in further experiments. 
 
4.3 The N-terminal region of VAMP4 participates in regulating its recycling 
from the plasma membrane to the TGN 
 
To investigate the recycling of VAMP4 from the PM to the TGN, NRK cells stably 
expressing VAMP4-EGFP were incubated with rabbit antibody against GFP at 37°C 
for 60 min. Antibodies binding to VAMP4-EGFP at the cell surface will be 
internalized together with VAMP4-EGFP, thus providing a useful assay for 
monitoring the recycling of the EGFP-fusion protein from the PM to the TGN. In this 
internalization experiment, the majority of internalized antibody was observed to 
colocalize with VAMP4-EGFP in the perinuclear region (Figure 10A, panel b). Since 
VAMP4-EGFP has been shown to be primarily localized at the TGN (Figure 8, Zeng 
et al., 2003), this result suggests that the antibody was bound to and internalized 
together with VAMP4-EGFP from the PM to the TGN. Some antibody molecules 
were also seen in vesicular structures characteristic of endosomes (panels b-c), 
suggesting that endosomes could be intermediates in the recycling of VAMP4-EGFP 
from the PM to the TGN. This is consistent with the fact that the antibody was 
internalized continuously and expected to mark transport intermediates in addition to 
the site of their steady state accumulation. Similar result was also observed when anti-











Figure 10: The N-terminal extension of VAMP4 mediates its recycling from the PM to the TGN
A: NRK cells stably expressing VAMP4-EGFP (panels a-c), VAMP5-EGFP (panels d-f) and V4nV5-EGFP (panels g-i) were 
incubated at 37oC in the continuous presence of anti-GFP antibody for 60 minutes. EGFP-fusion proteins are green; 












B: The experiment  was performed as in 9A with NRK cells stably expressing VAMP5-EGFP. Cells were then either fixed 
(panels a-c) or subjected to acid wash to strip off antibody remaining bound on the surface before being fixed for 
immunofluorescence
 
microscopy (panels d-f). EGFP-fusion proteins are green; internalized anti-GFP is red. The merged 
images are also shown (panels c and f). Bar: 50μm
Figure 10: The N-terminal extension of VAMP4 mediates its recycling from the PM to the TGN
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expressing VAMP4-EGFP (Figure 11). These results indicate that VAMP4 travels 
from the PM to the TGN.  
 
To study the function of the N-terminal extension of VAMP4 in the transport of the 
protein, the antibody internalization assay was performed with NRK cells stably 
expressing either VAMP5-EGFP or V4nV5-EGFP (Figure 10A). In contrast to the 
Golgi-localization of VAMP4-EGFP, VAMP5-EGFP was found predominantly at the 
PM with some distribution in the Golgi and other vesicular structures in the peripheral 
cellular regions (Figure 10A, panel d; Figure 10B, panels a and d), consistent with 
earlier reports (Zeng et al., 1998; Zeng et al., 2003). Cells expressing VAMP5-EGFP 
were found not to direct internalized antibody to the Golgi (Figure 10A, panels e-f; 
Figure 10B, panel b). The majority of antibody remained associated with the cell 
surface since these signals could be removed by surface stripping with acid buffer 
(Figure 10B, panel e). V4nV5-EGFP was found predominantly associated with the 
Golgi apparatus (Figure 10A, panel g). Significantly, cells expressing V4nV5-EGFP 
were able to internalize and direct the transport of anti-GFP antibody to the Golgi 
apparatus. In addition, some antibody signals were also observed in vesicular 
structures (Figure 10A, panels h-i), suggesting that the N-terminal extension of 
VAMP4 not only confers Golgi targeting on VAMP5-EGFP but also endows upon it 
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Figure 11: VAMP4-EGFP recycles between the PM and the TGN in MDCK cells
MDCK cells stably expressing VAMP4-EGFP were incubated at 37oC in the continuous presence of anti-GFP antibody for 
30 min. EGFP signal is green, internalized anti-GFP is red. The merged image is also shown (panel c). Bar: 50μm
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4.4 Low but detectable amounts of VAMP4-EGFP and V4nV5-EGFP are 
present on the PM  
 
The results from the antibody internalization assay suggest that at least some 
VAMP4-EGFP and V4nV5-EGFP are present on the cell-surface. To confirm the 
immunofluorescence results, surface biotinylation was employed to assess the plasma 
membrane distributions of various EGFP-tagged VAMP proteins. The underlying 
principle of this approach is that when cells are incubated with membrane 
impermeable sulfo-NHS-biotin at 4°C, only proteins that are exposed on the 
extracellular side of the plasma membrane would be accessible to biotinylation, 
whereas proteins in the cytosol or the intracellular compartments such as the Golgi 
apparatus would not be biotinylated (Low et al., 1991). Since the EGFP portion of 
these tagged proteins is located either in the lumen of intracellular compartments or 
exposed to the extracellular environment (Figure 12), the extent of biotinylation of 
various EGFP-fusion proteins would be a reliable assessment of the portion found at 
the PM.  
 
Untransfected NRK cells, stable transfectants expressing VAMP5-EGFP, VAMP4-
EGFP, and V4nV5-EGPF were each surface-biotinylated. Figure 13 shows the 
biotinylated proteins analyzed by immunoblotting. VAMP proteins were detected 
using anti-GFP antibody. α5 integrin was used as a positive control for a surface-
exposed protein (Laukaitis et al., 2001), whereas another TGN SNARE protein, Vti1a 
served as a negative control. The result shown in the upper panel of Figure 13 was 
from a short (5 seconds) exposure of the Western Blot nitrocellulose membrane to 
















Figure 12: Study the transport of proteins that recycle between the PM and intracellular compartments using 
antibody internalization assay 
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Figure 12: Study the transport of proteins that recycle between the PM and intracellular compartments using 
antibody internalization assay 
A: For integral membrane proteins.
 
The antibody in the extracellular
 
medium recognizes and binds to the exposed 
extracellular
 
domain of the interested protein on the cell surface. The bound
 
antibody would then be internalized and 
transported together with the interested protein inside the cell
 
to other intracellular compartments. By using a dye-conjugated 
secondary antibody to detect the bound antibody, the transport of the interested protein can be studied.
B: For tail-anchored proteins.
 
Tail-anchored protein does not have a lumenal/extracellular
 
domain that would be exposed 
on the cell surface. Thus, it cannot be recognized and bound by extracellular
 
antibody and the transport of tail-anchored 
protein cannot be studied using antibody internalization assay.
C: For EGFP-fusion tail-anchored proteins. The EGFP tag is fused behind the transmembrane
 
domain and serve as the 
lumenal/extracellular
 
domain. As the fusion protein is transported to the plasma membrane, this EGFP tag would be exposed 
on the cell surface. Extracellular
 
anti-GFP antibody would bind to the EGFP tag and subsequently be internalized and 
transport inside the cell together with the fusion protein. By using a dye-conjugated secondary antibody to detect the bound 









































































































Figure 13: Low but detectable amounts of VAMP4-EGFP and V4nV5-EGFP are accessible to surface biotinylation
NRK cells or stable pooled NRK expressing VAMP4-EGFP, VAMP5-EGFP, or V4nV5-EGFP were subjected to cell surface 
biotinylation. The biotinylated
 
proteins were then isolated using streptavidin-agarose. Bound proteins on the beads, along with 
20% of cell lysates
 
were analyzed by Western blot as indicated. The result shown in
 
the upper panel was from a short (5 
seconds) exposure. Biotinylated
 
VAMP5-EGFP is indicated by red hash. Biotinylated
 
VAMP4-EGFP is marked by red asterisk. 




and V4nV5-EGFP are 
indicated by red asterisk.
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was clearly accessible to surface biotinylation.  Similarly, the surface protein α5 
integrin was also readily detected at this short exposure. Biotinylated VAMP4-EGFP 
was very faintly detected (indicated by red asterisk). In contrast, Vti1a and V4nV5-
EGFP were not detected in the pulled-down (biotinylated) samples. However, when 
the same Western Blot membrane was exposed for a longer time (60 seconds), the 
result (Figure 13, the lower panel) shows that small portions of VAMP4-EGFP and 
V4nV5-EGFP (indicated by red asterisks) were accessible to surface biotinylation. 
This was not a non-specific signal since the other TGN SNARE, Vti1a, was still 
undetectable at this longer exposure. Therefore, the results show that low but 
detectable amounts of VAMP4-EGFP and V4nV5-EGFP are present on the cell 
surface. 
 
4.5 VAMP4-EGFP and V4nV5-EGFP are transported to the TGN via 
vesicular intermediates 
 
From the results of the antibody internalization assay described in section 4.2, when 
the antibody molecules were allowed to internalize continuously into cells expressing 
VAMP4-EGFP and V4nV5-EGFP, there were some antibody signals observed in 
peripheral vesicular structures (Figure 10A, panels b and h). This indicates that these 
vesicular structures may represent intermediates involved in the transport of VAMP4-
EGFP and V4nV5-EGFP from the PM to the TGN. To investigate this possibility, the 
kinetics and subcellular structures involved in one round of transport of the EGFP-
fusion proteins from the PM to the TGN were examined. NRK cells stably expressing 
VAMP4-EGFP were incubated with anti-GFP antibody on ice. The low temperature 
treatment allows the binding of anti-GFP antibody to VAMP4-EGFP at the PM but 
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not the internalization of the antibody-protein complex. After one hour of incubation, 
unbound antibody was washed off. Cells were then incubated at 37oC to allow the 
VAMP4-EGFP proteins at the PM to cycle back to the TGN, together with the bound 
antibody. The transport of these EGFP-fusion protein molecules back to the TGN was 
investigated through the detection of their bound anti-GFP antibody using 
immunofluorescence microscopy (Figure 14, upper panels).  
 
The antibody was first detected as fine punctated structures distributed across the cell 
surface before the culture was warmed up to 37°C (Figure 14, upper panels, 0 
minute). The majority of the cellular VAMP4-EGFP was mainly confined to the TGN 
(green signals, Figure 14, upper panels). The signal of VAMP4-EGFP itself at the PM 
was not observed, probably because the amount of VAMP4-EGFP at the PM is too 
low to be detected by fluorescence microscopy. After incubation at 37°C for 4 min, 
antibody was detected in larger clusters in both peri-Golgi and peripheral regions. 
Antibody labeling became increasingly enriched in the TGN after 8-15 min of 
incubation at 37°C with a concomitant decrease of antibody labeling in the peripheral 
vesicular structures. The majority of the antibody was found concentrated in the TGN 
from 30 min onward. These results suggest that recycling of VAMP4-EGFP involves 
internalization from the cell surface followed by vesicular intermediates that move 
from the peripheral to the peri-Golgi region and eventually to the TGN. Similar 
results were observed when cells expressing V4nV5-EGFP were examined (lower 
panels, Figure 14), suggesting that the N-terminal extension can mediate endocytosis 
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Figure 14: Involvement of vesicular intermediates in VAMP4-EGFP recycling
NRK cells expressing VAMP4-EGFP (upper panels) or V4nV5-EGFP (lower panels) were incubated with anti-GFP antibody at 
4oC for 1 hour to allow binding of antibody to surface EGFP-fusion proteins. After a brief washing, cells were incubated at 
37oC in the absence of antibody for the indicated periods of time to follow the trafficking of fusion protein-bound antibody. 




The antibody internalization assay and immunofluorescence microscopy are two 
common methods that have been used in a number of reports that study the recycling 
of various proteins between the PM and the endosome/TGN (Molloy et al., 1994; 
Ghosh et al., 1998; Mallet and Maxfield, 1999; Lin et al., 2004, to say a few). These 
studies have made use of the fact that the reported proteins are integral membrane 
proteins, which possess lumenal/extracellular domains. When these proteins reach the 
PM, their lumenal domains would be exposed on the cell surface. Specific antibodies 
are then able to bind to these extracellular domains and follow the proteins of interest 
through their recycling back to the TGN. By investigating the transport of the 
internalized antibodies using immunofluorescence microscopy, one can study the 
transport of the proteins of interest (Figure 12A).  
 
As the first step in examining the tentative TGN targeting model of VAMP4, these 
approaches were employed to investigate the trafficking pathway of VAMP4. 
However, the application of these methods in studying tail-anchored proteins (such as 
VAMP4) is severely limited due to their lack of the extracellular domains (Figure 
12B). Therefore, to overcome this problem, it was necessary to use a C-terminally 
tagged VAMP4-EGFP in this study (Figure 12C). It was first necessary to determine 
if the fusion protein function similarly to endogenous VAMP4. The function of 
SNAREs is primarily regulated by their accurate targeting to their destined 
localizations (Sollner et al., 1993b; Jahn and Sudhoff, 1999; Lin and Scheller, 2000; 
Chen and Scheller, 2001; Bock et al., 2001; Hong, 2005). Furthermore, a SNARE acts 
together with its cognate partners in the context of a SNARE complex to regulate the 
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docking-fusion step in vesicular trafficking (Chen and Scheller, 2001; Rothman, 
2002; Jahn et al., 2003; Sudhof, 2004; Hong, 2005). Using immunofluorescence 
microscopy analysis, it is demonstrated that VAMP4-EGFP is correctly localized at 
the TGN (Figure 8; Zeng et al., 2003). Furthermore, the ability of VAMP4-EGFP to 
interact with the endogenous partners of VAMP4 was also confirmed by 
coimmunoprecipitation. The results thus demonstrate that the EGFP tag does not 
interfere with the function of this v-SNARE protein. VAMP4-EGFP is therefore 
validated for use in further experiments to dissect the transport pathway of VAMP4. 
 
The next step in this study was to investigate if VAMP4-EGFP would cycle between 
the TGN and the PM. The hypothesis is that VAMP4-EGFP would be circulating 
from the TGN to the PM and thus its transport from the PM back to the TGN could be 
followed using the antibody internalization assay. The results showed that the 
antibody was successfully internalized and transported to the TGN in cells expressing 
VAMP4-EGFP, indicating that VAMP4-EGFP indeed recycles from the PM back to 
the TGN. A similar result was obtained with the chimera V4nV5-EGFP but not with 
VAMP5-EGFP, suggesting that the N-terminal extension of VAMP4, which contains 
its TGN-targeting signal, plays an important role in regulating this recycling. This 
suggests the possibility of a connection between the TGN-targeting signal and the 
recycling pathway of VAMP4 to maintain the steady state distribution of this SNARE 
protein in cells.  
 
Since the extracellular anti-GFP antibody was able to bind to the EGFP-fusion 
SNAREs and be transported together into the cells, VAMP4-EGFP and V4nV5-EGFP 
should be detectable on the cell surface using other methods. However, immuno-
102
 electron microscopy studies did not show any detectable labeling of VAMP4 at the 
PM (Steegmaier et al., 1999). In a previous study using selective biotinylation assay 
(Zeng et al., 2003), V4nV5-EGFP was also not detected on the cell surface. In an 
attempt to address this seemingly contradictory finding, the biotinylation assay was 
performed again with different parameters. Careful inspection showed that there are 
low but detectable amounts of VAMP4-EGFP and V4nV5-EGFP at the PM. Taken 
together with the fact that even in NRK cells stably expressing VAMP4-EGFP, 
conventional detection of GFP signal did not reveal significant expression of 
VAMP4-EGFP on the cell surface, the results suggest that the low and possibly 
transient appearance of recycling VAMP4 on the PM may limit its detection by 
immunogold labeling.  Furthermore, the levels of endogenous VAMP4 in many cell 
lines are not high enough, resulting in the detection of VAMP4 mainly in the TGN 
where it is mainly localized.  Thus, the findings in this study are not inconsistent with 






VAMP4-EGFP recycles from the plasma membrane to the TGN primarily 
through clathrin-dependent endocytosis and via the SE/RE compartments 
 
5.1 VAMP4-EGFP is transported primarily via clathrin-dependent 
endocytosis 
 
To delineate the molecular aspects of VAMP4-EGFP recycling, the mode of VAMP4-
EGFP endocytosis from the surface was investigated. Since VAMP4 is known to be 
present in TGN-derived clathrin-coated vesicles (Steegmaier et al., 1999), a number 
of inhibitors of clathrin-mediated endocytosis (from general to specific) were 
employed to determine whether the internalization of VAMP4-EGFP is dependent on 
clathrin. The findings are described in detail in the following sections. 
 
5.1.1 The endocytosis of VAMP4-EGFP in cells under either potassium 
depletion or hypertonic treatment 
 
Potassium depletion and hypertonic treatment are two known inhibitors of clathrin-
mediated endocytosis. Both sequester clathrin from membrane and thus inhibit the 
formation of clathrin-coated pits, which, in turn, inhibits endocytosis (Larkin et al., 
1983; Daukas and Zigmond, 1985; Madshus et al., 1987; Heuser and Anderson, 1989; 
Hansen et al., 1993). In this study, the antibody internalization assay was performed 
in VAMP4-EGFP expressing NRK cells under these conditions. The results are 




























Figure 15: Inhibition of internalization of VAMP4-EGFP by either potassium depletion or hypertonic treatment
A:
 
After a hypotonic shock, NRK cells expressing VAMP4-EGFP were incubated with anti-GFP in the absence (panels a-
 
f) or presence (panels g-l) of K+
 
for 30 (panels a-c and g-i) or 60 min (panels d-f
 
and j-l). EGFP-fusion protein is green, 






After hypertonic treatment, NRK cells expressing VAMP4-EGFP were incubated with anti-GFP in the presence (panels 
a-f) or absence (panels g-l) of 0.45 M of sucrose for 30 (panels a-c and g-i) or 60 min (panels d-f
 
and j-l). EGFP-fusion 
protein is green, internalized anti-GFP antibody is red. The merged images are also shown (panels c,
 
f, i and l). Bar: 50μm
30 min
60 min
VAMP4-EGFP       Internalized Ab
 
Merge VAMP4-EGFP      Internalized Ab
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Figure 15: Inhibition of internalization of VAMP4-EGFP by either potassium depletion or hypertonic treatment
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When VAMP4-EGFP-expressing cells were depleted of potassium and then allowed 
to bind to and internalize anti-GFP antibody in K+-free medium, the antibody 
remained as fine punctate structures distributed across the cell surface after 30 min of 
incubation at 37°C (Figure 15A, panel b), while the majority of cellular VAMP4-
EGFP was at the TGN (Figure 15A, panel a). The majority of the antibody remained 
surface-distributed even after 60 min incubation in K+-free medium (Figure 15A, 
panel e), indicating that the VAMP4-EGFP proteins at the PM are not internalized 
when cells are depleted of potassium. On the other hand, in parallel cultures, when 
cells depleted of potassium were allowed to internalize antibody in K+-containing 
medium for the same periods of time, efficient delivery of antibody to the TGN was 
observed (Figure 15A, panel h and k).  
 
Similarly, when VAMP4-EGFP-expressing NRK cells were pretreated with 0.45M of 
sucrose (hypertonic medium) and then were allowed to bind to and internalize anti-
GFP antibody for 30 min in hypertonic medium, the antibody was detected primarily 
on the PM (Figure 15B, panel b). Even after 60 min of incubation, the majority of 
antibody failed to be delivered to the TGN in hypertonic buffer (Figure 15B, panel e) 
and the antibody was found to be distributed in peripheral large vesicles. In contrast, 
hypertonically-treated cells transported surface-bound antibody to the TGN when 
incubated in normal medium after only 30 min (Figure 15B, panel h). These results 
suggest that VAMP4-EGFP is internalized primarily via clathrin-mediated 




5.1.2 The endocytosis of VAMP4-EGFP in cells overexpressing dominant 
negative mutant of Eps15, a regulator of clathrin-mediated endocytosis 
 
The EGFR (Epidermal Growth Factor Receptor) pathway substrate clone 15 (Eps15) 
is a component of the plasma membrane clathrin-coated pits. It has been shown that 
Eps15 is constitutively associated with AP-2 (Benmerah et al., 1995, 1996; Tebar et 
al., 1996) and not found in the coated vesicles (Cupers et al., 1998), suggesting that 
its function is coated-pit restricted. Furthermore, there is evidence that Eps15 is 
required for the early steps of clathrin-mediated endocytosis (Carbone et al., 1997; 
Benmerah et al., 1998).  
 
Structurally, Eps15 is composed of three distinct domains (Fazioli et al., 1993; Wong 
et al., 1994): the N-terminal portion contains three repeats of EH (Eps15 homology) 
domains (Wong et al., 1995), followed by a coiled-coil central domain and then a 
proline-rich C-terminal domain. The EH domains are required for the correct clathrin-
coated pits targeting of Eps15 (Benmerah et al., 1999), while the C-terminal domain 
mediates the interaction between Eps15 and AP-2 via three AP-2 binding sites 
(Benmerah et al., 1996, 1998; Iannolo et al., 1997). Using a series of deletion 
mutants, Benmerah et al. (2000) have shown that in addition to the EH domains, the 
AP-2 binding sites also play an important role in targeting Eps15 correctly into the 
clathrin-coated pits. Their study also shows that only Eps15 mutants that still bind 
AP-2 but are not able to correctly localize to clathrin-coated pits would inhibit 
clathrin-coated pits assembly. These mutants (termed EΔ95/295 [or EH29] and DIII) 
also inhibit transferrin uptake, which is used as a marker of the clathrin-mediated 
endocytosis. As another approach in the investigation of the recycling pathway of 
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VAMP4-EGFP from the plasma membrane, the internalization of anti-GFP antibody 
was examined in cells overexpressing these dominant negative mutants. 
 
Figure 16 illustrates the constructs for the Eps15 mutants that were used in this study 
(adapted from Benmerah et al., 2000). The re-cloning of the mutants from EGFP-
fusion proteins into their FLAG-tagged versions is described in Materials and 
Methods, section 2.2.2. Firstly, the inhibitory effects of three mutants: EH29, DIII and 
D3Δ2 on transferrin uptake in HeLa cells were investigated (Figure 17A). The results 
showed that cells expressing either FLAG-EH29 (panels a-c) or FLAG-DIII (panels 
d-f) had much lower level of internalized transferrin, compared to surrounding 
untransfected cells. On the other hand, overexpression of FLAG-D3Δ2 (panels g-i), a 
mutant which could neither bind to AP-2 nor target to clathrin-coated pits, did not 
inhibit the internalization of Tf-AF555. The results are consistent with those reported 
in the study of Benmerah et al. (2000), and the FLAG-tagged versions of the Eps15 
mutants were validated for use in further experiments. 
 
As shown in Figure 17A, the EH29 mutant (panels a-c) had a stronger inhibitory 
effect on the internalization of Tf-AF555 compared to mutant DIII (panels d-f). This 
has also been described previously (Benmerah et al., 2000). Thus, a subsequent 
antibody internalization assay was performed after FLAG-EH29 was transiently 
expressed in HeLa cells stably expressing VAMP4-EGFP. The effect of this mutant 
on the PM-to-TGN transport of VAMP4-EGFP was observed (Figure 17B). Cells 
were incubated with both anti-GFP antibody and Tf-AF647 for 30 min at 37oC. The 
inhibition of Tf-AF647 internalization was used as a surrogate marker for the 






















Eps15 mutants were inserted into pFLAG-C2 vector so that they are expressed as N-terminally FLAG-tagged 
protein. The EH domains were impaired in EH29 mutant due to the deletion of 201 amino acids (residues 95-295) 
from the wild-type Eps15. The DIII construct corresponds to the 368 amino acids at the C-terminus of Eps15 
(residues 529-896). The D3Δ2 constructs was created based on the DIII construct, from which
 
the AP-2 binding 
sites (residues 620-739) had been removed.
Figure 16: The schematic illustration of the expression constructs of FLAG-tagged Eps15 mutants
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Figure 17: Inhibition of endocytosis
 





Eps15 mutants EH29, DIII and D3Δ2 were transiently expressed as FLAG-tagged proteins in HeLa
 
cells. EH29 (panels a-c) 
or DIII (panels d-f), but not D3Δ2 (panels g-I) inhibited internalization of AF555-conjugated transferrin
 
Tf-AF555. Green signals 
are FLAG-fusion proteins; red signals are Tf-AF555. The merged images are also shown (panels c, f and i). Bar: 50μm 111
B:
 
FLAG-EH29 was transiently expressed in HeLa
 
cells stably expressing VAMP4-EGFP. Cells were then incubated with anti-
 
GFP antibody and Tf-AF647 for 30 min at 37oC. VAMP4-EGFP is green; internalized anti-GFP signal is red, Tf-AF647 is blue. 
The merged image is shown in panel d. The inhibition of Tf-AF647 was used as a surrogate marker for the expression of 
EH29. EH29 potently blocked endocytosis
 
of anti-GFP antibody. Bar: 50μm
VAMP4-EGFP                  Internalized antibody                     Tf-AF647                                   Merge
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Figure 17: Inhibition of endocytosis
 




blocked endocytosis of anti-GFP antibody, again indicating that VAMP4-EGFP is 
transported from the PM via clathrin-mediated endocytosis. 
 
5.1.3 The endocytosis of VAMP4-EGFP in cells depleted of clathrin 
 
The transport of VAMP4-EGFP was then examined in cells depleted of clathrin. If 
VAMP4-EGFP recycling is indeed clathrin-dependent, then the internalization of anti-
GFP antibody should be inhibited when clathrin expression is knocked-down using 
siRNA. The siRNA target sequence for human clathrin heavy chain (CHC) has been 
documented previously (Motley et al., 2003; Hirst et al., 2005). The knockdown 
effect of this siRNA on the CHC protein level in HeLa cells is shown in Figure 18A. 
Cells were transfected with either siRNA targeting CHC or scrambled siRNA 
(scRNA). The lysates were then analyzed for the level of CHC by Western blot. The 
results show that the amount of CHC was noticeably reduced in cells that were 
transfected with CHC siRNA, as compared to non-transfected cells or cells 
transfected with scRNA.  
 
Figure 18B shows the effect of CHC depletion on the recycling of VAMP4-EGFP. 
HeLa cells stably expressing VAMP4-EGFP were transfected twice with either 
scRNA (panels a-d) or siRNA targeting CHC (panels e-h) with a 24 hours interval. 
Forty-eight hours after the second transfection, cells were pulse-labelled with rabbit 
anti-GFP antibody for 10 min at 37oC, followed by 30 min incubation in the absence 
of anti-GFP antibody. The internalization of the bound anti-GFP antibody was 
performed in the continuous presence of Tf-AF555. The endocytosed antibody and 





















































cells twice with 
24 hours interval. Cells were harvested 48 hours after the second transfection. The lysates
 
(20μg of proteins for each sample) 
were analyzed for the level of CHC by Western blot.
B:
 









(panels a-d) or siRNA
 
targeting CHC (panels e-h). The internalization of anti-GFP antibody 
was then performed in the continuous presence of Tf-AF555. The inhibition of endocytosis
 
of Tf-AF555 was used as 
surrogate marker for functional knockdown of CHC. VAMP4-EGFP is green; internalized anti-GFP antibody is blue, Tf-AF555 
is red. The merged images are shown in panels d and h. In panel h, cells in which CHC was functionally impaired are marked 
by asterisks; whereas arrows indicate cells with functionally unimpaired CHC. Bar: 50μm
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immunofluorescence microscopy. The inhibition of Tf-AF555 internalization was 
used as a surrogate marker for functional knockdown of CHC. The result shows that 
in cells where transferrin endocytosis was inhibited (marked by asterisk), the 
internalization of anti-GFP antibody was also inhibited; whereas in neighboring cells 
(marked by arrow) where TF-AF555 was endocytosed efficiently, anti-GFP antibody 
was also efficiently internalized to the perinuclear region (where the Golgi and 
transferrin-marked peri-Golgi recycling endosome were likely positioned). The results 
indicate that the transport of VAMP4-EGFP is dependent on clathrin-mediated events.  
 
5.2 VAMP4-EGFP is recycled to the TGN through the SE/RE compartments 
 
5.2.1 The colocalization of internalized anti-GFP antibody with SE and RE 
markers 
 
As shown in section 4.4, vesicular intermediates are involved in transport of VAMP4-
EGFP to the TGN. The nature of these intermediates was examined using the 
antibody internalization assay and immunofluorescence microscopy analysis. NRK 
cells stably expressing VAMP4-EGFP were allowed to bind anti-GFP antibody on 
ice. After the removal of unbound antibody, cells were incubated at 37oC for various 
time periods. The transport of VAMP4-EGFP, together with its bound anti-GFP 
antibody, from the PM back to the TGN, was examined using immunofluorescence 
microscopy.  In addition to the labeling of bound anti-GFP antibody, cells were 
double-labeled with markers of various endosomal compartments of the endocytic 
pathway. The organelles involved in the PM-to-TGN transport of VAMP4-EGFP was 
thus investigated. 
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This study first examined the distribution of internalized anti-GFP antibody in cells 
double-labeling with EEA1; a marker protein of the SE compartments (Figure 19A). 
Internalized antibody was clearly detected in vesicular intermediates that are positive 
for EEA1 after internalization of surface-bound antibody for 2-4 min (2 and 4 min 
panels). The antibody was mainly distributed in the peripheral vesicular structures 
during 2-6 min of internalization; after which, it moved into more peri-Golgi vesicular 
intermediates and remained colocalized with EEA1. During the 4-10 min period of 
internalization, the majority of internalized antibody was seen in EEA1-marked SE 
compartments. The antibody began to segregate away from EEA1-marked SE after 10 
min. By the 20 min time point, the majority of antibody was segregated away from 
EEA1-positive SE and became enriched in the perinuclear region. These results 
suggest that endocytosed VAMP4-EGFP is first delivered to the peripheral EEA1-
marked SE and then to the peri-Golgi intermediates before being transported the 
Golgi apparatus.    
 
This study next compared the distribution of internalized anti-GFP antibody (to mark 
the pathway of VAMP4-EGFP) as well as internalized anti-transferrin receptor (TfR) 
(which marks the SE-to-RE transport) simultaneously (Figure 19B). During the first 5 
min of incubation, anti-GFP antibody colocalized well with anti-TfR antibody, 
primarily in the peripheral intermediates. After 10 min of internalization, a significant 
amount of anti-GFP antibody was observed in anti-TfR-positive peri-Golgi vesicles, 
characteristic of the RE and this colocalization at the peri-Golgi region persisted until 
the 20 min point; but anti-GFP and anti-TfR antibodies became segregated at 40 min. 
These results suggest the peri-Golgi intermediate involved in VAMP4-EGFP 
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Figure 19: VAMP4-EGFP recycles through the SE and RE
A: NRK cells expressing VAMP4-EGFP were incubated with anti-GFP antibody at 4oC for 1 hour to mark the surface pool of VAMP4-
 
EGFP. Cells were then incubated at 37oC in the absence of antibody for the indicated periods of time. Endogenous EEA1 is green, 







5 min 10 min2 min 60 min20 min 40 min
B: NRK cells expressing VAMP4-EGFP were incubated with anti-GFP antibody and anti-TfR
 
at 4oC for 1 hour. After washing, cells 
were then incubated at 37oC in the absence of the antibody for the indicated periods of time. Internalized anti-TfR
 
is green, 
internalized anti-GFP antibody is red. The merged images are also shown. Bar: 50μm
Figure 19: VAMP4-EGFP recycles through the SE and RE
19B
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 Double-labeling of internalized anti-GFP antibody with endogenous LBPA (a marker 
of LE compartments) was also performed (Figure 20). The distribution of internalized 
anti-GFP antibody was investigated at various time points during a transport period of 
60 min, which is sufficient for VAMP4-EGFP to cycle back to the TGN from the PM 
(section 4.4, Figure 14, upper panels). The results show that the majority of the 
internalized anti-GFP antibody is not significantly colocalized with the LE marker 
LBPA at any examined time point. This indicates that VAMP4-EGFP is probably 
transported to the Golgi via peripheral SE and then peri-Golgi RE. 
 
The recycling pathway of TGN proteins from the PM back to the TGN through SE 
and RE compartments was first demonstrated for TGN38 by Ghosh et al. (1998), 
using the chimera Tac-TGN38. Tac-TGN38 is a chimera consisting of the 
extracellular domain of the interleukin-2 receptor α-chain (T cell antigen or Tac) with 
the cytoplasmic and transmembrane domain of TGN38. When the chimera is 
transported to the PM, the Tac domain is exposed to and bound by the anti-Tac 
antibody. The TGN-targeting signal in the TGN38 portion would then mediate the 
transport of this chimera back to the TGN (Ghost et al., 1998). Hence, the Tac-
TGN38 chimeric protein was employed as another marker for the SE/RE-to-TGN 
pathway to further verify the recycling pathway of VAMP4-EGFP. Figure 21 shows 
the co-internalization of anti-Tac and anti-GFP antibodies in CHO cells stably 
expressing both Tac-TGN38 and VAMP4-EGFP. Anti-GFP antibody was well 
colocalized with anti-Tac antibody through the whole course of transport from the PM 
to the TGN, again indicating that VAMP4-EGFP, like Tac-TGN38, transports along 
the SE/RE-to-TGN recycling pathway.   
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Figure 20: VAMP4-EGFP does not recycles through the LE
NRK cells expressing VAMP4-EGFP were incubated with anti-GFP antibody at 4oC for 1 hour to mark the surface pool of 
VAMP4-EGFP. Cells were then incubated at 37oC in the absence of antibody for the indicated periods of time. Endogenous 
LBPA is green, internalized anti-GFP is red. The merged images are also shown. Bar: 50μm
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Figure 21: VAMP4-EGFP and Tac-TGN38 are co-transported from the PM to the TGN
122
Figure 21: VAMP4-EGFP and Tac-TGN38 are co-transported from the PM to the TGN
CHO-TacTGN38 cells, which stably express Tac-TGN38, were transfected
 
to express VAMP4-EGFP.  A stable pool of 
transfectants
 
was incubated with rabbit anti-GFP antibody and mouse monoclonal anti-Tac
 
at 4oC for 1 hour. After a brief 
washing step, cells were then incubated at 37oC in the absence of antibodies for the indicated periods of time. EGFP signal is 
blue, internalized anti-Tac
 
signal is green, and internalized anti-GFP signal is red. The merged images are also shown. Bar: 
50μm
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5.2.2 Accumulation of anti-GFP antibody at SE/RE compartments when 
endosome-to-TGN recycling pathway is blocked 
 
5.2.2.1 Anti-GFP antibody is blocked at the RE at 18oC 
 
If peri-Golgi RE is involved in the transport of VAMP4-EGFP from peripheral SE to 
the TGN, then internalized VAMP4-EGFP would be accumulated in the RE if 
transport from RE to the Golgi apparatus is blocked. It has been well established that 
reduced temperature (such as 18oC) blocks traffic from the RE to the Golgi apparatus 
(Mallard et al., 1998; Tai et al., 2004). The antibody internalization assay was 
performed at 18oC with NRK cells stably expressing VAMP4-EGFP. Cells were 
allowed to internalize the bound anti-GFP antibody simultaneously with Tf-AF647 
(fluorescent dye-conjugated transferrin) at 18°C for 60 min (Figure 22). The 
endocytosed Tf-AF647 served as a marker of the RE compartments. One hour is 
sufficient for VAMP4-EGFP to cycle efficiently from the PM back to the TGN, with 
the signals of bound anti-GFP antibody clearly separated from the RE compartments, 
as shown in section 5.2.1, Figure 19B. As expected, when cells were allowed to 
internalize both anti-GFP antibody and Tf-AF647 at 37°C for 60 min, the majority of 
antibody was delivered to the TGN (panel b) while Tf-AF647 was dynamically 
distributed in the peri-Golgi RE as well as peripheral endosomal compartments (panel 
a). In marked contrast, at 18°C, internalized antibody was observed to accumulate in 
perinuclear compact structures (panel e) that are Tf-AF647-positive (panels d, f and 
f1). In a parallel experiment, control NRK cells were allowed to internalize Tf-FITC at 
18°C for 60 min (panels j-l). Cells were then double-labeled with a Golgi marker, the 
matrix protein GM130. The perinuclear, Tf-FITC-positive compartments (panel j) are 
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Figure 22: VAMP4-EGFP recycling is arrested at the peri-Golgi
 
RE at 18oC
Cells expressing VAMP4-EGFP were incubated at 37oC (panels a-c) or at 18oC (panels d-i) with either anti-GFP alone (panels 
g-i) or both anti-GFP and Tf-AF647 (panels a-f) for 1 hour. Internalized anti-GFP is red (panels b, e and h), Tf-AF647 (panels a 
and d) or endogenous LBPA (panels g) is green. The merged images
 
are also shown (panels c, f and i). Panel f1
 
shows the 
enlarged image of a part of panel f. 
As a control, NRK cells were incubated at 18oC with Tf-FITC for 1 hour (panels j-l). Cells were then analyzed to view the 
internalized transferrin
 
(panel j) and endogenous GM130 as revealed by antibody labeling
 
(panel k). The merged image is 
shown in panel l. Panel l1
 
shows the enlarged image of a part of panel l, indicating the peri-Golgi
 






show another control experiment where cells expressing VAMP4-EGFP were incubated at 18oC with Tf-AF647 
(green) and anti-GFP (red) for 1 hour. Cells were then incubated in DMEM at 37oC for an additional 30 min before being fixed 
for viewing. Bar: 50μm
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clearly segregated away from the Golgi apparatus marked by GM130 (panels k and 
l1). Taken together, these results indicate that when VAMP4-EGFP cycle back to the 
TGN from the PM at 18°C, it was trapped in the peri-Golgi RE.  
 
Consistent with the notion that the LE was not involved in the traffic of VAMP4-
EGFP to the TGN, VAMP4-EGFP accumulated at 18°C at peri-Golgi RE (panel h) 
did not show any significant overlap with LE, which was marked by LBPA (panel g). 
In another experiment, after the antibody internalization at 18°C, VAMP4-EGFP-
expressing cells were subsequently warmed up to 37°C for an additional 30 minutes. 
Under these conditions, the signal of internalized anti-GFP antibody and Tf-AF647 
were observed to be clearly segregated: the antibody was transported to the Golgi 
(panel n), whereas Tf-AF647 was re-distributed dynamically in the peri-Golgi RE and 
peripheral endosomes (panel m). These results support the notion that peri-Golgi RE 
is involved in transport of VAMP4-EGFP from the PM to the TGN.     
 
5.2.2.2 Disruption of microtubular network by nocodazole does not 
affect the traffic of VAMP4-EGFP 
 
It has been shown that the disruption of microtubules by nocodazole inhibits the 
traffic route involving the LE such as transport of furin from the PM to the TGN via 
the LE. At the same time, this disruption has no significant effect on traffic involving 
the SE and the RE (such as traffic of TGN38) (Mallet and Maxfield, 1999). Consistent 
with the notion that VAMP4-EGFP is transported from the PM to the TGN via the SE 
and then the RE compartments, cells pre-treated with nocodazole were able to 
internalize antibody efficiently to the fragmented Golgi (Figure 23, panel b) that was 
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VAMP4-EGFP             Internalized antibody                     GS15 Merge
Nocodazole
a b c d
DMSO
e f g h
Figure 23: Nocodazole
 
does not affect VAMP4-EGFP recycling
After 30 min pretreatment with 33 µM of nocodazole
 
(panels a-d) or 0.1% DMSO (panels e-h), VAMP4-EGFP-expressing 
cells were incubated with rabbit anti-GFP antibody for 30 min at 37C in the continuous presence of nocodazole
 
(a-d) or 
DMSO (e-h). EGFP signal is green, internalized anti-GFP is red, and endogenous GS15 is blue. The merged images are 
also shown (panels d and h). Bar: 50μm
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marked by VAMP4-EGFP (panel a) as well as GS15 (panel d), a Golgi SNARE (Xu 
et al., 1997; Xu et al., 2002).  This observation lends further support to the notion that 
the majority of VAMP4-EGFP is transported from the PM to the TGN without the 
involvement of the LE. 
 
5.2.2.3 BFLA1 and ConA inhibit recycling of VAMP4-EGFP at the 
level of peri-Golgi RE 
 
Bafilomycin A1 (BFLA1) and concanamycin A (ConA) are two known inhibitors of 
endosomal acidification by inhibiting vacuolar proton pumps (V-ATPase) (Bowman 
et al., 1988; Dröse et al., 1993). To evaluate the role of endosomal acidification in the 
trafficking of VAMP4-EGFP, NRK cells stably expressing VAMP4-EGFP were pre-
treated with either 50nM BFLA1 or 100nM ConA; and then the antibody 
internalization assay was performed. Cells were incubated with both anti-GFP 
antibody and Tf-AF647 at 37oC for 60 min in the continuous presence of either 
BFLA1 (Figure 24, panels d-f) or ConA (panels g-i). As a control, a similar 
internalization assay was also performed in a parallel culture of VAMP4-EGFP-
expressing cells, in the absence of drugs (panels a-c). The endocytosed Tf-AF647 
served as a marker of the RE compartments (panels a, d and g). The PM-to-TGN 
transport of VAMP4-EGFP was examined through the detection of its bound antibody 
(panels b, e and h). One hour is sufficient for VAMP4-EGFP to cycle efficiently from 
the PM to the TGN, with the signals of bound anti-GFP antibody clearly segregated 
from the RE compartments, marked by fluorescent dye-conjugated transferrin, as 
shown in section 5.2.1, Figure 19B. As expected, in the control cells (panels a-c), after 
60 min of incubation, the majority of antibody was delivered to the TGN (panel b), 
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Figure 24: Arrest of VAMP4-EGFP recycling in peri-Golgi
 
RE when vacuolar ATPase
 
is inhibited by BFLA1 or ConA
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Figure 24: Arrest of VAMP4-EGFP recycling in peri-Golgi
 
RE when vacuolar ATPase
 
is inhibited by BFLA1 or ConA
NRK (panels j-o) or VAMP4-EGFP-expressing NRK (panels a-i) cells were pre-incubated with DMEM alone (panels a-c), or in 










and m-o) for 30 min at 37oC. 
Cells were then incubated with anti-GFP and Tf-AF647 (panels a-i) or Tf-FITC alone (panels j-o) for 30 min in the absence or 
presence of the drug as indicated. Dye-conjugated Tf
 
is green, internalized anti-GFP (panels b, e and h) or endogenous 




are the enlarged images of the indicated portion of the merged images, l and 
o, respectively. Bar: 50μm
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separated from the Tf-AF647-positive compartments. However, in the presence of 
either BFLA1 or ConA, internalized anti-GFP antibody (panel e and h) was found 
accumulated in perinuclear compact structures marked by Tf-AF647 (panel d and g). 
These strutures were clearly segregated from the Golgi apparatus marked by GM130 
(Figure 24, panels k-o, l1 and o1). When the inhibitors were removed and the treated 
cells were incubated in normal culture media, the antibody was observed to be 
delivered to the Golgi (Figure 25, panels b and e) while Tf-AF647 was re-distributed 
dynamically between peri-Golgi RE and peripheral endosomes (Figure 25, panels a 
and d). These observations once more support the conclusion that VAMP4-EGFP is 




After establishing that VAMP4-EGFP is transported between the TGN and the PM, 
the transport pathway of VAMP4-EGFP was next investigated. This further examines 
the tentative model for the TGN targeting mechanism of VAMP4. Since VAMP4 can 
interact with AP-1 (Peden et al., 2001; Hinners et al., 2003), a clathrin binding 
adaptor complex (Gallusser and Kirchhausen, 1993; Kirchhausen, 1999), it was 
reasonable to assume that VAMP4-EGFP was internalized through the clathrin-
mediated endocytic pathway. The inhibitory effects of potassium depletion and 
hypertonic treatment on the recycling of VAMP4-EGFP, observed by the antibody 
internalization assay, support this theory. However, although potassium depletion and 
hypertonic treatment are two well-known inhibitors of clathrin-dependent endocytosis 
(Larkin et al., 1983; Daukas and Zigmond, 1985; Madshus et al., 1987; Heuser and 













Figure 25: Rescue of VAMP4-EGFP recycling after treatment with BFLA1 or ConA
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Figure 25: Rescue of VAMP4-EGFP recycling after treatment with BFLA1 or ConA
VAMP4-EGFP-expressing NRK cells were pre-incubated with either 50 nM
 





for 30 min at 37oC. Cells were then incubated with anti-GFP antibody and Tf-AF647 in the continuous presence of either drug 
for an additional 30 min, washed and subjected to further 30 min
 
incubation in fresh DMEM, without the drug at 37oC. Tf-
 
AF647 signal is green, internalized anti-GFP signal is red. Bar: 50μm
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independent endocytosis or have other effects on cells (Madshus et al., 1987; Walker 
et al., 1999; Werbonat et al., 2000). Thus, more specific inhibitors of clathrin-
mediated transport, such as overexpression of the dominant negative mutant of Eps15, 
a specific regulator for the formation of clathrin-coated pits, and the knock-down of 
the clathrin heavy chain were employed. In both cases, the recycling of VAMP4-
EGFP is severely inhibited, clearly indicating that VAMP4-EGFP is transported 
primarily through clathrin-mediated endocytosis. 
 
After internalization from the PM, VAMP4-EGFP is recycled to the TGN via 
intermediate vesicular structures (Figure 10A; Figure 14). Previous studies of similar 
recycling of other TGN resident proteins have described at least two possible 
pathways for this transport: i) the SE –RE – TGN pathway (for TGN38, Ghosh et al., 
1998) or ii) the SE –LE – TGN pathway (for furin, Mallet and Maxfield, 1999). The 
transport of internalized anti-GFP antibody was examined in cells labeled with 
markers for each of those endocytic compartments. The results show that anti-GFP 
antibody, that marked the recycled VAMP4-EGFP, is transported through the SE and 
the RE, but not the LE, back to the TGN.  
 
Consistent with this result, Tac-TGN38, another chimeric protein that uses the same 
recycling pathway (Ghosh et al., 1998), colocates with VAMP4-EGFP through the 
course of transport from the PM to the TGN. For addition evidence, the recycling of 
VAMP4-EGFP was also studied in the presence of nocodazole. Nocodazole is a 
microtubule-disrupting compound, which has been reported to inhibit endosome 
maturation (Gruenberg et al., 1989; Bomsel et al., 1990) but not the internalization or 
endocytic recycling (Sakai et al., 1991; Takeuchi et al., 1992; Jin and Snider, 1993). 
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 Thus treatment with nocodazole would inhibit the transport through LE but not SE/RE 
(Mallet and Maxfield, 1999). As it turns out, nocodazole does not inhibit the recycling 
of VAMP4-EGFP. Moreover, when the antibody internalization assay was performed 
either under low temperature or with disturbance of endosomal acidification, the 
internalized anti-GFP is accumulated in the RE but not the LE. Both low temperature 
and inhibition of V-ATPase do not completely block internalization or sorting events 
in the SE or endosome-to-PM transport. Rather, they arrest the transport from 
endosomal compartments later than the SE, such as RE or LE (Harding and Unanue, 
1990; Johnson et al., 1993; Reaves and Banting, 1994; van Weert et al., 1995). 
Therefore, taken together, the results of this study establish that VAMP4-EGFP is 
recycled from the PM back to the TGN via the SE and the RE compartments, but not 
the LE. This is in accordance with the kinetics result (section 4.4, Figure 14), in which 
the majority of the antibody could be found accumulated at the perinuclear region 
after 8-15 min. This time length is relatively shorter than for proteins transported 
through the LE pathway such as furin, (Mallet and Maxfield, 1999) but similar to 
proteins recycled via the RE like TGN38 (Ghosh et al., 1998). The result is also in 
agreement with the reported function of VAMP4 in the SE/RE-to-TGN transport 




Role(s) of the N-terminal extension of VAMP4 in the recycling of the protein 
 
6.1 The recycling of V4nV5-EGFP mutants 
 
The role of the TGN-targeting signal of VAMP4 in regulating the transport of this 
protein was investigated. Firstly, the recycling of the various V4nV5-EGFP mutants 
was examined using the antibody internalization assay and immunofluorescence 
microscopy analysis. As shown in Figure 26, in NRK cells stably expressing either 
V4nV5-EDD or V4nV5-SA or V4nV5-FF mutant, the majority of internalized anti-
GFP antibody was delivered to the perinuclear region after 15 min. This kinetic 
property of mutant proteins transport is comparable to that of V4nV5-EGFP (Figure 
14, lower panel, 15 min). In contrast, there was significant delay in the transport of 
anti-GFP antibody in cells expressing either V4nV5-LL or V4nV5-5A mutant. In both 
cases, after 15 min incubation, the majority of antibody was still found to be surface-
bound and/or in finely punctated vesicular structures, instead of accumulating at the 
perinuclear region as compared to other mutants. These results suggest that the 
double-Leu motif as well as the distal acidic cluster act in regulating the recycling 
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Figure 26: The double-Leu
 
motif and the second acidic cluster play important role(s) in mediating efficient recycling of V4nV5-EGFP
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Figure 26: The double-Leu
 
motif and the second acidic cluster play important role(s) in mediating efficient recycling 
of V4nV5-EGFP
NRK cells expressing various V4nV5-EGFP mutants were incubated with anti-GFP antibody at 4oC for 1 hour to allow binding 
to surface fusion proteins. After a brief washing, cells were incubated at 37oC in the absence of antibody for the indicated 
periods of time to follow the trafficking of fusion protein-bound antibody. Internalized anti-GFP antibody was labeled with 
secondary antibodies conjugated to Cy3 (red). Bar: 50μm
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6.2 The recycling of VAMP4-EGFP mutants 
 
6.2.1 The Double-Leu motif and the second acidic cluster take part in mediating 
the transport of VAMP4-EGFP from the PM back to the TGN  
 
Since the VAMP5 portion of the various chimeric V4nV5-EGFP mutants may 
interfere with the recycling of these proteins, the antibody internalization assay was 
then repeated with VAMP4-EGFP mutants. Accordingly, various site-directed 
mutants generated in the context of VAMP4-EGFP (Figure 27) were stably expressed 
in NRK cells, and their recycling was examined by antibody uptake and transport 
(Figure 28A).  
 
NRK cells stably expressing EGFP-fusion proteins were incubated with rabbit anti-
GFP antibody on ice for 1 hour to allow the binding of the antibody to the EGFP-
tagged proteins at the PM. Unbound antibody was then removed by cold washing, and 
the cells were subsequently incubated at 37oC for 30 min. The internalization of 
VAMP4-EGFP mutants from the PM was examined by the detection of their bound 
anti-GFP antibody. The results in Figure 28A show that mutation of the proximal 
acidic cluster (V4-EDD) or the di-Phe residues (V4-FF) had no major effect on 
endocytosis and delivery of anti-GFP antibody to the TGN (panels h and n, 
respectively). However, mutation of the double-Leu motif (V4-LL) completely 
abolished delivery of antibody to the TGN, and antibody was observed in fine 
punctated structures distributed throughout the entire cells, characteristic of surface-
bound antibody (Figure 28A, panel e). Consistent with this observation, no antibody 
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Figure 27: The schematic illustration of expression constructs of VAMP4-EGFP and its mutants
Site-directed mutations were created in the context of VAMP4-EGFP. VAMP4-EGFP/LL-AA has the double-Leu
 
motif (residues 
25–26) replaced by two Ala residues. The first acidic cluster EDD (residues 27–29) was mutated into three Ala residues in 
VAMP4-EGFP/EDD-3A. VAMP4-EGFP/DEEED-5A has the distal acidic cluster (DEEED, residues 31–35) replaced by a stretch 
of five Ala residues. The two Phe
 
residues at positions 36–37 were replaced by Ala residues in VAMP4-EGFP/FF-AA. NE, N-
 

























NRK cells expressing VAMP4-EGFP (panels a-c), VAMP4-EGFP/LL-AA (panels d-f), VAMP4-EGFP/EDD-3A (panels g-i), 
VAMP4-EGFP/DEEED-5A (panels j-l) and VAMP4-EGFP/FF-AA (panels m-o) were incubated at 4oC with rabbit anti-GFP 
antibody in cold DMEM for 1 hour. After a brief wash, cells were
 
then incubated in fresh DMEM at 37oC for 30 min. EGFP signal 
is green. Internalized anti-GFP signal is red. The merged images are also shown. Bar: 50μm
Figure 28: The TGN targeting signal of VAMP4 plays a role in mediating VAMP4-EGFP recycling
28A
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B: The experiment was performed as in A. Cells were then washed twice in cold acid washing buffer to strip off antibody 
remaining bound on the surface before being fixed for immunofluorescence
 
microscopy. EGFP signal is green. Internalized anti-
 




















VAMP4-EGFP                V4-LL                    V4-EDD                    V4-5A                       V4-FF28B
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removed by acid-stripping after the antibody uptake and delivery assay (Figure 28B, 
panel e). Furthermore, higher surface level of GFP signal was detected in V4-LL cells 
as compared to the VAMP4-EGFP expressing cells, as assessed by flow cytometry 
(Figure 29).  These results suggest that the double-Leu motif is essential for 
internalization of VAMP4-EGFP.  
 
Although the bound anti-GFP antibody was still delivered to the TGN in cells 
expressing the mutant with an altered distal acidic cluster (V4-5A) (panel k, Figure 
28A), even after acid-stripping (panel k, Figure 28B), more antibody was clearly 
found in the vesicular intermediates, indicating either an arrest or delay of VAMP4-
EGFP traffic from the SE and the RE to the TGN. This indicates that the distal acidic 
cluster contributes to efficient transport of VAMP4-EGFP from endosomal 
intermediates to the TGN.  
 
6.2.2 The Ser-30 takes part in mediating the transport of VAMP4-EGFP from 
the TGN back to the PM  
 
To investigate the possible function of the Ser-30 residue in the transport of VAMP4, 
four mutants were created (Figure 30). In VAMP4-EGFP/S-A (V4-SA), Ser-30 is 
replaced by Ala residue. Ser-30 is changed to aspartic acid (Asp or D) or glutamic 
acid (Glu or E) in VAMP4-EGFP/S-D (V4-SD) and VAMP4-EGFP/S-E (V4-SE), 
respectively. Both Asp and Glu are negatively charged amino acids that would mimic 
the charged state of phosphorylated Ser. Therefore, V4-SD and V4-SE mutants mimic 
the VAMP4 that is permanently phosphorylated at Ser-30 (regarding the charged state 
only but not account for the phospho group), in contrast to V4-SA mutant, which 
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Figure 29: The level of VAMP4-EGFP on the cell surface is enhanced by mutation of double-Leu
 
motif 
as assessed by flow cytometry
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Figure 29: The level of VAMP4-EGFP on the cell surface is enhanced by mutation of double-Leu
 




expressing either VAMP4-EGFP or VAMP4-EGFP/LL-AA were trypsinized
 
and incubated with anti-
 
GFP antibody on ice for 1 hour. After cold washing, cells were then incubated with PE-conjugated secondary antibody for 1 hour 
on ice before being subjected to flow cytometry
 
analysis. The histograms of PE signals in the two pools are shown in the right 
panels, respectively. As control, cells were incubated with PE-conjugated secondary antibody without prior incubation with the 
anti-GFP antibody (thus representing the non-specific signal) for 1 hour on ice before being analyzed by flow
 
cytometry. The 












Figure 30: The schematic illustration of expression constructs of various Ser-30 mutants in VAMP4-EGFP context 






(VAMP4-EGFP/S-T). NE, N-terminal extension; SNARE, SNARE domain; TM, transmembrane
 
domain. These constructs 
were each transfected
 
into NRK cells and pools of stable transfectants
 
were selected and expanded for further experiments.
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represents a permanently unphosphorylated VAMP4. The fourth mutant, VAMP4-
EGFP/S-T (V4-ST), contains threonine (Thr) instead of serine at position 30. This 
mutant should remain capable of being phosphorylated by CKII. Thus, of the four 
mutants, V4-ST represents a protein that is most similar to wild-type VAMP4 in 
regards to the phosphorylation state of the thirtieth residue in its peptide. 
 
The antibody internalization assay results (Figure 31) show that there was no 
internalized antibody observed in NRK cells stably expressing V4-SA (Figure 31, 
panel b) after 30 min incubation. In marked contrast, cells stably expressing V4-SD 
and V4-ST mutants were found to be able to transport anti-GFP antibody efficiently 
to the TGN (Figure 31, panels e and k). Surprisingly, there was no anti-GFP antibody 
signal found in cells stably expressing V4-SE mutant. These finding suggests that it is 
not the presence of the phospho group at Ser-30 position that is important for the 
transport of VAMP4 from the TGN to the PM. Rather, it is the negative charge and 
the steric size of the phosphorylated Ser-30 that is of importance in regulating the 




This chapter evaluates the role of the recycling pathway of VAMP4 in governing the 
steady state distribution of VAMP4 in the TGN. Hence, the role of the TGN-targeting 
signal in the recycling of VAMP4 from the PM to the TGN was examined. If TGN 
targeting of VAMP4 is an event independent of recycling, then this signal should not 
be crucial for recycling. However, if this recycling is directly contributing to the 
steady state TGN accumulation of VAMP4, then mutations of this TGN targeting 
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Figure 31: The Ser-30 residue participates in regulating VAMP4-EGFP transport to the PM
NRK cells expressing VAMP4-EGFP/S-A (panels a-c), VAMP4-EGFP/S-D (panels d-f), VAMP4-EGFP/S-E (panels g-i), VAMP4-
 
EGFP/S-T (panels j-l) were incubated at 4oC with rabbit anti-GFP antibody in cold DMEM for 1 hour. After a brief wash, cells were 
then incubated in fresh DMEM at 37oC for 30 min. Panels a, d, g and j show the EGFP signal of these
 
fusion proteins. Internalized 
anti-GFP antibody was detected by Cy3-conjugated goat anti-rabbit secondary antibody (panels b, e, h and k). The merged 
images are also shown (panels c, f, I and l). Bar: 50μm 149
signal are expected to alter the recycling of VAMP4-EGFP from the surface to the 
TGN. 
 
Antibody internalization in cells stably expressing various mutations created in the 
V4nV5-EGFP context shows that the internalization and transport of anti-GFP 
antibody is impaired for both double-Leu and the second acidic cluster mutations. As 
discussed in chapter 3, both structural motifs take part in mediating the efficient TGN 
targeting of V4nV5-EGFP. In contrast, there is no apparent difference in the uptake 
and transport of antibody in cells expressing either V4nV5-EDD, or V4nV5-SA, or 
V4nV5-FF mutant, compared to wild-type V4nV5-EGFP. Thus, these mutants, which 
do not significantly affect TGN targeting, appear to also not have any major effect on 
the recycling of the protein. Taken together, these results suggest that the recycling of 
the SNARE protein VAMP4 plays a role in mediating its steady state TGN 
distribution.  
 
The advantage of using V4nV5-EGFP is that it focuses on studying the targeting 
signal in the N-terminal extension of VAMP4. The presence of the full-length 
VAMP5 in V4nV5-EGFP also allows better observance of the differences between 
various mutants, such as with V4nV5-LL or V4nV5-5A. However, VAMP5 may also 
interfere with the recycling of the chimera.  It is thus necessary to study the effects of 
the targeting signal on the recycling of VAMP4 using VAMP4 itself. Therefore, 
various side-directed mutations were generated to the TGN-targeting signal in 
VAMP4-EGFP and their transport was investigated using the antibody internalization 
assay. The results once again show that motifs (double-Leu motif and the distal acidic 
cluster) that are required for TGN targeting of VAMP4 are also important for its 
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efficient recycling from the PM to the TGN. The strong correlation between the 
importance of the motifs in TGN targeting as well as recycling from the PM to the 
TGN via endosomal intermediates suggests that the recycling of VAMP4 is important 
to maintain steady state enrichment of VAMP4 in the TGN. Furthermore, the results 
indicate that the double-Leu motif and the distal acidic cluster contribute to TGN 
targeting by acting at different steps: double-Leu motif in endocytosis while the distal 
acidic cluster in efficiency of delivery from the vesicular intermediates to the Golgi 
apparatus.   
 
In section 6.1, the examination of the transport of V4nV5-SA mutant suggested that 
the phosphorylation of the Ser-30 residue did not seem to be important for either the 
targeting or the recycling of the chimeric protein. However, when the mutation is 
created in the parent protein, VAMP4-EGFP, no antibody signal is found in cells 
expressing V4-SA mutant. This result indicates that the V4-SA is unable to transport 
to the PM, and thus extracellular anti-GFP antibody can not bind to its EGFP tail to be 
internalized into the cells. This suggests that the phosphorylation of Ser-30 residue 
may be important to the transport of VAMP4 from the TGN to the PM. In the case of 
V4nV5-SA mutant, although Ala-30 cannot be phosphorylated to participate in 
mediating the transport of the mutant to the PM, the VAMP5 is a plasma membrane 
protein by itself. Thus, the default targeting signal in the cytoplasmic domain of 
VAMP5 should be able to mediate the transport of the chimera from the TGN to the 
PM. Once at the PM, the TGN-targeting signal in the N-terminal extension, which is 
not mutated, would regulate the recycling of V4nV5-SA back to the TGN. This 
scenario explains the results obtained with V4nV5-SA mutant: i) it is primarily 
localized at the TGN and ii) it recycles efficiently between the TGN and the PM. 
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 Since the antibody is internalized to the TGN efficiently with V4nV5-SA, it indicates 
that the phosphorylation of Ser-30 may not be crucial for the recycling of VAMP4 
from the PM back to the TGN. 
 
The phosphorylation of Ser-30 yields a phospho group and also endows a negative 
charge at this position. Both or either of these features could be important for the 
transport of VAMP4 to the PM. To investigate this issue, V4-SD, V4-SE and V4-ST 
mutants were created. V4-SD and V4-SE mutants contain acidic amino acid as the 
substitute for Ser-30, which mimic the negative charge of phosphorylated Ser. On the 
other hand, Ser-30 is replaced by a functionally equivalent Thr-30 in V4-ST mutant. 
Since Ser-30 is phosphorylated by CKII (Hinner et al., 2003), a Ser/Thr protein kinase 
(Allende and Allende, 1995), V4-ST should be also phosphorylated by CKII. 
 
Both V4-SD and V4-ST mutants are able to transport from the TGN to the PM and 
then recycle to the TGN. This result indicates that the presence of a negatively 
charged moiety but not the phospho group at the thirtieth residue is important for the 
transport of VAMP4 to the PM. However, in contrasts to V4-SD, mutant V4-SE is 
impaired in TGN-to-PM transport. Like Asp (D), Glu (E) is an acidic amino acid. 
Thus, the changing of Ser-30 to Glu-30 would also endow the V4-SE protein with a 
negative charge at the thirtieth amino acid position, and V4-SE was expected to be 
transported in a similar fashion to V4-SD. The contrasting results observed with these 
mutants may be due to differences in the sizes/structures of the substituted amino 
acids, which may result in different secondary structures. This could affect the 
interaction of the mutants with other proteins that regulate the TGN-to-PM transport 
of VAMP4.   
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Chapter 7 
General discussions and future perspective 
 
This study investigated: 
 
(i) The TGN-targeting signal in the N-terminal extension of VAMP4 
(ii) The recycling pathway of VAMP4  
(iii) The role(s) of the TGN-targeting signal in regulating the recycle of 
VAMP4 
 
Due to technical limitations in studying the recycling of endogenous VAMP4, this 
study examined instead the trafficking pathway of a C-terminally EGFP-tagged 
VAMP4. The main techniques employed were Ala mutagenesis screening, antibody 
internalization assay and immunofluorescence microscopy. All EGFP-tagged 
SNAREs were stably expressed to avoid mislocalization caused by overexpressing of 
transiently transfected proteins (Lowe et al., 1997; Subramaniam et al., 2000). The 
EGFP-fusion VAMP4 was correctly targeted to the TGN and able to function in a 
similar way to endogenous VAMP4. The main findings of this study are: 
 
(i) The double-Leu motif and its downstream second acidic cluster in the N-
terminal extension of VAMP4 play important roles as its TGN targeting 
signals. They have different, but collaborating roles in regulating the 
efficient TGN targeting of VAMP4. 
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(ii) VAMP4-EGFP is efficiently recycled between the TGN and the PM. This 
recycling is mediated by clathrin-dependent endocytosis, followed by 
transport to the SE and then the RE before being accumulated in the TGN. 
(iii) A strong correlation of residues (the double-Leu motif and the second 
acidic cluster) important for the PM-to-TGN recycling and steady state 
TGN distribution of VAMP4 indicates that this recycling pathway is part 
of the overall mechanism governing steady state enrichment of VAMP4 in 
the TGN. The double-Leu motif regulates the internalization of VAMP4-
EGFP from the PM to the endosomes; while the second acidic cluster 
regulates the transport of VAMP4-EGFP from the endosomes to the TGN. 
(iv) The negative charge and the steric size of the amino acid at the thirtieth 
residue (Ser-30 in wild-type VAMP4) are important for the transport of 
VAMP4-EGFP from the TGN to the PM 
 
The recycling pathway of VAMP4 to the TGN through the SE/RE compartments is 
consistent with the role defined for VAMP4 in regulating traffic from the SE/RE to 
the TGN (Mallard et al., 2002), and thus, perhaps expected. However, this study 
shows, for the first time, the presence of a recycling pathway of VAMP4 between the 
TGN and the PM. There are two previous reports that seem to be at odds with the 
results of this study regarding this PM-to-TGN recycling pathway. Firstly, using 
immuno-electron microscopy (EM), Steegmaier et al. (1999) reported that there were 
no detectable VAMP4 at the PM in PC12 cells. However, it is possible that in PC12, 
the amount of endogenous VAMP4 is not sufficient for it to be detected efficiently by 
EM, a technique highly dependent on the sensitivity of the antibody employed. Even 
in cells stably transfected with VAMP4-EGFP, the protein on the PM is only 
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detectable by methods that amplify the EGFP signal such as biotinylation, antibody-
based flow cytometry or by inhibiting endocytosis, as demonstrated in this thesis. 
Consistent with this possibility, low and detectable amounts of VAMP4-EGFP and 
V4nV5-EGFP were found to be accessible to selective surface biotinylation. This low 
and likely transient appearance of the rapidly recycling VAMP4 at the PM may be the 
reason why the previous EM study had been unable to detect endogenous VAMP4 at 
the PM. This is further supported by the recent report of Cocucci et al. (2008), which 
suggests that VAMP4 functions in the fusion of enlargeosomes with the PM. 
Enlargeosomes are small vesicles that are competent for rapid regulated exocytosis 
(Borgonovo et al., 2002; Cocucci et al., 2004, 2007). The findings from this 
enlargeosomes study further support the hypothesis that i) VAMP4 is transported to 
the PM and ii) its recycling is likely to be rapid. Thus, it would be problematic to 
detect the presence of endogenous VAMP4 at the PM using a number of conventional 
methods such as EM or IF.  
 
Secondly, another antibody internalization study in MDCK cells showed that 
VAMP4-EGFP did not recycle from the PM to the TGN (Steegmeier et al., 2000). 
The basis for this discrepancy between MDCK and NRK cells is not known. 
However, Steegmaier et al. studied the transport of transiently overexpressed 
VAMP4-EGFP. Earlier studies have indicated that intracellular trafficking of 
SNAREs using exogenous expression in transfected cells is only reliably revealed in 
stably transfected cells, as overexpression of SNAREs in transiently transfected cells 
often leads to the aberrant distribution of SNAREs (Lowe et al., 1997; Subramaniam 
et al., 2000). Therefore, in this thesis, the recycling of VAMP4-EGFP and its mutant 
derivatives have been examined in stably transfected NRK, HeLa or CHO cells. 
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Stably transfected cells also have a higher signal/noise ratio as more cells expressing 
comparable levels of the protein can be studied at the same time. To have more cells 
that are expressing and to avoid clonal variations, pooled transfectants instead of 
stable clonals were used. These transfected cells were further sorted by flow 
cytometry for EGFP-positive cells so that a more homogenous population derived 
from the pooled transfectants was actually used in subsequent experiments. In stably 
transfected MDCK cells expressing VAMP4-EGFP, the recycling of the fusion 
protein was also observed using the antibody uptake approach (Figure 11). Thus, the 
findings in this study overcome the shortcomings of systems employed in previous 
studies and extend the understanding about the transport of VAMP4 beyond those 
reports.  
 
This study shows that the double-Leu motif, the second acidic cluster and the Ser-30 
residue in the N-terminal extension of VAMP4 play distinct roles in regulating the 
transport of this protein. Although the roles of the double-Leu motif and the Ser-30 
residue as targeting signal have been implied in previous studies (Steegmaier et al., 
1999, Peden et al., 2001, Hinners et al., 2003), this research specifies for the first time 
the role of the second acidic cluster in regulating the localization as well as the 
trafficking of VAMP4. It also shows that the steric size and the negative charge of the 
phosphorylated Ser-30 rather than the presence of the phospho group per se are 
important for regulating the TGN-to-PM transport of VAMP4. Furthermore, this 
study also suggests that these signals play distinct roles in concert to ensure the 
correct localization of VAMP4. Since the functions of SNAREs are primarily 
regulated through the targeting of specific SNAREs to their defined subcellular 
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locations, the findings indicate that these signals may also be important in regulating 
the function of VAMP4. 
 
The N-terminal domain of SNAREs has been reported to function in regulating 
SNARE proteins (Calakos et al., 1994; Dulubova et al., 1999; Misura et al., 2000; 
Tochio et al., 2001; Antonin et al., 2002a, Martinez-Arca et al., 2003). ). However, 
the structure of this domain varies greatly between SNARE subgroups (Figure 3) and 
its functions are still poorly understood. The double-Leu motif has also been 
suggested to mediate efficient targeting and recycling of several SNAREs other than 
VAMP4 (Darsow et al., 1998; Kasai and Akagawa, 2001; Kasai et al., 2008). In 
studying the TGN targeting signals in the N-terminal region of VAMP4, this study 
offers a better understanding on the targeting mechanisms of SNAREs. It also 
contributes some insights into the role of the NE domain in regulating SNARE in 
general and VAMP4 by itself. 
 
From the current results, one can propose a schematic model for the recycling 
pathway of VAMP4 (Figure 32). In this model, although the majority of VAMP4 is 
found at the TGN at steady state, the protein is also transported to the PM. The 
putative phosphorylation of the Ser-30 residue is likely to take part in regulating this 
TGN-to-PM transport. Once VAMP4 reaches the PM, it is internalized via clathrin-
coated vesicles and delivered to the sorting endosome, transported to the peri-Golgi 
recycling endosome and then recycled to the TGN.  The double-Leu motif of its TGN 
targeting signal is necessary for the internalization from the PM; whereas the distal 
acidic cluster is involved in efficient retrograde delivery from the endosome to the 













Figure 32: A schematic model depicting the recycling pathway of VAMP4
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Figure 32: A schematic model depicting the recycling pathway of VAMP4
VAMP4-EGFP internalized from the PM by clathrin-mediated endocytosis
 
is at first delivered to the sorting endosomes
 
(SE) marked by EEA1 and TfR, and then transported to the peri-Golgi
 
RE marked by TfR
 
before being delivered to the 
TGN. This is revealed by the accumulation of VAMP4-EGFP at the TfR-marked compartments when cells were 
incubated at 18oC or treated with BFLA1 or ConA. The negative charge at the position of Ser-30 in the TGN-targeting 
signal of VAMP4 is important for the transport of VAMP4-EGFP from the TGN to the PM. The double-Leu
 
motif is 
necessary for the internalization from the PM; whereas the distal acidic cluster is involved in efficient delivery from the 
endosome
 
to the TGN.  The strong correlation of signal responsible for TGN targeting and recycling indicates that this 
recycling pathway contributes to the steady-state enrichment of VAMP4 in the TGN. The elucidation of this recycling 
pathway is in line with the function of VAMP4 as a v-SNARE participating in traffic from the RE to the TGN.
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recycling indicates that this recycling pathway contributes in a pivotal manner to the 
steady state distribution of VAMP4 in the TGN. Accordingly, proteins recognizing 
these targeting motifs will be part of the machinery involved in this PM recycling and 
endosome-Golgi transport.  
 
The SE-RE-Golgi transport pathway was first demonstrated for a TGN protein called 
TGN38 (Ghosh et al., 1998). The steady state accumulation of TGN38 in the TGN 
depends on this recycling pathway. This pathway is also utilized by several toxin 
molecules, including shiga toxin (via its B subunit), cholera toxin (also via its B 
fragment), and ricin (Mallard et al., 1998; Sandvig and van Deurs, 2000; Sandvig and 
van Deurs, 2002) for gaining entry from the outside of the cell to the Golgi apparatus. 
These toxins can then be transported in a retrograde fashion from the Golgi apparatus 
to the ER, where they are translocated to the cytosol to exert their toxic effects.  
Recently, several other proteins have also been shown to utilize this pathway of 
endosome-TGN transport. A fraction of the CI-M6PR and the CD-M6PR may also 
travel through this pathway (Medigeshi and Schu, 2003; Lin et al., 2004; Ghosh et al., 
2003) in addition to their recognized recycling pathway from the late endosome to the 
TGN (Kornfeld and Mellman, 1989; Riederer et al., 1994; Diaz and Pfeffer, 1998; 
Orsel et al., 2000), which is best defined by the recycling route of the TGN protease 
furin (Mallet and Maxfield, 1999). GLUT4, which is present in storage vesicles and is 
mobilized to the surface upon insulin stimulation to mediate glucose uptake, may also 
use this pathway to sort itself into storage compartments for the next round of 
deployment to the surface (Bryant et al., 2002; Shewan et al., 2003). Parathyroid 
hormone (PTH)-related peptide (PTHrP) receptor (Tawfeek and Abou-Samra, 2004) 
and other proteins such as P-selectin (Straley and Green, 2000), membrane-type 
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matrix metalloproteinases (MT-MMPs) (Kang et al., 2002; Remacle et al., 2003; 
Wang X et al., 2004), copper transporters (Petris and Mercer, 1999; Petris et al., 
2002), and sortilin (Nielsen et al., 2001) are some other examples of proteins that may 
recycle in this manner. Further studies of this SE-RE-TGN transport pathway in 
relation to the physiology and pathology of different cell types would be of much 
interest. Accordingly, the VAMP4-EGFP protein could serve as a useful marker for 
this pathway, and the antibody internalization assay has proved to be a valuable tool 
in investigating protein trafficking along the endocytosis routes. Due to the correlation 
between the targeting signals of VAMP4 and its recycling, further studies on proteins 
that interact with these motifs will offer more insights into the regulatory mechanisms 
of this transport pathway. 
 
AP-1, PACS-1, and the 39 kD subunit (physophilin or p39) of V-ATPase have all 
been shown to interact with VAMP4 (Steegmaier et al., 1999; Peden et al., 2001; 
Hinners et al., 2003). They are therefore potential candidate proteins involved in 
regulating the trafficking of VAMP4. Previous biochemical studies have shown that 
VAMP4 can directly interact with AP-1 via its double-Leu motif (Hinners et al., 
2003; Peden et al., 2001). The interaction between VAMP4 and AP-1 seems to be 
modulated by PACS-1, another interacting protein of VAMP4 (Hinners et al., 2003). 
Since AP-1 is enriched in the TGN and endosome, AP-1 is unlikely to be involved in 
the double-Leu motif-mediated endocytosis from the surface. Rather, the results in 
this study indicate that the double-Leu motif may bridge VAMP4 with clathrin as 
endocytosis of VAMP4-EGFP is clearly dependent on clathrin.  This observation 
raises the question as to the biological significance of the interaction of double-Leu 
motif with AP-1.  One possibility is that, beside a role in endocytosis, this motif may 
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also play an additional role in the endosome and/or TGN to facilitate the steady state 
accumulation of VAMP4 in the TGN.  Future study is needed to resolve the role of 
AP-1 in VAMP4 trafficking. 
 
When cells were treated with V-ATPase inhibitors such as BFLA1 or ConA, an 
accumulation of internalized antibody in the RE was observed. This result indicates 
that acidification mediated by V-ATPase is not important for endocytosis and delivery 
to the endosomes, but is required for transport of VAMP4 from the RE to the Golgi. 
This also indicates a specific role for V-ATPase in the endosome-to-TGN traffic. The 
importance of V-ATPase in the transport after the sorting events at the SE has been 
reported previously (Reaves and Banting, 1994; van Weert et al., 1995). Furthermore, 
it has been reported that physophilin/p39 of V-ATPase can be co-immunoprecipitated 
with antibody against VAMP4 (Steegmaier et al., 1999). Thus, even though the exact 
function of V-ATPase in endosomal transport is not yet known, it is possible that V-
ATPase could regulate VAMP4 so that the general traffic from the RE to the TGN 
mediated by VAMP4 is indirectly influenced by V-ATPase. Future experiments 
addressing the nature of the interaction of VAMP4 with physophilin and the 
functional relevance of this interaction will be needed. Besides, the specific inhibitors 
of V-ATPase, BFLA1 and ConA, have been used in a number of reports studying 
viral infection (for example: Palokangas et al., 1994; Perez and Carrasco, 1994; 
Guinea and Carrasco, 1995; Ochiai et al., 1995; Nawa, 1997; Hansen et al., 1998; 
Tscherne et al., 2006). As shown by the current work, BFLA1 and ConA can also 
offer an additional approach beside the low temperature block to further dissect the 
endocytotic trafficking pathways of other cellular proteins. 
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Although this study has addressed several issues on the targeting and recycling 
mechanisms of VAMP4-EGFP to its destined location, many factors remain 
unknown. These would include the regulators of the pathway, the specific interacting 
partners of VAMP4 and the possible ways they work together to regulate the 
recycling of the protein. It would be of interest to identify proteins that interact 
specifically with certain VAMP4 mutants but not with others. GST (glutathione S-
transferase) pull-down, immunoprecipitation or yeast-two-hybrid assay are some 
approaches that can be performed in future studies in attempts to indentify VAMP4 
N-terminal region interacting proteins. On the other hand, there are a number of 
reports about proteins that regulate the endosome-to-TGN pathway, such as sorting 
nexins (Haft et al., 2000; Seaman, 2005), retromer complexes (Arighi et al., 2004; 
Carlton et al., 2004; Seaman, 2004), PACS1 (Wan et al., 1998; Crump et al., 2001), 
and epsinR (Saint-Pol et al., 2004). Of these proteins, PACS1 and AP-1 have been 
reported to interact with VAMP4 (Peden et al., 2001; Hinners et al., 2003). It was also 
found recently that Vps45, a SM protein, interacts with STX16, a t-SNARE partner of 
VAMP4 (Wang et al., 2005). The possibility for either of these proteins to regulate 
the transport of VAMP4 might be determined by using siRNA to knock-down their 
expression and then to study the recycling of VAMP4-EGFP in these knocked-down 
cells. Biochemical assays such as biotinylation to determine the efficiency of the 
transport of VAMP4 to the cell surface in cells that lack either of these potential 
regulators would also be informatic. 
 
Both the SNARE complex consisting of STX16, STX6, Vit1a and VAMP4 (Mallard 
et al., 2002) as well as the SNARE complex consisting of STX5, Ykt6, GS28, and 
GS15 (Tai et al., 2004) have been shown to regulate traffic from the endosomes to the 
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TGN.  To investigate whether either or both of these SNARE complexes are involved 
in mediating the recycling of VAMP4-EGFP, antibody internalization assay has been 
performed in VAMP4-EGFP-expressing HeLa depleted of either STX16 or GS15 
(Tran et al., 2007). The preliminary results showed that knockdown of either SNARE, 
using siRNA, had no apparent effect on the endocytosis and recycling of VAMP4-
EGFP. These findings are surprising considering that VAMP4 itself has been 
implicated as part of the cognate SNARE complex responsible for SE/RE-to-TGN 
transport (Mallard et al., 2002). This suggests that either the SE/RE-TGN recycling of 
VAMP4 may involve novel docking-fusion machinery or the two SNARE complexes 
are functionally redundant. Therefore, additional experiments that investigate the 
recycling of VAMP4-EGFP in cells that are i) depleted of other SNARE components 
of either complex and ii) depleted of SNARE components from both complexes are 
required.  
 
It has also been reported that there are more than one retrograde transport pathways 
from the endosome to the TGN, which seems to involved different tethering factors 
(Derby et al., 2007; Lieu et al., 2007). Thus, besides SNARE proteins, the role(s) of 
tethering factors such as Golgins in regulating the recycling of VAMP4-EGFP could 
also be investigated using similar strategies. These studies would shed more light on 
the mechanism underlying membrane trafficking of not only VAMP4, but also other 
proteins at the interface of endosomes and the TGN. 
 
It should be noted that so far, VAMP4 is the only R-SNARE that are found mainly at 
the TGN (Steegmaier et al., 1999). Based on its subcellular localization, the authors 
suggested that VAMP4 functions in TGN-to-endosome transport pathway. Since the 
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TGN is one of the main sorting hubs in the biosynthetic/secretory pathway (Gu et al., 
2001), this suggests that VAMP4 may play important role in the outward flow of 
intracellular transport.  However, VAMP4 has been reported to function instead in a 
SNARE complex mediating the inward transport of endosome-to-TGN (Mallard et 
al., 2002). Moreover, in these previous studies, the possible role(s) of VAMP4 
functioning in transport between the TGN and the PM had not been indicated. In this 
thesis, it is shown for the first time that VAMP4 also cycles between the TGN and the 
PM, suggesting a potential function of this v-SNARE in the biosynthetic/secretory 
pathway. In supporting of this hypothesis, subsequent preliminary works have found 
that VAMP4 is expressed at high level in cells such as Min6 or AtT20, both of which 
are secretory cell lines with highly active regulated exocytosis pathway. The level of 
endogenous VAMP4 is also high in the CHO cells, which has been reported to have 
non-secretory, regulated exocytosis (Bargonovo et al., 2002). Moreover, a recent 
study has also reported that VAMP4 participates in mediating the regulated 
exocytosis of enlargeosomes in PC12-27 cells (Cocucci et al., 2008). It has been 
reported that the enlargeosomes seem to participate in regulating the enlargement of 
the PM. This process appears to be involved in a number of processes that required 
rapid cellular surface dynamics and expansion, such as growth, wound healing, 
migration or differentiation (Borgonovo et al., 2002; Cocucci et al., 2004, 2007, 
2008).  Therefore, it would be of much interest to investigate if VAMP4 plays 
important role(s) in physiological as well as pathological processes. Two approaches: 
i) knock-down VAMP4 by siRNA and ii) overexpression of V4-SA mutant, which 
seems to be a negative dominant mutant for the transport of VAMP4 from the TGN to 
the PM, could be used to investigate the possible role(s) of VAMP4 in regulated 
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 exocytosis. Further studies on VAMP4 could possibly reveal a new aspect in the 
biological function of this v-SNARE protein.  
 
In summary, this study investigated the recycling pathway of VAMP4 and the role of 
the TGN-targeting signal in its N-terminal extension domain in regulating its 
localization and recycling. The findings offer a better understanding of the targeting 
mechanisms of SNAREs and suggest a novel function for VAMP4 in the TGN-to-PM 
transport pathway. Further studies will be required to investigate the possible 
biological functions of VAMP4 in this pathway, especially with regards to the 
regulated secretion. In addition, it would also be of interest to study the interacting 
partners of VAMP4, which may participate in regulating its recycling and, through 
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The Cytoplasmic Domain of Vamp4 and Vamp5 Is Responsible for
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SNAREs represent a superfamily of proteins respon-
sible for the last stage of docking and subsequent fusion
in diverse intracellular membrane transport events.
The Vamp subfamily of SNAREs contains 7 members
(Vamp1, Vamp2, Vamp3/cellubrevin, Vamp4, Vamp5,
Vamp7/Ti-Vamp, and Vamp8/endobrevin) that are dis-
tributed in various post-Golgi structures. Vamp4 and
Vamp5 are distributed predominantly in the trans-Golgi
network (TGN) and the plasma membrane, respectively.
When C-terminally tagged with enhanced green fluores-
cent protein, the majority of Vamp4 and Vamp5 is cor-
rectly targeted to the TGN and plasma membrane, re-
spectively. Swapping the N-terminal cytoplasmic region
and the C-terminal membrane anchor domain between
Vamp4 and Vamp5 demonstrates that the N-terminal
cytoplasmic region of these two SNAREs contains the
correct subcellular targeting information. As compared
with Vamp5, Vamp4 contains an N-terminal extension of
51 residues. Appending this 51-residue N-terminal ex-
tension onto the N terminus of Vamp5 results in target-
ing of the chimeric protein to the TGN, suggesting that
this N-terminal extension of Vamp4 contains a dominant
and autonomous targeting signal for the TGN. Analysis
of deletion mutants of this N-terminal region suggests
that this TGN-targeting signal is encompassed within a
smaller region consisting of a di-Leu motif followed by
two acidic clusters. The essential role of the di-Leu motif
and the second acidic cluster was then established by
site-directed mutagenesis.
Intracellular traffic between different membrane compart-
ments involves diverse membrane-enclosed intermediates in
the form of small transport vesicles and/or larger containers/
carriers (1–5). These transport intermediates are generated at
a given donor compartment by the concerted action of mem-
brane proteins as well as cytosolic coat proteins and then de-
livered to the vicinity of a specific acceptor compartment. After
faithful tethering of the intermediates with the target compart-
ment, a process catalyzed by the action of Rab small GTPases
and their effectors (6–7), the final short range docking of the
intermediates with the acceptor membrane is mediated by the
interaction of vesicle-associated SNAREs1 with target SNAREs
to form trans-SNARE complexes that may mediate the subse-
quent physical fusion between the intermediates and the target
compartment (8–10).
Combined efforts using approaches of genetics, biochemistry,
molecular biology, and bioinformatics have led to the identifi-
cation of about 35 distinct members of the SNARE superfamily
characterized by the presence of a common structural domain
referred to as the SNARE motif (11). Based on whether the
residue in the center of the SNARE motif is an Arg or a Gln and
the relatedness of SNARE sequences, SNAREs have been
roughly classified into four families: the R-SNAREs, Qa-
SNAREs, Qb-SNAREs, and Q-syntaxins (10, 12). For SNAP-23,
SNAP-25, and SNAP29/GS32, both Qa-SNARE and Qb-
SNARE motifs coexist in the same protein (10). For a given
transport event, it is generally believed that each family con-
tributes one SNARE motif so that the four SNARE motifs will
form a parallel, highly twisted, four helices bundle that cata-
lyzes the fusion (8). The emerging theme is that the combina-
torial use of these SNAREs will give rise to a wide spectrum of
trans-SNARE complexes that mediate various transport events
(13–14). A given SNARE may participate in several different
transport processes by incorporating into different SNARE
complexes. The availability of a specific set of SNAREs is thus
important in membrane traffic. The function of SNAREs is
regulated primarily through targeting/sorting of specific
SNAREs to defined subcellular compartments and/or transport
intermediates (8–10). Additional regulations may be mediated
by interacting with sequestering/inhibitory factors (15) and/or
phosphorylation (16). The physiological relevance of SNARE
targeting/trafficking is reflected by several studies (17–20)
showing the importance of SNARE targeting motifs in various
cellular functions of SNARE. The demonstration that a spec-
trum of transport machinery proteins participates in SNARE
trafficking further sustains the importance of SNARE target-
ing/trafficking in cellular physiology (21–23). For example, the
trafficking signals of Vamp2/synaptobrevin2 are well defined
(24–25), and only wild-type Vamp2, but not mutants defective
in proper trafficking, could support regulated secretion when
the endogenous protein was inactivated (17–18). Similarly,
only wild-type but not endocytosis-defective Vamp2 could sup-
port axonal polarization of developing neurons (19). Snc1p is a
yeast Vamp involved in exocytic transport from the late Golgi
to the plasma membrane as well as in endocytosis (26–27). The
trafficking of Snc1p is crucial for its function and involves
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and Research (A*Star), Singapore. The costs of publication of this
article were defrayed in part by the payment of page charges. This
article must therefore be hereby marked “advertisement” in accordance
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1 The abbreviations used are: SNAREs, soluble NSF attachment pro-
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Introduction
Protein transport in the secretory and endocytic pathways is
mediated by membrane-enclosed intermediates in the form of
small vesicles or larger containers. These shuttling vehicles are
generated from a donor compartment and delivered to the
target compartment. After a process referred to as tethering,
these intermediates are docked and then fused with the target
compartment in a process catalyzed by SNARE (soluble N-
ethyl maleimide sensitive factor adaptor protein receptor)
(Söllner et al., 1993; McNew et al., 2000; Bonifacino and
Glick, 2004; Hong, 2005). SNARE-mediated fusion of
vesicles/containers with a target compartment is evolutionally
conserved from yeast to human and is used in diverse
transports in the secretory and endocytic pathways (Weimbs et
al., 1997; Fasshauer et al., 1998; Hong, 2005). For a given
transport, v-SNARE associated with the vesicle interacts with
t-SNARE on the target compartment to form a trans-SNARE
complex between two apposing membranes (Sutton et al.,
1998; Weber et al., 1998; Antonin et al., 2002). t-SNARE
generally consists of a heavy chain and two light chains, thus
providing three SNARE motifs (Fukuda et al., 2000; Hong,
2005). During the formation of a typical trans-SNARE
complex, the four SNARE motifs (one from v-SNARE and
three from t-SNARE) assemble into a four-helical bundle to
catalyze the fusion event (Söllner et al., 1993; Weber et al.,
1998; Bock et al., 2001; Chen and Scheller, 2001; Antonin et
al., 2002; Jahn et al., 2003).
The function of SNAREs is best defined for exocytosis of
synaptic vesicles. Fusion of synaptic vesicles with the
presynaptic membrane of neurons is mediated by interaction
of VAMP2/synaptobrevin as a v-SNARE with a t-SNARE
assembled from syntaxin1 and SNAP-25 (Söllner et al., 1993;
Sutton et al., 1998; Jahn et al., 2003; Sudhof, 2004). Syntaxin1
and VAMP2 have one SNARE motif each, whereas SNAP-25
has two tandem SNARE motifs. The structure resolved by x-
ray crystallography revealed that the four-helical bundle
assembled from the four SNARE motifs is characterized by 16
layers of mostly hydrophobic interactions between amino acid
side chains (Sutton et al., 1998; Antonin et al., 2002). The
central zero layer is defined by a cluster of hydrophilic
interactions between three Gln (Q) residues (derived from t-
SNARE) and one Arg (R) residue (derived from v-SNARE).
Based on the residue predicted to reside at the zero layer,
SNAREs can be classified into either Q-SNAREs or R-
SNAREs (Fasshauer et al., 1998). After membrane fusion, the
SNARE complex becomes a cis complex in the target
compartment and is disassembled into free v-SNARE and t-
SNARE subunits via the action of NSF (N-ethylmaleimide-
sensitive factor) and -SNAP (soluble N-ethylmaleimide-
sensitive factor attachment protein). The v-SNARE is generally
recycled back to the donor compartment, whereas the t-
SNARE subunits are reused for the next rounds of fusion (Hohl
et al., 1998; Wimmer et al., 2001; Marz et al., 2003).
Most of the nine known R-SNAREs (Sec22b, Ykt6,
VAMP1, VAMP2, VAMP3/cellubrevin, VAMP4, VAMP5,
VAMP7/Ti-VAMP, VAMP8/endobrevin) function as v-
VAMP4 is enriched in the trans-Golgi network (TGN) and
functions in traffic from the early and recycling endosomes
to the TGN, but its trafficking itinerary is unknown. Cells
stably expressing TGN-enriched VAMP4 C-terminally-
tagged with EGFP (VAMP4-EGFP) are able to internalize
and transport EGFP antibody efficiently to the TGN,
suggesting that VAMP4-EGFP cycles between the cell
surface and the TGN. The N-terminal extension of VAMP4
endows a chimeric VAMP5 with the ability to cycle from
the surface to the TGN. Detailed time-course analysis of
EGFP antibody transport to the TGN as well as
pharmacological and thermal perturbation experiments
suggest that VAMP4-EGFP is endocytosed by clathrin-
dependent pathways and is delivered to the sorting and
then recycling endosomes. This is followed by a direct
transport to the TGN, without going through the late
endosome. The di-Leu motif of the TGN-targeting signal is
important for internalization, whereas the acidic cluster is
crucial for efficient delivery of internalized antibody from
the endosome to the TGN. These results suggest that the
TGN-targeting signal of VAMP4 mediates the efficient
recycling of VAMP4 from the cell surface to the TGN via
the sorting and recycling endosomes, thus conferring
steady-state enrichment of VAMP4 at the TGN.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/120/6/929/DC1
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Membrane targeting
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